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Summary
Ribonucleotide reductase catalyses the reduction of ribonucleoside diphosphates to
deoxyribonucleoside diphosphates, this enzyme plays a central role in nucleotide
metabolism and is essential for DNA replication. Herpes simplex virus type 1 (HSV-1)
ribonucleotide reductase is composed of two subunits, a 136kDa large subunit (Rl) and a
36kDa small subunit (R2). The large subunits of the herpes simplex (typel and type2)
members of the alphaherpesvirus family are unusual in that they have a 325 amino
terminal extension which shows no homology to any other reductase large subunit
sequenced (Nikas et aL, 1986). Both HSV-1 Rl(Conner et al., 1992b) and HSV-2
Rl(Chung et al, 1989; Chung et al, 1990) autophosphorylate and in HSV-2 Rl the
autophosphorylating activity maps to the unique amino terminal region (Luo et al, 1991;
Ali et al, 1991). The herpes simplex viruses are similar in many aspects, their pathology
is similar and both are neurotropic, becoming latent in sensory ganglia. These similarities
are reflected in the conservation of genes between the two types. Pri^nrv sp.nuences of
(corresponding
all the HSV-1 genes has been determined (McGeoch et al, 1988) andj in tne n a  v-2 genes 
sequenced a high degree of homology has been noted. R l is unusual in that it shows a 
varying degree of conservation, with a carboxy terminal portion which is 80% conserved 
between HSV-1 and HSV-2 and an amino terminal region which shows only 38% 
conservation. The lack of conservation of this region raised the question of how the 
autophosphorylating/kinase activities of the two differ.
To determine if this lack of conservation explains the differences that were observed in
both the autophosphorylating and transphosphorylating activities of HSV-1 and HSV-2
Rl, HSV-2 Rl was overexpressed in E.coli and purified to apparent homogeneity using
the same expression system and purification scheme used for HSV-1 Rl. Analysis of
E.coli expressed HSV-2 Rl showed that it has properties similar to those described for
HSV-1 Rl (Conneretal., 1992b). Autophosphorylation of HSV-2 Rl is similar to that of
HSV-1 Rl in its stimulation by basic polypeptides. Like HSV-1 Rl the HSV-2 large
subunit is susceptible to proteolytic cleavage. Proteolytic cleavage products of a similar
Mwt arp. observed in type 1 and type 2 Rl extracts. Previously it has been shown that 
portions of the
removal ojamino terminal region of HSV-1 Rl did not affect in vitro reductase activity. 
Cleavage may be important in the modulation of the amino terminal-associated activity 
allowing it to interact with and modulate the activities of other proteins. In contrast to 
previous observations (Chung et al, 1989), transphosphorylation of histones by the HSV- 
2 Rl expressed in E.coli was not observed. That HSV-2 or HSV-1 Rl do not 
transphosphorylate can not be ruled out as the substrate may be very specific, protein 
kinases can have very specific substrates, it is also possible that a co-factor is required to
Summary
promote transphosphorylation.
The unique amino terminal region of HSV-1 Rl, like that of HSV-2 Rl, contains the 
intrinsic autophosphorylating activity. Mutations were made in HSV-1 Rl to localise and 
identify regions of R l important in its autophosphorylating activity. The 
autophosphorylating activity was shown to reside within the first 257 amino acids of 
HSV-1, at least 70 amino acids of the unique region of Rl can be deleted without 
affecting the ability of this region to autophosphorylate. Mutation of the amino terminal 
region of Rl has identified regions which when mutated by the insertion of a linker either 
increase |or decrease the autophosphorylating activity. An increased 
autophosphorylating activity was observed with two independent insertion mutants 
located within a similar region. This region may function normally to down-regulate the 
autophosphorylating activity possibly by masking sites of catalytic importance or sites of 
autophosphoryation, a conformational change may normally be required to overcome this 
inhibitory region. A deletion mutant mapping to the insertion sites at which increased 
autophosphorylation was observed also had increased autophosphorylating activity, 
providing further evidence that sequences downstream of these residues are involved in 
the control of the autophosphorylating activity.
Insertions which decrease activity map to regions upstream of the proposed nucleotide
binding site of the unique amino terminal region, it has been postulated that this region in
| an (component
the HSV-2 Rl amino terminus lS^mportant^t a stable kinase doamin (Luo and Aurelian, 
1991). A secondary structure prediction by Nikas et al., (1986) showed that this region 
may form a compact hydrophobic p-sheet structure. Mutation of this region may simply 
lead to a decreased activity by the destabilisation of a region structurally important. An 
internal deletion mutant, which removes 93 amino acids of the unique region completely 
destroys activity, sites of either catalytic importance or sites of phosphorylation map to 
within this region.
Comparison of the localisation of the amino terminal region in stably transfected cell 
lines with the localisation of full length Rl in infected cells showed that the localisations 
are similar, although in the cell lines the pattern of localisation was more defined, being 
almost exclusively cytoplasmic, | with some nuclear localisation being observed The 
reductase and kinase regions of HSV-1 Rl do not appear to have different subcellular 
localisations. Preliminary analysis of the ability of HSV-1 to replicate in cell lines 
expressing the amino terminal region suggest that this region may impair virus 
replication. Further analysis is required to determine how replication is blocked.
The unique region of HSV Rl may have a function in the pathogenicity of these viruses 
the unusual pattern of expression of the large subunit mediated by an unusual promoter 
region may allow Rl to be expressed in the absence of anjj de novo gene expression.
Summary
Cleavage may be important in releasing the amino terminal region from the reductase 
portion of Rl allowing it to interact with other proteins and the autophosphorylating 
activity may allow this region to be self-regulatory. An autophosphorylating activity has 
been described for a protein which does not function as a protein kinase and this activity 
is thought to be a way in which this protein regulates its own function (Csermely et al.,
1991). The autophosphorylation of Rl may be important in the regulation of a non­
kinase activity. The role of the unique region in the virus life cycle will be determined by 
the construction of a mutant in which this region has been deleted.
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Chapter 1. Introduction
1A Herpesvirus biology
1A.1 The herpesviruses 
1A.1.1 Classification
The Herpesviridae are a large and diverse family of viruses, at least seven of which are 
known to infect humans (Roizman, 1990). Initial classification of herpesviruses was made 
according to the virus host range, duration of the reproductive cycle, the cytopathology of 
the virus and the characteristics of the latent infection (Roizman and Furlong, 1974). More 
recently, herpesviruses have been re-classified according to their genome structure 
(Roizman, 1982) see Figure 1A.1.
Alpha-herpesviruses e.g. HSV-1, HSV-2 and VZV
This class of herpesviruses has a varied host range both in vivo and in vitro some have a 
wide host range others are more restricted. The reproductive life cycle is short. These 
viruses are very cytopathic, infection spreading rapidly in tissue culture. The majority of 
this class form latent infections in sensory ganglia.
Beta-herpesviruses e.g. HCMV
The in vivo host range of this class is very narrow, frequently species and genus restricted. 
In vitro and in vivo these viruses are not very cytopathic, the virus replicates slowly and 
infected cells become enlarged (cytomeglia). Viral DNA can remain stable in both the 
nucleus and the cytoplasm of the cell allowing establishment of cells carrying viral DNA. 
Latency occurs in secretory glands, lymphoreticular cells and kidneys.
Gamma-herpesviruses e.g EBV
Like beta-herpesviruses this class is very host restricted, replication occurring only in the 
same host family to which the virus belongs. Replication in vitro can occur in 
lymphoblastoid cells, lytic replication is observed in some epithelial and fibroblast cells. 
The viruses tend to be specific for B- or T- lymphocytes. In lymphocytes replication is
1
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often blocked at a prelytic stage, the viral genome persisting in the cell with minimum viral 
gene expression, cell death occurs without virus production. The replicative cycle and 
cytopathogenicity of this family of herpesviruses is variable. Latency is established in 
lymphoid tissue.
Analysis of the complete genome of the herpesvirus channel catfish virus showed that this 
virus, originally thought to belong to the alphaherpesvirus family belongs to a new 
taxonomic group (Davison, 1992).
Virus no. of isomers genome
type
CCV 1
HVS 1
EBV 1
VZV 2
HSV 4
MCMV 1
l = >
C
D
Figure 1A.1 Classification of herpesviruses according to genome arrangement.
Examples of genomes types A to F are channel catfish virus (CCV), herpesvirus saimiri (HVS), Epstein-Barr 
virus (EBV), varicella-zoster virus (VZV), herpes simplex virus (HSV) and murine cytomegalovirus 
(MCMV) respectively. Unique sequences in the genomes are shown as lines, arrowed lines show possible 
inversions. Open boxes are large (> 1Kb) repeats, shaded boxes are repeats of small reiterated sequences: 
arrows above the boxes denote whether repeats are direct or inverted. The small terminal direct and internal 
inverted repeats of HSV (the “a” sequences) are indicated. The number of possible isomers of each molecule 
are also given.1 (Reproduced from Roizman, 1982)
1A.1.2 Pathogenicity of the human herpesviruses
Herpesviruses cause a range of clinical disorders, some of which are described below.
HSV-1 causes vesicular lesions of the mouth, lips and nasal membranes, ocular keratitis 
and occasionally more severe symptoms such as encephalitis, particularly in 
immunocompromised individuals (Smith et al, 1941; Gallardo, 1943; Rawls, 1985).
HSV-2 is the main agent of sexually transmitted genital herpes. It is closely related to 
HSV-1 and some overlaps in their clinical manifestations occur (Whitley, 1985). HSV-2
2
* Vmwl75 was shown to specifically be associated with light particles (virions which lack a 
nucleocapsid) and not virions by Szilagyi and Cunningham (1991), it can therefore be concluded 
that the association of Vmwl75 with virions described by Yao and Courtney (1989) was due to 
contaminating light particles in the virion preparations.
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has also been implicated in the aetiology of cervical cancer. HSV-1 and HSV-2 often 
establish latency in trigeminal and sacral ganglia respectively, the periodic recurrence of 
lytic infection leading to outbreaks of lesions at peripheral sites (Klein, 1982; Knox et al, 
1982; Hill, 1985).
VZV is the causative agent for chickenpox (varicella), a disease resulting from primary 
infection normally found in children, and of shingles (herpes zoster), a localised vesicular 
condition occurring in adults which appears to be caused by reactivated, latent VZV 
(Weller et al, 1958;Gleib, 1985).
HCMV infections can cause complications in immunosuppressed individuals and in 
patients with acquired immune deficiency syndrome (AIDS). It is also sometimes 
associated with neurological damage in neonates (Alford and Britt, 1984). Infection of the 
vast majority of the human population, however, results only in a mild, sub-clinical 
condition.
EBV infects B-lymphocytes and is the causative agent of infectious mononucleosis. It is 
associated with! Burkitt’s lymphoma, nasopharyngeal carcinoma and jlymphomas in 
immunosuppressed individuals (Neiderman et al, 1976; Miller 1985).
HHV6 was first isolated from immunosuppressed patients but it can infect T-cells in vitro 
(Salahudin et al, 1986). It is linked to the childhood illness exanthum subitum (Roseala 
infantum; Yamanishi etal., 1988).
HHV7 is present in CD4+T cells and is purified from peripheral blood mononuclear cells 
under conditions promoting T-cell activation (Frenkel et al, 1990). The role of HHV7 in 
human disease is, as yet, unknown.
1A.1.3 Virus Structure
All herpesviruses have a similar structure: an outer lipid membrane surrounds an
amorphous, proteinaceous structure known as the tegument; the tegument in turn surrounds
the icosahedral nucleocapsid (Roizman and Furlong, 1974). The virus envelope contains at
least eight virus-encoded glycoproteins. The tegument is the least well defined part of the
virion, several virus proteins have been shown to be associated with this part of the virus:
the immediate early gene transactivator Vmw65 (Batterson and Roizman, 1983); the early\ ^
gene transactivators Vmwl75^Yao and Courtney, 1989) and VmwllO (Yao and Courtney,
1992), the host shut-off protein (UL41) which down regulates host cell protein synthesis 
(Kwong et al, 1988) and the protein kinase encoded by UL13 (Cunningham et a l, 1992).
3
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Seven virus encoded proteins form the nucleocapsid, a structure composed of 150 
hexameric and 12 pentameric capsomers, see Figure 1A.2.
Figure 1A.2 The structure of HSV-1. The virion is composed of three main components a) shows 
the nucleocapsid surrounding the virus genome, b) shows the virus tegument and c) shows die outer lipid 
membrane.
1A.1.4 HSV-1 genome organisation
The genome of HSV-1 is a linear duplex DNA molecule (Becker et al., 1968; Roizman and 
Furlong, 1974) with a molecular weight of 152Kb (McGeoch et al, 1988). The HSV-1 
genome is composed of two covalently linked segments, long (L) and short (S), each 
flanked by inverted repeat sequences (R); terminal (TRL or TRS) or internal (IRL or IRS), 
(Sheldrick and Berthelot, 1974). The inverted repeats RL and RS share a 400bp a 
sequence (McGeoch et al, 1988) which is the minimum terminal repetitive sequence 
required for optimal circularisation (Wadsworth et al, 1975). One or more copies of the a 
sequence are located internally at the joint between the long and short segments in the 
opposite orientation to the terminal a sequence (Sheldrick and Berthelot, 1974; Wadsworth 
e ta l, 1975; Wagner and Summers, 1978).
The HSV-1 genome exists as four isomers (Figure 1A.3), present in equimolar amounts in 
virus DNA preparations (Delius and Clements, 1976; Wilkie, 1976). The a sequence was 
originally thought to mediate isomerisation but mutants which lack an a sequence can also 
recombine indicating that the a sequence is not essential for genome recombination 
(Varmuza and Smiley, 1985; Weber eta l, 1988).
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Figure 1A.3 Isomers of HSV-1. The “a” sequence present as a direct repeat at the termini of the 
genome and, in an inverted orientation, at the L-S junction allows the HSV-1 genome to rearrange into four 
possible isomers. The four isomers shown are present in equimolar amounts and are designated P 
(prototype), IS (inverted short), IL (inverted long) and ILS (inverted L and S).j (Reproduced from McGeoch, 1987)
1A.1.5 HSV-1 gene arrangement
The complete sequence of HSV-1 has been determined (McGeoch e ta l . 1988) giving a 
total genome length of 152260 residues. The genome has a high G+C content of 68.3% 
ranging from 64% in US to 80% in RS. To date/74 open reading frames have been 
identified. Functions are known for several HSV-1 genes and predictions have been made 
about function of others by the comparison of their predicted amino acid sequence with the 
sequences of proteins of known function. The majority of the open reading frames, 56, are 
located in the unique long region (UL) of the HSV-1 genome. All the genes involved in 
viral DNA replication and nucleotide metabolism map to the unique long region. Of th^ 13 
open reading frames located within the unique short region (US) the majority, 8, are 
associated with the virion. The open reading frames for the transactivators |Vmwl75 and 
I Vmwl 10 are located in the repeat regions flanking the unique short region (RS) and unique 
long region (RL) respectively. One recently identified gene, RL1, which encodes ICP34.5, 
the neurovirulence factor (McGeoch and Barnett, 1991; Chou e ta l , 1990; Chou and 
Roizman, 1992), maps to the internal repeat region its open reading frame bridging the IRS 
and IRL, see Figure 1A.4.
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IE17S
n j i i o IE175
Figure 1A.4 Organisation of genes in HSV-1. The HSV-1 genome is shown on four successive 
lines, unique regions are represented by solid lines and major repeat regions as open boxes. The size and 
orientation of proposed open reading frames (ORFs) are shown by arrows. The origins of replication are also
indicated. (Reproduced with modifications from McGeoch, 1988a)
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T able 1A .1. Properties of HSV-1 encoded proteins (Reproduced from McGeoch et al, 1993)
Genes of HSV-1
gene Function essential
RL1 Neurovirulence factor (ICP34.5) ne
RL2 EE protein; transcriptional regulator (ICPO, VmwllO) ne
UL1 Glycoprotein L; complexes with glycoprotein H (UL22) e?
UL2 Uracil-DNA glycosylase ne
UL3 Function unknown ne
UL4 Function unknown ne
UL5 Component of DNA helicase-primase essential for DNA 
replication
e
UL6 Role in virion morphogenesis (VP11-12?) e
UL7 Function unknown
UL8 Component of DNA helicase-primase complex essential 
for DNA replication
e
UL9 Ori-binding protein essential for DNA replication; DNA 
helicase
e
UL10 Function unknown; probable integral membrane protein ne
UL11 Myristylated tegument protein; role in envelopment 
and transport to nascent virions
ne
UL12 Deoxyribonuclease; role in maturation/packaging of 
nascent DNA
e
UL13 Tegument protein (VP 18.8); probable protein kinase ne
UL14 Function unknown —
UL15 Function unknown; possible NTP-binding motifs e?
UL16 Function unknown ne
UL17 Function unknown e?
UL18 Capsid protein (VP23) —
UL19 Major capsid protein (VP5) e
UL20 Integral membrane protein; role in egress of nascent 
virions
e/ne
UL21 Function unknown —
UL22 Virion surface glycoprotein H; complexes with 
glycoprotein L (UL1); role in cell entry
e
UL23 Thymidine kinase ne
UL24 Function unknown ne
UL25 Virion protein e
UL26 Proteinase, acts in virion maturation; N-terminal portion 
is capsid protein (VP24)
e
UL26.5 Internal protein of immature capsids (VP22A.); processed 
by UL26 proteinase
e
UL27 Virion surface glycoprotein B; role in cell entry e
UL28 Role in capsid maturation/DNA packaging e
UL29 Single-stranded DNA-binding protein essential for DNA 
replication (ICP8)
e
UL30 Catalytic subunit of replicative DNA polymerase; 
complexes with UL42 protein
e
UL31 Function unknown
UL32 Function unknown
UL33 Role in capsid maturation/DNA packaging e
UL34 Membrane-associated phosphoprotein; substrate for US3 
protein kinase
UL35 Capsid protein
UL36 Very large tegument protein (VP1-3, Vmw273) e
UL37 Function unknown; may have DNA-binding role —
UL38 Capsid protein (VP19C) e
UL39 Ribonucleotide reductase large subunit (ICP6, Vmwl36, 
Rl)
e/ne
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Table 1 continued
UL40
UL41
UL42
UL43
UL44
UL45
UL46
UL47
UL48
UL49
UL49A
UL50
UL51
UL52
UL53
UL54
UL55
UL56
LAT
RSI 
US1 
US2 
US3 
US4 
US5 
US6 
US7 
* US8 
US9 
US 10 
US11 
US 12
Ribonucleotide reductase small subunit (Vmw38, R2) e/ne
Virion protein; host shutoff factor ne
Subunit of replicative DNA polymerase; increases e
processivity; complexes with UL30 protein 
Function unknown; probable integral membrane protein ne
Virion surface glycoprotein C; role in cell entry ne
Virion protein ne
Modulates IE gene transactivation by UL48 protein ne
Tegument protein (VP13-14?); modulates IE gene ne
transactivation by UL48 protein
Major tegument protein; transactivates IE genes (VP16, e
Vmw65, aTIF)
Tegument protein (VP22) —
Possible membrane glycoprotein e?
Deoxyuridine triphosphate ne
Function unknown ± e
Component of DNA helicase-primase complex essential e
for DNA replication
Glycoprotein K e?
IE protein; post-translational regulator of gene expression e
(ICP27, Vmw63)
Function unknown ne
Function unknown ne
Family of transcripts, some extending into Rs, expressed ne
in latency; function unknown; protein coding capacity 
uncertain
IE protein; transcriptional regulator (ICP4, Vmw 175) e
IE protein; function unknown (ICP22, Vmw68) e/ne
Function unknown ne
Protein kinase; phosphorylates UL34 ne
Virion surface glycoprotein G ne
Virion surface glycoprotein J? ne
Virion surface glycoprotein D; role in cell entry e
Virion surface glycoprotein I ne
Virion surface glycoprotein E ne
Virion protein ne
Virion protein ne
Virion protein; ribosome-associated in infected cell ne
IE protein; function unknown (ICP47, Vmw 12) ne
UL49.5
US8.5
Membrane protein 
Function unknown
1A.2 Entry of HSV-1 into cells
ne
ne
Entry of HSV-1 into cells is pH independent (Wittels and Spear, 1991) indicating that the 
entry of HSV-1 does not occur by endocytosis. Currently, it is believed that HSV-1 enters 
the cell by the direct fusion of the virion envelope with the plasma membrane. Several 
studies have identified virion components involved in the attachment of the virus to the 
cell and the subsequent penetration of the virus. As yet no specific receptor, other than the 
cell surface proteoglycan heparin sulphate, involved in the interaction with either HSV-1, 
or HSV-2, has been identified, both viruses have a wide host range, the receptor involved 
is likely a common cell receptor.
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1 A. 2.1 Attachment of virus to cell
Initial attachment to the cell surface is dependent on two virus glycoproteins, gC and gB, 
and a common cell surface proteoglycan, heparin sulphate (Herold et al., 1992). Heparin 
inhibits the binding of HSV-1 to cells (WuDunn and Spear, 1989; Shieh et aL, 1992). Two 
cell lines resistant to infection by HSV-1 have been isolated both contain mutations in the 
pathway involved in heparin sulphate synthesis (Shieh et aL, 1992: Gruenheid et al.,
1993). Adsorption of HSV-1 to these lines is drastically reduced demonstrating the 
importance of heparin sulphate in attachment of virus to the plasma membrane.
Binding of the viral glycoproteins gB, gC and gH to the cell surface was demonstrated by 
affinity purification of cellular membrane proteins labelled with biotin (Kuhn et al, 1990). 
Biotinylated cell surface proteins were affinity purified with avidin, incubated with virion 
lysates and viral proteins interacting with the cell surface proteins were identified by 
Western blot analysis using an HSV-1 specific rabbit antisera. The Mwts of the proteins 
interacting with the cell surface proteins were found to correspond to the virus 
glycoproteins gB, gC and gH, the identity of these proteins was confirmed using mono- 
specific antisera raised against gB, gC and gH.
Initial attachment is mediated by the virus glycoprotein gC. Interactions between gC and 
heparin have been demonstrated; gC can be purified on heparin affinity columns (Shieh et 
al., 1992). An HSV-1 mutant in gC shows an impaired ability to bind to cells (Herold et 
al., 1991). Further evidence for the role of gC in the initial attachment of the virus to the 
cell came from analysis of spontaneous mutants which were resistant to neomycin, a drug 
which interferes with the binding of virus to the cell (Langeland et a l, 1987); all 
neomycin resistant strains contained alterations in the gC open reading frame (Langeland 
et al., 1990; Campadelli-Fiume et al., 1990) Virus infection can be neutralised by anti-gC 
antibodies (Svennerholm et al., 1991; Fuller and Spear, 1985). The glycoproteins, gB and 
gH, also play a role in virus penetration of the cell. Mutants in gC show impaired binding 
to the cell, in the absence of gC, cell binding can be partially complemented by gB, 
another glycoprotein which interacts with heparin (Kuhn et al, 1990).
1 A.2.2 Penetration of cell membrane
HSV-1 mutants have been isolated which bind to the cell surface but fail to penetrate the 
plasma membrane; mutants in gD bind to the cell membrane but fail to penetrate (Ligas 
and Johnson, 1988; Johnson and Ligas, 1988). Glycoprotein D is essential for virus-cell 
membrane fusion and for the fusion (syncytia) of infected cells. In addition, gB is involved 
in membrane fusion, mutation of this gene demonstrated directly the role of this
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glycoprotein on viral penetration, mutants become attached to the cell but fail to penetrate 
(Cai et a l, 1987). Mutation of gH inhibits virus penetration of the cell but not the 
attachment of the virus to the cell (Forrester et al, 1992).
1A.3 The HSV-1 regulatory cascade
HSV-1 genes fall into three temporal classes whose expression is co-ordinately regulated 
and sequentially ordered in a cascade fashion (Honess and Roizman, 1974). The five 
immediate early genes; IE1, IE2, IE3, IE4 and IE5 and the large subunit!of ribonucleotide 
reductase are the first genes to be transcribed after infection (Clements et al., 1977). 
Transcription of all the immediate early genes with the exception of Vmwl 10 (Godowaski 
and Knipe, 1985;Weinheimer and McKnight, 1987) is then down regulated in response to 
synthesis of IE3 (Vmwl75) (O’Hare and Hayward, 1985b; Beard e ta l , 1986; Gelman and 
Silverstein, 1987; Roberts et al, 1988). Expression of Vmwl75, the major regulatory 
protein of the virus, is continuously required for expression of early genes (Dixon and 
Schaffer, 1980; Preston, 1979; Watson and Clements, 1978; 1980). Finally, once DNA 
replication has been initiated, late genes are expressed (Holland et a l, 1980). Optimal 
levels of late gene expression require the presence of both Vmw 175 and Vmw63 
(McCarthy et a l, 1989; McMahan and Schaffer, 1990; Rice and Knipe, 1988; Su and 
Knipe, 1989; Sacks et a l, 1985). Late gene products are mainly structural polypeptides. 
The regulatory cascade of HSV-1 is shown in Figure 1A.5.
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Figure 1A.5 HSV-1 regulatory cascade. Gene expression in HSV-1  falls into three distinct 
classes, immediate early (IE) gene expression is stimulated by the virion protein Vmw65. Following 
expression of the immediate early gene product, Vmw 175, early (E) gene expression is initiated. Finally 
once DNA replication has been initiated the late (L) genes are expressed. The down regulation of immpHiate 
early gene expression by Vmw 175 is also shown.
(Reproduced with modifications from an original diagram by R. D. Everett)
1 A.3.1 Immediate early gene expression 
1A.3.1.1 Cis-acting sequences.
(a) TAATGARATWmw65
Vmw65 is a component of the HSV-1 virion which specifically up-regulates transcription 
from HSV-1 immediate early promoters. Fusion of the promoters of immediate early 
genes to the HSV thymidine kinase gene showed that increases in tk activity was i^ow 
independent of synthesis of viral gene products (Post et al., 1981). Mutants incapable of 
releasing viral DNA have immediate early transactivating activity, indicating that the 
transactivator was located in the virion tegument (Batterson and Roizman, 1983). The
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virion component responsible for immediate early transactivation, Vmw65, was identified 
(Campbell et al, 1984) and found to be present in significant quantities, between 500-1000 
molecules per virion (Heine et a l ., 1974). The upstream element which responds to 
Vmw65 transactivation of immediate early genes was identified by sequence comparison ( 
Mackem and Roizman, 1982a,b; Whitton and Clements, 1984). The sequence 
TAATGARAT appears in several copies upstream of the immediate early genes in both 
HSV-1 and HSV-2, and confers Vmw65 inducibility to otherwise non-responsive genes 
(Preston et al, 1984; Bzik and Preston, 1986).
Vmw65 alone does not interact with DNA (McKnight et al, 1987; Marsden et a l ., 1987). 
Reports by O’Hare and Goding, (1988) and Preston et al, (1988) described the 
identification of the cellular component which mediates transactivation of immediate early 
genes by Vmw65. The cellular factor, Oct-1, belongs to the pou homeodomain family of 
transcription factors (Herr et a l, 1988; O’Hare et a l, 1988). A closely related 
homeodomain protein Oct-2 interacts with the TAATGARAT element but fails to produce 
Vmw65 specific transactivation, demonstrating the specificity of the Vmw65/Oct-l 
interaction (Gerster and Roeder, 1988; apRyhs et al, 1989). A third, recently purified 
(Kristie and Sharp, 1993) and cloned cellular factor (Wilson et al, 1993), is important in 
the TAATGARAT complex formation, this factor, HCF (Gerster and Roeder, 1988;jKristie 
et al, 1989; Xiao and Capone, 1990; Katan et al, 1990), promotes assembly of Vmw65 in 
the transactivating complex. HCF interacts with Vmw65 and brings the virus 
transactivator to the target TAATGARAT site whereupon binding of Oct-1 the fully 
functional complex is formed.
Transactivation by Vmw65
The carboxy terminal acidic tail, a region of 79 amino acids, forms the transcriptional 
activation domain of Vmw65 (Ace et al, 1988; Cousens et al, 1989; Greaves and O’Hare, 
1989; Treizenberg et al, 1988a). This region when coupled to the DNA binding domain of 
Gal 4 produces similar levels of transactivation to the HSV-1 TAATGARAT/Oct- 
1/HCF/Vmw65 complex (Sadowski et al., 1988). The 79 amino acid transactivation 
domain of Vmw65 can be further separated into two functionally distinct regions (Reiger et 
a l ., 1993; Walker et al, 1993), the N- and C-terminal portions of the transactivation 
domain (which each form a predicted helical structure). Both the N- and C-terminal 
regions function as transcriptional activators (Walker et al, 1993), full activity requiring 
both. Interactions between the Vmw65 transactivation domain and the basal transcription 
factor TFIIB have been demonstrated (Lin and Green, 1991; Lin et a l, 1991). The 
interaction between TFIIB and Vmw65 is not sufficient for full activation , in vitro 
transcription assays demonstrated that a factor associated with the TF11D complex (TBP) is 
required for full activity (Brou et al, 1993; Tanese et al, 1991). A TAF (transcriptional
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activating factor), a factor which mediates the effect of an upstream activator on the pre­
initiation complex, TAFII40 from Drosophilla, interacts with the TFIIB/Vmw65 complex 
(Goodrich et al., 1993), see Figure 1A. 6. Studies by Walker et al., (1993) identified a 
135kDa polypeptide which appears to be specifically associated with the activation 
domain, possibly another TAF; Goodrich et al., (1993) have proposed that there may be 
another TAF interaction.
Figure 1A.6 Interactions between Vmw65 and the basal transcription machinery.
Vmw65 interactions with the basal transcription machinery and the upstream activator Oct-1, interactions 
between Vmw65 and TFIIB and TAFII40 are also shown. (Modification of diagram by Goodrich et al., 1993)
1 A.3.1.3 GA-rich motifs/ ets binding proteins
In addition to the TAATGARAT element which mediates the response to Vmw65 
(Preston and Tanhill, 1984; Bzik and Preston, 1986) an additional GA-rich motif is 
important in immediate early gene expression, as shown for the expression of Vmwl75 
(Triezenberg et al, 1988b). Analysis of the upstream region of Vm wl75 identified an 
element, a hexamer, GCGGAA, which, in addition to TAATGARAT, is required for 
optimal levels of Vmw 175 expression. The proteins binding to this element belong to the 
ets family of DNA binding proteins. The interaction with the Vmw 175 upstream region 
involves two distinct proteins, a DNA binding protein G ABPa and a transactivating 
protein GABPp (LaMarco et al., 1991; Thompson et al., 1991). Regions which bind 
G ABPa and GAPBp are also found upstream of IE110, IE63 and IE68/12. Formation of 
the IEC (Vmw65/Oct-l/HCF) is essential for mediating a response to Vmw65, GABPa 
and GABPp promote the formation of the IEC on TAATGARAT. The distance separating 
the TAATGARAT from the GA rich motif determines the ability of the GA-rich binding 
proteins (GABPa and GABPp) to promote IEC formation. The orientation of the GA-rich 
motif is also important (Bailey and Thompson, 1992).
TAFs
TATA
TAATGARA'
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1A.3.2 Immediate early gene products
The immediate early genes of HSV-1 are transcribed in the absence of viral gene 
expression (Honess and Roizman, 1974; Clements et al., 1977). Five immediate early 
genes have been identified; IE-1, IE-2, IE-3, IE-4 and IE-5. The expression of these genes 
and the functions of the gene products will be described in the following Sections.
Glasgow nomenclature Chicago nomenclature
Gene Product Gene Product
IE-1/IE110 VmwllO a0 ICPO
IE-2/UL54 Vmw63 a l l ICP27
IE-3/IE175 Vmwl75 a4 ICP4
IE-4/US1 Vmw68 a l l ICP22
IE-5/US12 Vmwl2 a47 ICP47
Table 1A.2 Nomenclature of HSV-1 immediate early genes and their products.
1A.3.2 1 Vmwl75
Vmwl75 is a large, phosphorylated, nuclear-localised protein (Pereira etal., 1977) which 
exists as a homodimer (Metzler and Wilcox, 1985), and is essential for viral replication, 
being continuously required for early and late gene expression (Preston, 1979; Watson and 
Clements, 1980). Vmwl75 is also important in the autoregulation of IE gene expression, 
O’Hare and Hayward (1985b) showed that Vmwl75 can repress both basal and Vmw65 
induced expression from the Vmw 175 promoter.
Comparison of HSV-1 Vmwl75 with the VZV homologue lead to the identification of five 
conserved structural regions, regions 2 and 4 showing the greatest homology (McGeoch et 
al; 1986; Davison and McGeoch, 1986). Regions of Vmw 175 important in the 
transactivation of early and late gene expression and for repression of immediate early 
gene expression have been mapped by insertional and deletion mutagenesis (Paterson and 
Everett, 1988). Mutation of region 2 showed this region was important in both the 
transactivation of the early genes, in the synergy with Vmw 110 and the repression of 
immediate early gene expression. Mutation of region 4 also affected the transactivation of 
early genes in the presence of Vmwl 10.
14
Chapter 1. Introduction
Transactivation by Vmw 175
Transactivation by Vmw 175 is observed with promoters in which the only recognisable 
cis-acting element is the TATA box (Imbalzano et a l , 1991; Mavromara-Nazos et a l , 
1986; Shapira et al, 1987). Several studies have investigated the interaction of Vmwl75 
with the early promoters, tk (Papavassilou and Silverstein, 1990; Kristie and Roizman, 
1986) and gD (Everett, 1984; Tedder et al, 1989; Faber and Wilcox, 1986). Conflicting 
results were obtained, although Vmw 175 interacts with the tk promoter, no specific contact 
sites, as described for the gD promoter, were identified. These observations led to the 
proposal that Vmw 175 may mediate transactivation by directly contacting the basal 
transcription apparatus (RNA pol II and the TFll factors which recruit pol n  to the TATA 
box). Vmwl75 can restore activity to a promoter in which upstream activator sequences 
have been deleted (Imbalzano et al, 1991). A cellular globin gene inserted into the tk 
locus of HSV-1 (Panning and Smiley, 1989) behaves like a virus early gene during 
infection; it was later demonstrated that expression of the globin gene was dependent on 
functional Vmw 175, supporting the proposal that early genes do not have a specific cis 
acting element which mediates their transactivation by Vmw 175 (Smiley and Duncan,
1992). Vmwl75 directly contacts two basal factors, TF11D (the TATA binding protein) 
and TFIIB and promotes the formation of a stable preinitiation complex (Smith et al,
1993). Vmwl75 shares properties found in other viral transactivators, adenovirus E1A 
(Lee et al, 1991) and EBV Zta (Lieberman and Berk, 1991), which do not directly contact 
DNA but promote preinitiation complex assembly.
Repression o f immediate early genes
Vmw 175 binds specifically to the sequence ATCGTCNNNYCGRC, found at the site of 
transcript initiation in the immediate early promoters (Faber and Wilcox, 1986). Binding 
to the immediate early promoters of IE1, IE2 (Kristie and Roizman, 1986) as well as to its 
own promoter (Faber and Wilcox, 1988; Katter-Cooley and Wilcox, 1989; Kristie and 
Roizman, 1986; Muller, 1987; O’Hare and Hayward, 1987) has been demonstrated. 
Vmw 175 interaction with the regulatory regions of the immediate early promoters leads to 
the repression of their expression (O’Hare and Hayward, 1985b; Gelman and Silverstein, 
1987a, b). In addition Vmwl75 has been shown to repress the LAT (latency associated 
transcript) promoter (Batchelor and O’Hare, 1990). The mechanism of Vmwl75 
repression was investigated by Gu et al, (1993). In the presence of Vmw 175 SP-1 
activated transcription was inhibited whereas basal transcription was unaffected leading to 
the proposal that repression, like activation, is mediated by contacts with the basal 
transcription complex, which in turn inhibits SP-1 stimulation of transcription, consistent 
with earlier observations that Vmwl75 inhibits Vmw65 activation of immediate early 
promoters (O’Hare and Hayward, 1985b). The interactions of Vmw 175 which promote 
and repress gene expression are shown in Figure 1 A.7.
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Figure 1A.7 Model showing different activities of Vmwl75. a) Shows how Vmw 175
repression of activated transcription may occur by blocking the site of transcription initiation b) Shows how 
the many relatively non-specific Vmwl75 binding sites act to increase the level of transcription via contacts 
with TFIIB by promoting formation of the pre-initiation complex assembly. (Reproduced from Smith et al, 1993)
1A.3.2.2 VmwllO
VmwllO is a llOkDa nuclear phosphoprotein (Ackermann et a l, 1984; Pereira et al., 
1977). Analysis of the function of Vmwl 10 as a transactivator using transient transfection 
assays with reporter constructs showed that VmwllO is a transactivator of all classes of 
virus genes as well as cellular genes (Everett, 1984; Gelman and Silverstein, 1985; Gelman 
and Silverstein, 1986; Mavromara-Nazos et al, 1986; Mosca et al., 1987; Quinalan and 
Knipe, 1985; Sekulovich et a l, 1988). Although not absolutely required for early and late
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gene expression, VmwllO is required for optimal levels of expression, achieved only when 
both VmwllO and Vmwl75 are present (O’Hare and Hayward, 1985a). Mutational 
analysis of VmwllO identified several regions important in function . Mutations fell into 
two categories: those which effect its synergy with Vmw 175 and those which are involved 
in the transactivating activity. Two regions important for the synergy with Vmwl75 were 
identified (Everett, 1989). Removal of the zinc finger of VmwllO, located towards the 
amino terminal region of the protein destroyed transactivating activity (Everett, 1989).
To determine the role of VmwllO in a productive HSV-1 infection, mutants in the 
VmwllO loci have been constructed (Stow and Stow, 1986; Sacks and Schaffer, 1987). 
Mutants lacking VmwllO fail to grow as efficiently as wild-type and replication is host- 
range and multiplicity dependent. To determine the), effect on virus gene expression and 
regions of VmwllO required for its function defined mutations in VmwllO were 
introduced into the virus (Cai and Schaffer, 1992; Chen and Silverstein, 1992). Expression 
of two early gene products, UL29 and the large subunit of ribonucleotide reductase, and 
three late proteins; gB, gC and ICP5, were significantly reduced, confirming that, as found 
in transient transfection assays (O’Hare and Hayward, 1985a), VmwllO is required for 
efficient early and late gene expression. In contrast to transient transfection data, 
immediate early gene expression in the VwmllO mutants was unaffected, Cai and 
Schaffer, (1992) proposed that VmwllO transactivation of immediate early genes is 
significant only in the absence of functional Vmw65. In a similar study Chen and 
Silverstein, (1992) also found that early and late gene expression was decreased in 
VmwllO mutants (lacking a functional zinc finger) and expression of immediate early 
gene, IE63, was reduced.
1A.3.2.3 Vmw63
The immediate early protein Vmw63, like Vmw 175, is essential for virus replication. 
Analysis of the function of Vmw63 in the regulation of HSV-1 gene expression indicated 
its role in post-transcriptional processes (Sandri-Goldin and Mendoza, 1992; McLauchlan 
et al, 1992). HSV-1 mutants in Vmw63 display a number of phenotypes; the expression 
of late gene products is significantly reduced (McCarthy et a l, 1989; McMahan and 
Schaffer, 1990; Rice and Knipe, 1990; Sacks et al, 1985); immediate early gene products 
accumulate (Smith et al, 1992) and DNA synthesis decreases (Sacks et a l, 1985; 
McCarthy et a l, 1989; Rice and Knipe, 1990). To determine the role of Vmw63 in late 
gene expression Smith et a l, (1992) analysed the levels of transcription by comparing the 
rate of initiation of transcription to levels of mRNA and protein. Levels of late gene 
protein and mRNA were reduced in cells infected with the Vmw63 mutant whereas the 
amount of transcript produced (initiated) was unaltered, it was concluded that Vmw63
17
Chapter 1. Introduction
plays a role in the processing of the nascent RNA. Vmw63 plays a role in HSV-1 
transcript polyadenylation, a factor which influences the efficiency of late transcript 
polyadenylation in infected cells (McLauchlan et al, 1989) is absent in cells infected with 
an Vmw63 mutant (McLauchlan et al., 1992). Vmw63 promoter independent activation of 
gene expression has been demonstrated with other viral regulatory sequences (Chapman et 
al., 1992). The localisation of the major DNA binding protein, UL29, into replication 
compartments in infected cells is altered in cells infected with a mutant in Vmw63, 
suggesting a role for Vmw63 in the localisation of UL29 (Curtin and Knipe, 1993).
Defined deletions in Vmw63 mapped regions of Vmw63 required for both its 
transactivating and transrepression activities (McCarthy et al, 1989; Rice and Knipe,
1990). The C-terminal portion of Vmw63 is important in both repression and activation, 
mutants in this region fail to down-regulate early gene expression and activate late gene 
expression (Rice et al, 1993). More defined mutational analysis separated the regions of 
the C-terminus involved in transrepression and transactivation, mutants which affect only 
the transactivation function of Vmw63 have been isolated, all map to the C-terminal 
region, the final 78 amino acids being critical for function (Rice and Lam, 1994). 
Transrepression was affected in some mutants isolated but the affect of the mutation was 
dependent on how it was constructed, substitution mutations in the C-terminal region 
which destroys transactivation but not transrepression have been isolated, whereas an 
insertional mutation at the same site destroys both activities (Rice and Lam, 1994). 
Mutation of the amino terminal portion of Vmw63 reduces the efficiency of viral DNA 
replication (Rice etal., 1993).
1 A.3.3 Early gene expression
Early gene expression peaks between 5-7 hr post-infection and is dependent on the 
presence of the immediate early transactivator Vmw 175 (Preston, 1979; Watson and 
Clements, 1977). A functional TATA box is the only cis-acting sequence absolutely 
required for early gene expression (Everett, 1984 ), Vmwl75 transactivation is mediated 
by its direct interaction with the TATA associated initiation complex (Smith et al, 1993). 
Early gene expression is down-regulated upon initiation of DNA replication, Vmw63 plays 
a role in this down-regulation (Sekulovich et al, 1988; McCarthy et a l, 1989; Rice and 
Knipe, 1990; Rice and Knipe, 1994).
1A.3.4 Early gene products
All HSV-1 genes involved in nucleotide metabolism and DNA replication are expressed at 
early times post-infection.
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1A.3.4.1 Enzymes involved in nucleotide provision
The HSV-1 encoded enzymes involved in nucleotide provision are shown below (Figure 
1 A.8), and the importance of these enzymes in viral replication will be discussed.
de novo 
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\  -  \
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DNA
dThd
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DNAdUMP dTMPrCTP rUTP
M-THFRR*
DHF dTDPdCDP dUDP
DHFR
dTTPdCTP dUTPdGTP.TP
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DNA synthesis
Figure 1A.8 Enzymes involved in nucleotide metabolism encoded by HSV-1. RR
(ribonucleotide reductase), DU (dUTPase), tk (thymidine kinase), DN (DNase), and DP (DNA polymerase) 
are all encoded by HSV-1. DHFR (dihydrofolate reductase) is provided by the cell. * encoded by HSV-1. 
(Reproduced from Morrison, 1991)
a) Thymidine kinase
Thymidine kinase (tk) provides dTMP, dCMP and dTDP for DNA synthesis. HSV-1 
thymidine kinase shows a relaxed substrate specificity when compared to the cellular 
enzyme, it can, for example, phosphorylate dCyd (Perera and Morrison, 1970; Jamieson 
and Subak-Sharpe, 1974; Jamieson et al, 1974). Because of the relaxed substrate 
specificity, its potential as an antiviral target was investigated. Elion et al, (1977) showed 
that an acyclic nucleoside analogue, acyloguanosine, was converted to a monophosphate 
by HSV-1 tk, this analogue is an efficient and specific inhibitor of HSV-1 DNA 
polymerase, inhibition occurring by premature chain termination. It is, to date, the only 
low toxicity antiviral known to be effective against HSV. Mutants in tk have been 
isolated, although non-essential for replication in tissue culture, tk mutants have been 
shown to have reduced pathogenicity (Coen et al, 1989; Tenser et al, 1989).
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b) dUTPase
dUTPase catalyses the hydrolyses of dUTP to dUMP and pyrophosphate, reducing dUTP 
pools in the cell. An activity unique to cells infected with HSV-1 was detected (Wohlrab 
and Francke, 1980) which differed from the cellular enzyme in that it has low levels of 
activity on dCTP and dTTP compared to the cellular enzyme (Caradonna and Cheng, 
1981). As found for tk, mutants in dUTPase are viable in cell culture (Fischer and Preston, 
1986), but important in virus pathogenicity (Pyles et al., 1992).
c) DNAse (alkaline nuclease)
An HSV-1 DNAse activity was first noted by Keir and Gold, (1963). The HSV-1 DNAse 
has been purified (Banks et al, 1983) and shown to exist as a phosphorylated monomer 
(Banks et al, 1985; Thomas e ta l, 1988). Its function is to provide nucleotides through 
the degradation of cellular DNA (Nutter et al, 1985). Mutants in the DNAse have been 
isolated, limited replication was observed in tissue culture indicating that it is an essential 
virus function (Moss, 1986). In another DNAse mutant (Weller et al, 1990) the DNAse 
was found to play a role in the egress of capsids from the nucleus, synthesis of viral DNA 
was reduced and the amount of capsids which fail to package DNA was dramatically 
increased (Snao et al, 1993). It has been proposed that the DNAse may play a role in the 
cleavage of the DNA prior to encapsidation.
d) Ribonucleotide reductase 
Ribonucleotide reductase is discussed in detail in section ID.
1A.3.4.2 HSV-1 DNA replication
1 A.3.4.2.1 Origins of DNA replication
Within the HSV-1 genome there are three origins of replication belonging to two classes: 
OriL, located in the unique long region of the genome and OriS, located in the short 
inverted repeats (Spaete and Frenkel, 1982; Stow, 1982; Stow and McMonagle, 1983; 
Vlasny and Frenkel, 1982; Weller et al, 1985). Plasmids containing either the OriS or 
OriL regions become amplified during HSV-1 infection (Challberg, 1986). The sequences 
of the origins are closely related; both contain inverted repeat sequence with a central AT- 
rich sequence (Weller e ta l, 1985; Murchie and McGeoch, 1982). Elements essential in 
OriS function have been identified (Lockson and Galloway, 1988; Deb and Doelberg, 
1988; Hemadez et a l, 1991; Weir and Stow, 1990). UL9 binding sites and some flanking 
sequences contain binding sites for both SP-1 and NF-1 are essential for replication (Wong 
and Schaffer, 1991).
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Fig 1A.9 UL9 binding sites in OriS. The three UL9 binding sites in OriS are shown, sites 1 and 2 
are essential for DNA replication. ((Modification of diagram by Challberg, 1991)
1 A.3.4.2.2 Gene products and their role in replication
HSV-1 genes involved in DNA replication were first identified by Challberg, (1986) using 
an HSV-1 origin dependent plasmid system. Seven HSV-1 gene products were found to be 
involved in replication (see Table 1 A.3 below).
Gene Function
UL30 DNA polymerase
UL42 Polymerase accessory protein
UL5 Helicase/primase
UL8 Helicase/primase
UL52 Helicase/primase
UL9 Origin binding protein
UL29 Major DNA binding protein
Table 1A.3 HSV-1 genes directly involved in viral DNA replication and their function 
in replication.
Although HSV-1 encodes many genes required for DNA replication cellular factors must 
also play a role as yet no HSV-1 gene product has been identified with DNA ligase or 
topoisomerase activity.
a) UL9, origin binding protein
UL9 binds to the origins of replication, three binding sites in OriS have been identified; 
two high affinity sites and one low affinity binding site (Weir et al., 1989; Olivo et al., 
1988; Elias and Lehman, 1988; Elias et al., 1990). UL9 binding to the high affinity sites is 
essential for DNA replication, mutation of these sites eliminates or greatly reduces 
replication. In contrast mutation of the low affinity binding site has little effect on 
replication (Lockson and Galloway, 1988; Hemadez etal., 1991; Weir and Stow, 1990). 
UL9 exists as a dimer (Bruckner et al., 1991; Fierer and Challberg, 1992), the DNA
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binding domain of UL9 maps to a region containing a putative coiled-coil (Deb and Deb,
1991), binding of UL9 to the high affinity sites is co-operative (Elias et al., 1990). UL9 
contains an intrinsic helicase activity, it has been postulated that UL9 plays a critical role 
in the initial melting of the origin, which then allows the recruitment of the HSV-1 DNA 
replication apparatus (Bruckner et a l , 1991).
b) UL30, the DNA Polymerase
A DNA polymerase activity unique to HSV-1 infected cells was first described by Keir and
Gold, (1963). The HSV-1 DNA polymerase has properties similar to those of other DNA
polymerases: (1) replication uses a specific primer to initiate replication,
oligoribonucleotides were found to initiate HSV-1 DNA replication; (2) the Km values for
dNTPs in the HSV-1 DNA polymerase was found to be lower than that of the cellular
enzyme indicating the higher dNTP binding affinity of the HSV-1 DNA polymerase, this
ensures that viral replication is favoured over cellular DNA replication; (3) the HSV-1
enzyme possess 3 ' —> 5" exonuclease activity, an activity important in the proof reading
of nascent DNA (Knopf, 1979; Powell and Purifoy, 1977) and homology to the 5'—>3'
exonuclease activity of DNA polymerases has been described within the N-terminal
portion of the HSV-1 DNA polvmerase (Crute and Lehman, 1989). Purified DNA 
. I (Vaughan et al., 1984; Gallo et al, 1988) 
polymerase is associated wim UL4Z,^tne puiymcrase accessory protein, and the major
DNA binding protein, UL29.
c) UL42 , the Polymerase accessory factor
* The role of the DNA Polymerase/UL42 interaction was first proposed by Gallo et al., 
(1989), purification of the HSV-1 DNA polymerase leads to a decrease in polymerase 
activity, full activity is recovered by the addition of UL42 to the assay (Gottlieb et al.,
1990). DNA polymerase exists as a heterodimer with UL42 in infected cells, the 
interaction is independent of any other viral protein (Gottlieb et al., 1990). Regions of 
UL42 required for polymerase interaction map to the carboxy terminal portion of UL42 
(Digard and Coen, 1990; Stow, 1993; Hart and Boehme, 1992; Digard et a l, 1993; Tenney 
et al., 1993). Mutational analysis has mapped sites of the DNA polymerase which interact 
with UL42 to the C-terminal region of DNA polymerase. A putative helical structure 
located in the C-terminal region of the DNA polymerase was proposed to be the site of 
interaction with UL42 (Tenney et al., 1993; Digard et a l, 1993). Optimal processivity by 
DNA polymerase and UL42 is only achieved in the presence of the major DNA binding 
protein UL29 (Hemadez and Lehman, 1990; Gottlieb et al., 1990).
d) UL29, the major DNA binding protein
The major DNA binding protein of HSV-1, UL29, is essential for HSV-1 DNA replication 
(Weller et al, 1983; Littler et a l, 1983; Conley et al., 1981). UL29 is important in both
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DNA replication and in late gene expression. Properties of UL29 include: (1) binding to 
single stranded DNA in vitro and in vivo (Ruyechan, 1983); (2) localisation to the cell 
nucleus and the formation of replication compartments (Gao and Knipe, 1992); (3) down- 
regulation of viral gene expression (Godowski and Knipe, 1986); (4) stimulation of late 
gene expression (Gao and Knipe, 1991). UL29 shares properties found in the E.coli 
single-stranded DNA binding protein; in its ability to disrupt duplexes of complementary 
homopolymers and to protect single stranded DNA from nucleases, UL29 binds to single 
stranded DNA and to a lesser extent duplex DNA (Powell and Purifoy, 1976; Knipe et al., 
1982; Ruyechan and Weir, 1984). Upon translocation to the nucleus UL29 interacts with 
the nuclear matrix to form pre-replicative sites, initiation of replication brings about the 
formation of replication compartments, the formation of which is completely dependent on 
a functional UL29 product (deBruyn and Knipe, 1988). Within the UL29 open reading 
frame a potential zinc finger was identified, zinc binding is critical for UL29 function 
(Gupte et al., 1991), the DNA binding domain of UL29 has been mapped to the putative 
zinc finger (Gao and Knipe, 1989; Leinbach and Heath, 1988).
UL29 mediates the melting of small region of duplex DNA (Boehmer and Lehman, 1993). 
End-labelled oligonucleotides annealed to single stranded DNA are displaced by UL29. 
By labelling oligonucleotides differing in size it was demonstrated that UL29 can displace 
these with almost equal efficiency. Displacement reactions were found to require 
saturation quantities of UL29 increasing with increased size of oligonucleotide. Duplexes 
of greater than 350 bases were not displaced.
e) UL5/UL8/UL52 ,the helicase/primase complex
A novel helicase/primase activity is induced in cells infected with HSV-1 (Crute et al., 
1988). The helicase/primase activity unique to HSV-1 infected cells has been isolated, 
three HSV-1 gene products; UL8, UL5 and UL52 are required for this activity (Crute et al., 
1989; Crute and Lehman, 1991; Dodson etal., 1989). Although the helicase/primase 
activity of HSV-1 normally exits as a tripartite complex, UL5 and UL52 alone contain full 
activity (Calder and Stow, 1990; Dodson and Lehman, 1991). UL5 contains a structural 
region common to helicases (Gorbalenya etal., 1988; Hodgman, 1988; McGeoch etal., 
1988; Lane, 1988), indicating that the other component essential for helicase activity, 
UL52, may be required to mediate a conformational change essential for UL5 helicase 
activity.
In vitro assays for lagging strand DNA synthesis showed UL8 was essential It was 
proposed that UL8 is important in the stabilisation of the primers with the template 
(Sherman et al., 1992). The roles of the HSV-1 replication proteins are summarised in 
Figure 1A.10.
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Figure 1A.10 HSV-1 proteins, their role in replication. Diagram summarises the model for 
DNA replication and the role of each of the HSV-1 gene products in leading (5' to 3') and lagging (3' to 5') 
strand synthesis. (Modification of diagram by Challberg, 1991)
1A.3.5 A replication/transcription relationship in HSV-1
DNA replication initiates true late gene expression. Localisation of the major DNA 
binding protein, UL29, into the replication compartments is disrupted in an HSV-1 mutant 
in Vmw63 (Curtin and Knipe, 1993). Both UL29 (Godowaski and Knipe, 1986) and 
Vmw63 (Knipe et a l, 1993) play a role in the down-regulation of early gene expression 
and the stimulation of late gene expression (Gao and Knipe, 1991). UL29 binding to DNA 
may mediate Vmw63 interaction with the transcription/processing apparatus. 
Transcription factors can also play a role in DNA replication (Lue and Komberg, 1993) 
and replication factors can also influence transcription; factors involved in origin 
recognition in yeast inhibit gene expression (Micklem et a l, 1993), a similar effect is 
observed with Vmw63 which down-regulates early gene expression, although no direct 
interaction between Vmw63 and any of the HSV-1 replication proteins has been 
demonstrated, the decrease in DNA synthesis observed in cells infected with a Vmw63 null 
mutant implies that Vmw63 may play either a direct or indirect role in viral DNA 
replication. A feature common to Vmw63 and UL29 is their ability to bind zinc. Zinc 
binding domains are known to play a role in protein-nucleic acid interactions and recently, 
their role in mediating protein-protein interactions has been described. The cellular 
elongation factor, TFIIS contains an unusual zinc binding motif which is critical in its 
interaction with RNA Pol II, an interaction which is important in the regulation of read-
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through (Agarwal et a l , 1991) and in nascent transcript cleavage (Reines, 1992; Reines 
and Mote, 1993). Whether similar interaction between RNA Pol II and the HSV-1 
transcriptional regulators/replication proteins mediates or alters Pol II activity is unknown.
1A.3.6 Late gene expression
Late gene expression falls into two distinct classes; leaky-late and true late. Leaky late 
gene expression can be observed in the absence of viral DNA replication (Blair and 
Wagner, 1986; Godowaski and Knipe, 1986; Holland et al, 1980; Pederson et a l, 1981) 
whereas true late gene expression occurs once viral DNA replication has been initiated 
(Holland et a l, 1980).
1A.3.6.1 Leaky-late gene expression
The immediate early gene products, Vmwl75, VmwllO and Vmw63 are all required for
optimal levels of leaky late gene expression seen prior to DNA replication (Costa et al,
1985; Everett, 1986; Sekulovich e ta l, 1988; Su and Knipe, 1989). Cis-acting sequences
required for the expression of leaky late genes include a functional TATA box and an
i post DNA replication
origin sequence, optimal levels of leaky-late gene expression^requme tne initiation of DNA 
replication (Johnson and Everett, 1986). A cis-acting sequence which binds the cellular 
factor YY1 (Mills et al, 1994) plays a critical role in the expression of the leaky late class 
of genes (Chen et al., 1992), deletion of the YY1 binding site in the VP5 promoter reduced 
levels of expression by 40-fold (Chen et al, 1992). YY1 has been proposed to be a major 
determinant of late gene subclass, binding sites exist in the gB and gC as well as the VP5 
leaky-late promoters, this appears to be a feature unique to this particular subclass (Chen 
e ta l, 1992).
1A.3.6.2 True late gene expression
Like the leaky late genes, true late genes require the immediate early gene products 
VmwllO, Vmwl75 and Vmw63 (Deluca e ta l, 1984; Deluca and Schaffer, 1985; Sacks et 
a l, 1985; Mavromara-Nazos e ta l., 1986). The promoters of both gC (Homa et al., 1986) 
and US 11 (Johnson and Everett, 1986) have been investigated, the only cis-acting 
requirements found were a functional TATA box and an Ori sequence. Expression only 
occurs once DNA replication is initiated (Holland et al., 1980; Wagner, 1985). J  Post- 
transcriptional processes also control levels of late gene expression (McLauchlan et al., 
1989:1992)
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1A.4 Virus maturation
1A.4.1 Capsid formation
Capsids are composed of seven virus proteins (VP5, VP19C, VP21, VP22A., VP23, VP24 
and VP26) of which two, VP21 and VP24, are produced by the proteolytic cleavage of a 
polyprotein precursor by the virion protease, an activity which resides in the VP22A. (Liu 
and Roizman, 1991,1992; Preston et al, 1992). The outer icosahedral shell is composed of 
VP5, VP19C, VP23 and VP26. VP22A forms the internal scaffold of the capsid, cleavage 
of this protein is thought to be critical in the packaging of the virus DNA. A temperature 
sensitive mutant in VP22A at the non-permissive temperature still forms capsids but fails 
to incorporate the DNA (Preston et al, 1983).
1A.4.2 DNA packaging
Concatameric virus DNA undergoes cleavage at the “a” sequence present at the termini of 
the virus genome (Davison and Wilkie, 1981; Mocarski and Roizman, 1982; Varmuza and 
Smiley, 1985; Nasseri and Mocarski, 1988). DNA is then packaged into the capsid, a 
process dependent on the proteolytic cleavage of VP22A, the “a” sequence also plays a 
role in packaging (Kaemer e ta l, 1981; Vlazny and Frenkel, 1981) and recently the 
importance of the viral DNAse in the packaging of DNA has been demonstrated (Snao et 
al, 1993).
1 A.4.3 Virion maturation
The capsid and tegument then become enveloped. Where envelopment occurs is at present 
unknown, two models have been proposed; envelopment occurring as the capsid is 
transported across the nuclear membrane or, whilst the capsid is transported through the 
cytoplasm. A mutant in the UL20 gene of HSV-1, a gene thought to encode a membrane- 
associated protein, shows a high accumulation of capsids in the space between the inner 
and outer lamellae of the nuclear membrane with a reduced number of naked capsids in the 
cytoplasm (Baines et a l, 1991). Disruption of Golgi function in the cell leads to an 
increased accumulation of cytoplasmic capsids (Cheung e ta l, 1991; Whealy e ta l, 1991), 
indicating that envelopment requires proper Golgi function. Of the virus glycoproteins, 
which are found distributed throughout the cell, gD has been shown to inhibit HSV-1 
fusion with membranes thereby preventing mature virions from re-entering the cell 
(Campadelli-Fume et al, 1990). It is obvious therefore that the virion as it is transported 
through the cell should avoid membranes containing gD, it has been postulated that special
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structures, virosomes, exist whose role is to transport the virion through the cell. Recently 
in vitro enveloped particles have been identified which lack capsids and DNA, these 
particles designated light (L) particles (Szilagyi and Cunningham, 1991: McLauchlan and 
Rixon, 1992) are thought to assemble independently of virion maturation.
1 A.5 Selected virus/host interactions
1A.5.1 Shut-off factor (UL41)
Infection of cells by HSV-1 and HSV-2 results in the down regulation of host protein 
synthesis (Fenwick and McMenamin, 1984; Schek and Bachenheimer, 1985; Strom and 
Frenkel, 1987). The infected cell factor responsible is a component of the virion, infecting 
cells with UV-irradiated virus (Fenwick and Clark, 1982; Fenwick and Walker, 1987; 
Schek and Bachenheimer, 1985; Strom and Frenkel, 1987) or infecting in the presence of 
actinomycin D (Schek and Bachenheimer, 1985; Strom and Frenkel, 1987), does not effect 
host mRNA destabilisation during infection. Using mutants in the host shut-off locus, it 
was found that not only is cellular mRNA half-lifedecreased, viral mRNAs have increased 
stability and accumulate as infection proceeds (Krikorian and Read, 1991; Kwong and 
Frenkel, 1987; Oraskar and Read, 1987, 1989; Strbm and Frenkel, 1987). The gene 
encoding this function has been mapped (Kwong et al, 1988) and the infected cell protein 
has been shown to exist in multiple forms according to its phosphorylation state (Read et 
al, 1993). How UL41 interacts with the mRNA and promotes its degradation is unknown.
1A.5.2 Neuropathogenicity
A region of HSV-1 which spans the long internal and short internal repeat region is 
important in determining the neuropathogenicity of the virus ( MacLean et al, 1991; Taha 
et al, 1990; Thompson et al, 1986; Thompson et al, 1983). The gene, RL2, whose product, 
ICP34.5, plays an essential role in the neuropathogenicity of the virus (McGeoch and 
Barnett 1991; Chou etal, 1990; Chou and Roizman, 1992) maps to this region of the 
genome. ICP34.5 plays a primary role in determining the neuropathogenicity of HSV-1 
(Chou et al, 1990; Chou and Roizman, 1992; |Bovolani et al, 1994), mutation of the 
ICP34.5 reading frame reduces the neuropathogenicity of HSV-1. Differences in the|effect 
of these mutations are observed between strains, in strain F the introduction of a stop 
codon into the ORF of ICP34.5 leads to a reduction in neurovirulence (Chou and Roizman,
1992) which is greater than that observed for strain 17+ (Bovolan et al, 1994). Bovolan et 
al, (1994) have suggested that the difference observed may in part be explained by the 
different strains of mice used for the analysis of these mutants.
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1A.5.3 HSV-1 Latency
Following infection, HSV-1 replicates prior to entry into the nerve axon. The virus is then 
transported to the cell body of the neuron by retrograde fast axonal transport, how the virus 
particle is transported is unknown. Acute ganglionic infection is observed, a stage at 
which the virus can be recovered from ganglionic homogenates, prior to the establishment 
of latency, a stage at which no virus can be recovered from homogenates. Factors which 
stimulate the reactivation of the virus include; stress, UV-irradiation, hypothermia, trauma 
at the original site of infection and nerve root section. Upon reactivation the virus is 
transported to the peripheral site of infection where virus replication can occur. Lesion 
development can occur at the peripheral site but this is not necessarily always the case 
(Reviewed by Hill, 1985)
1 A.5.3.1 Establishment of latency
Mutants in HSV-1 have been isolated which effectively establish latency but which fail to 
reactivate from the latent state, these include mutants in the enzymes involved in 
nucleotide provision; thymidine kinase (Coen et al, 1989; Tenser et al, 1989); 
ribonucleotide reductase (Jacobson et al, 1989) and dUTPase (Pyles et al, 1992). 
Expression , as analysed by fusion of promoters to j3-galactosidase, of genes from different 
classes of viral gene has been observed in the ganglia (Ho and Mocarski, 1988). There is 
no evidence for viral replication during the acute phase of infection in the ganglia, 
suggesting that a comparison of events occurring during lytic replication and those 
occurring during acute ganglia infection can not be made (Speck and Simmons, 1991). A 
recent model has proposed that cells which do not support HSV-1 replication contain a 
repressor of immediate early gene expression (Lillycrop et al., 1991). The 
presence/absence of this repressor determines the ability of the virus to replicate or enter a 
latent state. Lillycrop et al., (1991) found that Oct-2, a factor closely related to Oct-1 can 
interact with the TAATGARAT sequences in the promoters of the immediate early genes 
and down-regulate expression of these genes, this factor exists in neuronal cells derived 
from the dorsal root ganglia.
1A.5.3.2 Maintenance of the latent state
The latency-associated transcripts which are encoded by an 8.0Kb segment from the long 
repeat region (IRS and TRS) of the HSV genome are the only transcripts present during 
HSV latent infection (Stevens et al., 1987; Spivak and Fraser, 1987). The LAT transcript 
is antisense to the Vmwl 10 transcript. Although there are several forms of LAT transcript, 
8.0Kb (Dobson etal., 1988; Zwaagstraetal., 1990) 2.0Kb and 1.5Kb and 1.45Kb (Rocket
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al., 1987; Spivak and Fraser, 1987; Stevens etal., 1987; Wagner et a l, 1988), the 2.0Kb 
transcript is the most abundant and can be detected during lytic infection (Krause et al., 
1988; Spivak and Fraser, 1987; Spivak et al., 1991). The 1.5Kb and 1.45Kb LATs are 
thought to be derived from the splicing of the 2.0Kb LAT (Spivak et al, 1991; Wagner et 
al, 1988; Wechsler et al., 1988).
TRL UL IRL ms US TRS
UL56 RL2 Vmw 175
Vmw63 UL55
LAT
8kb ■■ 1 ~ —— Pri mary transcript
Stable RNA
Stable RNA 
Stable RNA
Figure 1A.11 Transcription around the LAT region of the HSV-1. The position of the 
LAT transcripts within the HSV-1 genome is shown, as are the positions of the immediate early gene 
products Vmwl75, Vmw63 and VmwllO which is antisense to the LAT transcript. The LAT transcripts 
which have been identified are shown, the primary transcript of 8.0Kb, the spliced short 1.5 and 1.45Kb 
transcripts and the stable intron from the primary transcript (2.0Kb) 
j (Reproduced with modifications from Fraser et al., 1992)
1A.5.3.3 Expression of LATs
Regulatory regions responsible for the tissue-specific expression of the LATs have been 
identified (Batchelor and O’Hare, 1990, 1992; Dobson et al., 1989; Leib e ta l, 1991; 
Zwaagstra etal., 1989, 1990, 1991). Deletion of sequences 5 ' to the LAT TATA box and 
the cAMP response element (CRE) showed that both cis-acting elements are required for
2.0Kb
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expression (Dobson et al, 1989). A more detailed analysis by Rader et al., (1993) 
investigated by site-directed mutagenesis the precise role of both the TATA box and the 
CRE element in LAT expression during different stages of the latent life cycle. The CRE 
element was found to be important in the expression of the LAT during reactivation 
whereas mutation of the TATA box decreased the number of neurons expressing the LATs. 
In a separate study Nicosa et a l, (1993) have shown that the expression of the 2.0Kb 
(major LAT species) was detectable when both the TATA and CRE elements were 
mutated; no 1.5Kb LAT was observed which led them to propose that a TATA-less 
promoter expresses the 2.0Kb form in the absence of a functional TATA box and that the 
TATA promoter expresses LAT during latency and the TATA-less promoter functions 
during reactivation.
1A.5.3.4 Reactivation
Reactivation is thought to be mediated by the immediate early gene product Vmw 110. In 
HSV-1 strain KOS deletion of the VmwllO ORF impaired the ability of this virus to 
reactivate (Leib et al, 1989), in contrast the mutant in strain 17+ showed only a reduction 
in the kinetics of reactivation and not the ability of the virus to reactivate (Clements and 
Stow, 1989). Using an in vitro model the importance of VmwllO in the reactivation of 
HSV-2 has been demonstrated (Harris et al; 1989; Zhu et al, 1990).
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IB Protein kinase structure and cellular processes controlled 
by phosphorylation
1B.1 Protein kinase classification/structure
IB. 1.1 Protein kinase classification
Protein kinases have been classified according to the acceptor amino acid group (Hunter, 
1991), see Table 1B.1.
Classification Acceptor amino acid Euk/pro
Serine/threonine Serine or threonine E/P
Tyrosine tyrosine E
Histidine histidine/arginine/lysine E/P
Cysteine cysteine P
Aspartyl/glutamyl acyl groups P
Table 1B.1 Classification of protein kinases.
Both protein serine/threonine and tyrosine kinases are well characterised, over 100 kinases 
belonging to this two categories have been identified, both by the purification of the 
kinases and by cloning using probes to regions of protein kinases which are well conserved 
(Hunter, 1987). The serine/threonine and tyrosine kinases are found in eukaryotic cells, 
the majority of protein kinases in the eukaryotic cell belong to the serine/threonine class of 
kinase. Protein kinases capable of phosphorylating serine/threonine and tyrosine have 
been identified (e.g. Weel+ (Featherstone and Russell, 1991), Clk and Nek (Ben-david et 
a l , 1991), YPK1 (Dailey etal., 1990) and SpKl (Stem etal., 1991). Autophosphorylation 
of Weel+, followed by phosphoamino acid analysis showed that phosphotyrosine and 
phosphoserine were present in equal amounts. Protein kinases capable of phosphorylating 
histidine, arginine and lysine exist in eukaryotic cells as proteins with phosphate on these 
residues have been isolated, but no protein kinase responsible has been isolated (Pesis et 
a l, 1988; Levy-Favatier etal., 1987).
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IB. 1.2 Protein kinase structure; subdomains and their role in catalysis
Comparison of the sequences of a large number of protein kinases led to the identification 
of discrete regions of conserved amino acids important in catalysis (Hanks et al., 1988). 
Although both the serine/threonine and tyrosine kinases share subdomains,stretches of 
amino acids have been identified which are characteristic to a particular class (Hanks et al., 
1988). Table 1B.2 shows the amino acid residues in each kinase subdomain and their 
predicted/known function in catalysis.
Motif Number Function
GTGSFG I Binds B-PO4  of ATP
K II Binds a  and B-PO4 S of ATP
E III Ion pairs with Lysine (domain II)
RDLKPEN VI Catalytic loop
R, ligand for Tbr(P)
D, catalysis 
K, catalysis 
N, stabilises loop
DFG VII Chelates Mg2+
D jvill Hydrogen bonds
E j ix Ion pairs to VII
R X Ion pairs to! IX
Table 1B.2 Protein kinase subdomains and their role in catalysis. The residues involved in 
protein kinase subdomain formation are shown with their predicted/known role in catalysis.
a) Subdomain I
A nucleotide binding site, a motif common in all enzymes which bind nucleotides, first 
identified by Rossmann et al, (1974). The binding site is a highly conserved structure, 
however the only amino acids which are highly conserved and which are the main 
characteristic feature of a nucleotide binding domain is a triad of glycines which form a 
loop structure important in the binding of the phosphate groups of the nucleotide 
(Rossmann et al., 1974; Branden, 1980; Jumak, 1985). The structure of the nucleotide 
binding site of cAMP-dependent protein kinase is shown in Figure 1B.1.
32
Chapter 1. Introduction
GiyLys
Figure 1B.1 Tertiary structure of nucleotide binding domain of cAMP-dependent 
protein kinase (PKA). The glycine triad directly involved in the interaction of ATP with the protein 
kinase is shown. The triad is flanked by a p-strand structure and an a-helix. The position of the three ATP 
phosphates is shown with respect to the glycine triad, j (Reproduced with modifications from Taylor et al, 1990)
b) Subdomain^ II
Downstream of the nucleotide binding site a lysine residue is located, normally spaced 
within 25 amino acids of the. glycine triad. The importance of this residue in catalysis has 
been demonstrated, an ATP analogue, p-fluorosulfonylbenzoyladenosine (FSBA), 
irreversibly binds to this lysine (Zoller et al., 1981). Mutation of this lysine leads to a loss 
of kinase activity (Chen et al, 1987; Chou et al, 1987). The lysine residue forms an ion 
pair with a conserved glutamate which brings the lysine into close proximity with the a  
and P phosphates of Mg-ATP.
c) Subdomain III
An invariant glutamate residue located downstream of the lysine in domain II (see above), 
which together with the glycine-rich loop bind and correctly position Mg-ATP. Mutation 
of the glutamate demonstrated that this residue is critical in catalysis (Gibbs and Zoller, 
1991).
d) Subdomain / VI
Subdomain 6 shows the greatest divergence between the serine/threonine kinases and the 
tyrosine kinases (Hanks et a l, 1988), this region can be used to determine the amino acid 
specificity of the kinase. All kinases contain two conserved amino acids in this region 
which vary according to the substrate for serine kinases, an aspartate and an arginine. The 
aspartate positions the hydroxyl acceptor group and the| arginine stabilises the catalytic 
loop by forming a hydrogen bond with the aspartate. A lysine (serine/threonine) or
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arginine (tyrosine) then mediates the transfer of the y phosphate from ATP to the hydroxyl 
group.
e) Subdomain VII
Highly conserved subdomain, three amino acids; phenylalanine, aspartate and glycine 
interact with Mg2+ to correctly orientate the phosphate to be transferred (Zheng et al.,
1993). Interaction between the substrate Mg^+ and this site neutralises the charge on the 
aspartate reducing the hydrophobicity of the active site and facilitating phosphate transfer. 
Mutation of the aspartate in this subdomain in yeast TpKl greatly reduced activity (Gibbs 
and Zoller, 1991a). The site of phosphate transfer and residues involved are shown in 
Figure IB .2.
Figure 1B.2 Catalytic domain of cAMP dependent protein kinase. Residues directly 
involved in catalysis are shown. (Reproduced from Taylor et al., 1992)
f) Subdomain VIII
This domain is highly conserved in tyrosine kinases, like subdomain 6 this iegion is an 
indicator of substrate specificity. The exact role of this region is unknown, the glutamate 
forms an ion pair with a conserved arginine in region 10, an interaction which is believed 
to play a key structural role. Mutation of this region leads to significant reduction in 
activity (Gibbs and Zoller, 1991b).
Site of phosphotransfer
Autophosphorylation
site
*
Glu
Arginine
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IB. 2 Cellular events controlled by protein kinases
Protein kinases play a. decisive role in many cellular processes; cell mobility, cell division, 
gene expression, translation and metabolism, a few are discussed in the following Sections.
1B.2.1 Cell Cycle
A protein kinase essential in the cell cycle was first identified in yeast. This 34kDa protein 
kinase, cdc2, plays an important role in the progression of the cell from G1 to the S 
(synthesis) phase and from the G2 to the M (mitotic) phase. Control of cdc2 during the 
different phases of the cell cycle is dependent on a family of proteins, the cyclins (Lew and 
Reed, 1992; Fitch et al, 1992; Richardson et al, 1992). Since the discovery of cdc2, 
several other protein kinases involved in cell cycle regulation have been identified 
(reviewed in Pines and Hunter, 1991). Cell cycle protein kinase activities are, like cdc2, 
modulated by their interactions with cyclins and are therefore called the cyclin dependent 
kinases (CDKs). Interactions between the CDKs and their corresponding cyclin are 
specific (see Figure 1B.3). The transition between phases in the cell cycle is mediated 
when the appropriate cyclin and CDK interact (Fang and Newport, 1991). The CDKs 
are structurally similar, just large enough to encompass all the conserved elements of a 
protein kinase, with a high degree of variability at the primary amino acid level. Sites of 
interaction between CDKs and their appropriate cyclin have been mapped (reviewed in 
Pines, 1993). In addition to the cyclins CDKs have been shown to interact with and 
modulate the activity of other cell proteins e.g. the retinoblastoma protein and its related 
factors (Kato et al, 1993; Hannon et al, 1993).
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Figure 1B.3 The control of the cell cycle by protein kinases. Progression through each stage 
of the cell cycle, M-phase, S-phase, G1 and G2-phases is controlled by protein kinases. The activity of the 
protein kinase is controlled by their interactions with cyclins. The protein kinases active at a particular phase 
of the cell cycle are shown in the pie-shaped diagram, some protein kinases are active in more than one phase 
of the cell cycle, this activity is dependent on the interaction of the cyclin dependent protein kinases with a 
particular cyclin present during the phase. (Reproduced from Pines, 1993)
1B.2.2 DNA replication/repair
a) DNA replication
Replication of DNA in the eukaryotic genome is tightly regulated and restricted to the S- 
phase of the cell cycle. Fusion of S-phase cells to G1 cells induces synthesis of DNA in 
the G1 cells (Rao and Johnson, 1970). From these experiments it was concluded that there 
is an inducer of DNA synthesis which accumulates during G1 (Rossow et a l, 1979). 
Replication is thought to be induced by the p34(cdc2) kinase (McVey et al, 1989; D’Urso 
et a l, 1990; Blow and Nurse, 1990; Fang and Newport, 1991). Analysis of SV40 
replication in vitro showed that a factor RPA-32, part of the trimeric RPA complex, is 
phosphorylated during or just prior to DNA replication. Phosphorylation occurs during the 
S-phase of the cell cycle (Dutta and Stilman, 1992). Dutta and Stilman, (1992) 
demonstrated RPA-32 phosphorylation by the cdc2 protein kinase, RPA-32 
phosphorylation by cdc2 stimulates DNA replication and unwinding in extracts from G1 
cells.
An additional factor involved in DNA replication, PCNA (proliferating cell nuclear 
antigen), is important in both DNA replication and repair and associates with D-cyclins 
and the Dl-cyclin associated kinase (Xiong et al, 1992). Although the phosphorylation of
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PCNA has not been demonstrated, the phosphorylation state of the cyclin with which it 
becomes associated may play a role in the function of this protein.
b) DNA repair
In yeast a protein kinase, Dun-1, is induced by agents which promote DNA damage (Zhou 
and Elledge, 1993). The phosphorylation of this protein increases with DNA damage. The 
importance of Dun-1 autophosphorylation has been demonstrated, mutation of residues in 
the nucleotide binding or catalytic domains of this protein kinase, followed by 
transfections with the plasmid expressing these mutants fail to rescue yeast strains carrying 
a Dun-1 mutation. It has been proposed that Dun-1 plays a primary role in the eukaryotic 
SOS response. The action of DUN-1 is thought to be mediated either by its direct 
interaction with the basal transcription machinery or by the modulation of a factor which 
itself interacts with the basal machinery.
IB.2.2 Control of transcription by protein kinases
a) Basal transcription
The synthesis of mRNA in eukaryotes is carried out by RNA polymerase II, a multi­
subunit enzyme that together with seven general transcription factors (TFIIA, IIB, IIC, IID, 
IIE, IIF and IIH) initiates transcription from Pol II promoters. The C-terminal domain 
(CTD) of RNA pol II contains multiple tandem repeats of a consensus sequence Tyr-Ser- 
Pro-Thr-Ser-Pro-Ser, this region has been shown to be essential for Pol II activity (Young,
1991). Pol II exists as two forms RNA Pol HA and a phosphorylated form, RNA Pol IIO, 
Lay bourn and Dahmus, (1990) demonstrated that the phosphorylation state of Pol II 
changes as the transcription cycle proceeds. Pol IIA preferentially associates with the 
preinitiation complex (Lu et al., 1991), whereas Pol IIO is found mainly in elongation 
complexes (Payne et al., 1989). Phosphorylation is thought to displace Pol II from the 
promoter triggering elongation. A protein kinase which can phosphorylate Pol II has been 
found which co-purifies with TE11H, a five polypeptide complex (Lu et al, 1992). Full 
kinase activity of this TF11H is achieved upon formation of a stable preinitiation complex. 
The yeast, saccharomyces cerevisae contains a homologue of TFIIH, which also has CTD 
specific kinase activity (Gileadi et al, 1992).
b) Upstream Activators
Brief external stimuli by polypeptide hormones, cytokines and neurotransmitters can lead 
to long term alterations in gene expression by signal regulated transcription factors. Of the 
transcription factors known, members of the Bzip family (Vinson et a l, 1989) are one the 
best characterised families. The AP-1 and CREB/ATF proteins which bind to TRE (TPA 
response elements) and CRE (cAMP response elements) respectively have been
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extensively studied (Angel and Karin, 1991; Montminy et a l, 1990; Karin, 1990). AP-1 
exists as either a heterodimer (c-fos/c-jun) or as a homodimer (c-jun/c-jun), heterodimers 
are more stable and therefore more transcriptionally active (Angel and Karin, 1991). AP-1 
activity is stimulated by polypeptides, growth factors, cytokines and neurotransmitters, 
signalling occurring via membrane associated protein kinases or by phospholipid turnover 
(Cantley et al., 1991). AP-1 activity is stimulated by increased transcription of c-fos or by 
post-translational modification of c-jun. Phosphorylation of c-jun occurs in the amino 
terminal region of the protein, a region in which the transactivation domain is located, this 
modification of c-jun has been shown to stimulate transactivation by c-jun by 5-10 fold 
(Binetruy et al., 1991; Smeal et a l, 1992). AP-1 activity is down regulated by| casein 
kinase II, sites in c-jun have been identified (Lin et al., 1992), phosphorylation of these 
sites reduces DNA binding activity (Smeal et a l., 1992; Boyle et al., 1991).
CREB activity is controlled by protein kinase A (PKA) (Montminy et al, 1990). Increases 
in intracellular levels of cAMP determine the activity of PKA, cAMP binds to the 
regulatory subunit promoting dissociation of the catalytic subunit and therefore activation! of 
PKA. The catalytic subunit can then translocate to the nucleus where it can phosphorylate 
CREB. The activity of CREB is dependent on its phosphorylation state, phosphorylation 
of CREB leads to a 10-20 fold increase in CREB transactivating activity (Gonzalez and 
Montminy, 1989; Hagiwara et al., 1992). Phosphorylation is thought to activate CREB by 
altering the conformation of the transactivation domain. The importance of 
phosphorylation of CREB has beenl demonstrated in a transgeneic mouse in which the 
CREB PKA phosphorylation site has been mutated, these mice display a dwarf phenotype, 
an indicator of abnormal pituitary function (Struthers et al., 1991).
1B.2.3 Control of RNA processing by protein kinases
The snRNP (small nuclear RNA binding protein) protein, U1-70K, is phosphorylated 
(Wooley et a l, 1982; Woppmann et al., 1990). The role of phosphorylation in the 
regulation of splicing, both constitutive and alternative, has been proposed (Tazi et al., 
1992; Mermoud et al., 1992). It is believed that the dephosphorylation of splicing factors 
is required for the cleavage and ligation of pre mRNA, a step which like the initial 
formation of the splicesome is ATP dependent (Tazi et al., 1992). A kinase activity co- 
purifying with the U1-70K protein has recently been described (Woppmann et al., 1993).
The kinase activity associates with snRNP particles, in particular the U1-70K protein 
although similar kinase activities were found in other snRNP complexes. The kinase 
activity is not dependent on the RNA component of the snRNP. Another complex, the 
alternative splicing factor (ASF) was also phosphorylated by this co-purifying kinase
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activity. The sites for phosphorylation are arginine and serine rich, a domain which is 
common to the splicing factors and RNA binding proteins.
IB.2.4 Phosphorylation and subcellular localisation
The intracellular localisation of Rab4, a guanine nucleotide binding protein, thought to be 
involved in the regulation of intracellular transport pathways, is dependent on its 
phosphorylation state. |Rab4, which is normally associated with endosomes, when 
phosphorylated by cdc2 (Bailly et al, 1991) dissociates from the endosome membranes 
(Van der Sluijs et al., 1992a,b). The interaction of the protein kinase MARCKS with 
membranes is also determined by its phosphorylation state, only when unphosphorylated 
can it associate with membranes (Hartwig et al, 1992). Phosphorylation of the growth 
factor receptor, PDGFr provides a signal for the recruitment and formation of a large 
signal-transduction complex capable of signalling from the plasma membrane to the 
nucleus (Blenis, 1993; Davis, 1993).1 PDGFr phosphorylation plays an essential role in 
altering the spatial distribution of specific enzymes allowing them to contact their relevant 
substrates.
1B.2.5 Control of translation by phosphorylation
Covalent modification of translational machinery components by phosphorylation is a 
principal means of regulating protein synthesis in eukaryotic cells. In particular the 
phosphorylation of the alpha subunit of initiation factor eIF-2, a key factor required for 
protein synthesis, is one of the best characterised translational control mechanisms. 
Phosphorylation of eIF-2 alpha leads to inhibition of protein translation (Moldave, 1985; 
Hershey, 1991). Protein kinases which phosphorylate eIF-2 alpha have been identified, the 
activity of of these kinases is dependent on: extracellular stimulation, availability of 
metabolites and viral infection (Pestka e ta l, 1987; Hinnebusch, 1990; Sen andLengyel,
1992). Protein kinases which are activated by viral infection are the RNA dependent eIF-2 
alpha protein kinases (PKR), there is also a family of protein kinases which are stimulated 
by haemin deficiency , the haemin-regulated eIF-2 alpha protein kinases and, a family of 
general eIF-2 alpha protein kinases involved in the general control of translation.
eIF-2 forms a ternary complex, eIF-2-GTP-methionyl-tRNAi whose formation is necessary 
for the binding of the initiator methionyl-tRNAi to the 40S ribosomal subunit, following 
binding eIF2 is released as an eIF-2-GDP complex. eIF-2 is then recycled prior to another 
round of initiation. Phosphorylation of eIF-2 alpha inhibits its interaction with eIF-2B, an 
interaction essential in the exchange of GDP for GTP, which is required to recycle an
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active eIF-2 alpha subunit. (Moldave, 1985; Hershey, 1991). The stimuli and kinases 
involved in eIF-2 alpha phosphorylation are summarised in Figure 1B.4.
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Figure 1B.4 Control of translation by phosphorylation of eIF-2 alpha. Several 
physiological signals have been shown to effect translation by the phosphorylation of eIF-2 alpha. The 
signals which stimulate eIF-2 alpha are shown and the protein kinases which mediate eIF-2 alpha 
phosphorylation are indicated (PKR, RNA-dependent protein kinase; GCN2, yeast general physiological 
protein kinase; HRI, haemin regulated protein kinase). Phosphorylation of eIJF-2 alpha inhibits complex 
formation with eIF-2B., preventing the interaction of the initiating tRNA with the small ribosomal subunit. 
(Reproduced from Samuel, 1993)
eIF-4F is a three subunit complex that binds to S' cap structure of eukaryotic mRNAs and 
facilitates ribosome binding by unwinding secondary structure in the mRNA 5’ noncoding 
region. A component of the eIF-4F complex, eIF-4E is a phosphoprotein. Reagents 
which stimulate protein kinase C increase eIF-4E phosphorylation (Xu etal., 1993; Morley 
e ta l, 1993). The phosphorylation of eIF-4E has been proposed to promote its association 
with eIF-4 alpha and eIF-4 gamma, assembly of the eIF-4F complex, this complex 
formation is thought to be an important translational control mechanism (Morley et al, 
1993).
Translation of specific transcripts can be specifically inhibited. Translation of the 
protamine transcript is regulated during germ cell development. A 18kDa
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phosphoprotein which binds to the 3' untranslated region of this message inhibiting its 
translation, the interaction is specific for this transcript. Dephosphorylation of the 18kDa 
protein leads to realease of the transcript and its subsequent translation (Yunhee et al.,
1993).
IB.3 Protein kinases and their role in signal transduction
Protein kinases play an integral role in signal transduction. Interaction between a 
polypeptide growth factor and its receptor can lead to long term changes in the cell.
1 B.3.1 Receptor tyrosine kinases
In response to a ligand binding a receptor tyrosine kinase, the receptor phosphorylates 
itself on tyrosine. Phosphorylation of individual residues on the receptor allows it to 
interact with cytoplasmic signalling molecules, these in turn mediate the j plfcitrophic 
responses of the cell to the growth factor. Regions of the signalling molecules which 
interact with the phosphotyrosine residues on receptors have been characterised (Matsuda 
et al, 1990), the interaction sites on these molecules are structurally similar and have been 
called SH2 domains (src homology domain). Many proteins have been shown to have SH2 
domains, these include; GAP (GTPase activating protein), cytoplasmic kinases, 
phospholipases and cytoskeletal-binding proteins.
Stimulation of platelet-derived growth factor P-receptor (PDGFpr) mediates the interaction 
of phosphotidylinositol-3-kinase (PtdIns-3-kinase), GAP, phospholipase C and c-Src with 
this receptor (Kypta et al, 1990). The interaction between the PDGFpr and PtdIns-3- 
kinase leads to increased Ras activity, Ras activation is important in the induction of 
mitogenesis (Cai e ta l, 1991), Ras activity is stimulated by its interaction with PtdIns-3- 
kinase (Sjolander et al, 1991). Intracellular protein kinase activity is also stimulated by 
growth factors, examples included raf-1, protein kinase C and the MAP kinase. Raf-1 
plays an important role in serum-induced proliferation, gene expression mediated by serum 
stimulation has been demonstrated for the c-fos transactivator (Sternberg and Horvitz,
1991). Figure IB.5 shows the interaction of PDGFpr with its signalling molecules and the 
effect of these interactions.
41
Chapter 1. Introduction
PtdINs-3-kinase
►  MAP kinase
Gene
ExpressionPDGFr PtdIns-3-kinase
and
Mitogenesis
Figure 1B.5 Interaction of PDGFpr with its signalling molecules and effects of these 
interactions. The interactions of the PDGFpr with its signalling molecules is shown in a) The interaction 
between PDGFpr and PtdIns-3-kinase, PLCy and GAP are shown. The effect of the interaction between 
PDGFpr and PtdIns-3-kinase is shown in b) PtdIns-3-kinase interaction with PDGFpr leads to increased Ras 
activity in the cell, the increase in Ras in turn leads to the stimulation of both the Raf and MAP 
serine/threonine kinases which in turn leads to the stimulation of gene expression and mitogenesis. 
Reproduced with modifications from a) Blenis and Resh, 1993 and b) Davis, 1993)
1 B.3.2 Signal transduction via cyclic nucleotides (cAMP and cGMP) 
a) cAMP
Interaction between hormones (e.g. thyroid-simulating hormone, epinephrine, and 
leutinising hormone) with their receptors leads to an increase in intracellular cAMP. The 
receptors may directly mediate cAMP production by being associated with the enzyme 
adenylate cyclase, which catalyses the formation of cAMP from ATP, or indirectly through 
a G protein (GTP binding protein). Indirect activation of adenylate cyclase is mediated by 
receptor binding ligand which alters its conformation allowing the receptor to interact with 
the G protein which in turn leads to displacement of GDP by GTP and in turn 
conformationally changes the G-protein allowing it to interact with and stimulate adenylate 
cyclase.
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bjProtein kinase A
In the absence of cAMP protein kinase A exists as an inactive tetramer composed of two 
catalytic subunits and two regulatory subunits. Binding of cAMP to the regulatory subunit, 
leads to the dissociation of the catalytic subunit which, in turn leads to the activation of the 
catalytic subunit (Granot et al., 1980). All physiological responses to cAMP are dependent 
on protein kinase A. Many Substrates for protein kinase A have been identified these 
include; enzymes involved in cellular metabolism, ribosomal proteins and structural 
proteins.
c) cGMP
The synthesis of cGMP by guanylate cyclases is stimulated by peptide hormones or by the 
increase in cellular levels of nitric oxide (NO). There are two forms of guanylate cyclases; 
the membrane associated (stimulated by peptide hormones) or the cytoplasmic form 
(stimulated by NO). The intracellular levels of NO are controlled by the enzyme NO 
synthetase, this enzyme is activated by glucocorticoids (Radomski e ta l, 1990), increased 
levels of NO in turn lead to increased cGMP synthesis.
d) Protein kinase G
Protein kinase G, like protein kinase A, is regulated by its interaction with a cyclic 
nucleotide. Little is known about protein kinase G substrates and the affect of their 
phosphorylation on the cell.
1B.3.3 Diacylglycerol/Ca2+ and protein kinase C
a) Diacylglycerol +
Protein kinase C is activated via diacylgycerol (DAG). Both growth factor receptors and 
cytoplasmic growth factor-activated tyrosine kinases (Rhee and Choi, 1992) stimulate 
protein kinase C activity. Inositol 1,4,5-triphosphate (IP3) mediates the affect of the 
receptor/ligand interaction. Following stimulation of a receptor the conformation of the 
receptor becomes altered allowing it to interact with G proteins which in turn interact with 
and stimulate the activity of phospholipase C, a membrane associated enzyme which 
hydrolyses phosphatidylcholine (or phosphotidylinositol 4,5-bisphosphate) to produce 
DAG (Exton, 1990; Billah and Anthes, 1990). IP3 promotes the release of Ca^+ from 
intracellular calcium stores, calciosomes which are modified portions of the endoplasmic 
reticulum (Berridge, 1993), calcium also activates protein kinase C.
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b) Protein kinase C
Protein kinase C exist as multiple subspecies in a number of tissues (Kikkawa et al, 1989). 
Each subspecies has distinct enzymological characteristics and differential tissue 
expression and intracellular localisation. The subspecies show varied requirements for 
Ca2+ and phospholipid metabolites (Ogita et al, 1992; Koide et al, 1992). DAG binding 
to protein kinase C promotes its autophosphorylation which in turn promotes the 
phosphorylation of exogenous substrates. The diversity of protein kinase C makes it a 
versatile regulator in the cell.
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1C Viral encoded protein kinases
The protein kinases encoded by the herpesviruses and vaccinia virus will be discussed. 
Although protein kinases have been described for other viruses, such as retroviruses, the 
transduced protein kinases of retroviruses are of cellular origin and will not therefore be 
discussed.
1C.1 HSV protein kinases
Several early reports described kinase activities associated with herpesviruses; HSV 
(Rubenstein et a l, 1972; Lemaster and Roizman, 1980); PRV (Tan, 1975) and equine 
herpesvirus (Randall et al., 1972). Lemaster and Roizman, (1980) showed that the kinase 
activities of HSV were associated with the capsid-tegument of virions. Purification of a 
virion-associated kinase activity from infected cells was first described by Stevely et al, 
(1985). The PRV virion-associated protein kinase activity was stimulated by virion 
disruption, suggesting that the kinase(s) was part of the virion tegument/capsid and not the 
virus envelope. Several protein kinase activities were described, two activities were 
found to have properties identical to cellular casein kinases; in their elution profiles from a 
phosphocellulose column, their ability to utilise GTP as a phosphate donor and their 
inhibition of activity by heparin.
Partial purification of virus specific kinase activity was first described by Katan et al., 
(1985). Both the HSV-1 and the PRV kinases show an increase in activity during virus 
growth (Purves et a l, 1986). Virus gene expression is essential for induction of the kinase 
activity; in cells treated with cycloheximide prior to infection or, in cells infected with UV- 
irradiated virus, the kinase activity was not induced. In HSV-1 the ts mutant tsK (when at 
non-permissive temperature (produces a nonfunctional form of Vmwl75 preventing early 
and late gene expression) at the non-permissive temperature failed to induce the kinase 
activity (Purves et al, 1986). The protein kinases of herpesviruses and their substrates 
where identified are shown in Table 1C.1.
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Virus Gene Family Substrate
HSV-1 US3 US3 UL34
v z v ORF66 US3 N/D
HSV-1 UL13 UL13 Vmw68 (IE protein) 
VP22 (capsid protein)
VZV ORF47 UL13 ORF62 (Vmwl75 homologue)
PRV N/D UL13 N/D
HCMV UL97 UL13 Gancyciclovir (nucleoside analogue)
Table 1C.1 Herpesvirus protein kinases and their substrates. Table shows the kinase, the 
gene encoding the kinase where-determined, the family to which the kinase belongs and the substrates of the 
kinase where identified. N/D=not determined
1C. 1.1 US3 kinase family 
a) HSV-1 US3
The US3 protein kinase is a cytoplasmic protein kinase found in small quantities in the
virion. Confirmation that US3, an HSV-1 gene predicted to encode a protein kinase
(McGeoch and Davison, 1986), encodes a protein kinase came from analysis of an HSV-1
mutant with this gene deleted (Purves et al., 1991). Cytoplasmic extracts from cells
infected with wt HSV-1, the US3 deletion mutant or a revertant of the deletion were
I byfractionated and compared for kinase activity^HPLC elution profiles. In cells infected with 
the US3 deletion mutant the virus-specific kinase activity was absent, extracts from cells 
infected with the revertant showed the reappearance of this activity confirming that the 
kinase is encoded by US3.
A substrate for the US3 protein kinase was identified by comparison of phosphoprotein
profiles from in vivo labelled cytoplasmic extracts prepared from cells infected with wt
HSV-1, the US3 deletion mutant and its revertant (Purves et a l , 1991). A phosphoprotein
of 30kDa in WT infected cell extracts was absent in extracts from cells infected with the
US3 deletion mutant, a 34kDa phosphoprotein not observed in wt infected cell extracts 
l of
appears in extracts^cells infected with the deletion mutant. The presence/absence of the 
30kDa and 34kDa phosphoproteins is dependent on the presence of a functional US3 open 
reading frame.
Intertypic recombinants mapped the gene encoding the 30kDa substrate to the unique long 
region of the genome, between the UL31-35 genes. Of the four potential genes, the UL34 
gene was favoured since the predicted mwt of the polypeptide was within the observed 
Mwt range. An HSV-1 insertion mutant was constructed; using a Vmwl75 epitope the 
UL34 polypeptide was tagged. The 30kDa phosphoprotein reacted with anti-Vmwl75
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antisera, confirming that it was the product of UL34. Within UL34 a potential 
phosphorylation site for US3 was identified, mutation of this site altered the mobility of 
the 30kDa phosphoprotein, providing further evidence that UL34 is the US3 substrate.
Interactions between the US3 protein kinase and the UL34 substrate have been partially 
characterised by Purves et al, (1992). The 34kDa phosphoprotein observed only in lysates 
from cells infected with the US3 deletion mutant does not react with anti-UL34 antisera, 
confirming this product is not an alternative processed form of UL34. Several novel 
phosphoproteins have been observed in lysates from cells infected with the US3 deletion 
mutant; a 33kDa protein was invariably observed and occasionally otber^Dhosphoproteins 
were apparent. Novel phosphoproteins seen in the US3 deletion mutant^re observed only 
when UL34 is not phosphorylated; similar patterns are observed in a mutant in which the 
site of phosphorylation in UL34 is mutated (Purves et al, 1992). In its unphosphorylated 
state UL34 exists as a complex , phosphorylation of UL34 leads to the disruption of this 
complex.
Purified virions contain the UL34 gene product and UL34 is also associated with cell 
membranes. The localisation of UL34 to cell membranes is not dependent on its 
phosphorylation state (Purves et al, 1992). The exact role of the US3 protein kinase in 
viral replication has yet to be determined, no significant affect on viral replication has been 
observed with mutants in the US3 ORF (Purves et al, 1992).
h) VZV ORF66
ORF66 of VZV is the homologue of HSV-1 US3, the homology between these genes was 
first noted by McGeoch and Davison, (1986). Immunoprecipitations of in vivo phosphate 
labeled extracts from cells infected with a recombinant vaccinia virus expressing ORF66 
and from VZV infected cells demonstrated that the 48kDa ORF66 gene product is 
phosphorylated. However, Stevenson etal, (1994) failed to show in vitro phosphorylation 
of the recombinant vaccinia expressed protein. The intracellular localisation of ORF66 protein 
was found, like US3, to be exclusively cytoplasmic (Stevenson et al, 1994).
c) PRV homologue
The US3 homologue in PRV has been cloned and mapped to the unique short region of 
PRV (Zhang et al, 1990). The degree of homology to the HSV-1 gene is varied; showing 
the greatest homology toward the C-terminal catalytic domain and high degree of 
divergence toward then N-terminal domain. The protein kinase activity of this gene 
product was demonstrated by immunoprecipitation followed by in vitro kinase assays of 
extracts from PRV infected cell extracts (Zhang e ta l, 1990). Like the HSV-1 US3 gene 
product, the PRV US3 protein kinase is cytoplasmic and is detectable in small amount with in
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the PRV virion. Purified PRV US3 protein kinase phosphorylates virion proteins (Zhang 
eta l, 1990).
1C. 1.2 UL13 and homologues
This protein kinase, conserved throughout the alpha-,beta- and gamma-herpesviruses, was 
first identified at the UL13 locus of HSV-1 (Chee et a l , 1989; Hanks et a l , 1988; 
McGeoch and Davison, 1986; Smith and Smith, 1989); in VZV ORF 47; PRV gene has 
not as yet been defined; in HCMV the UL97 gene; in EBV the BGLF4 gene and in HHV6 
the 15R gene. The conservation of this protein kinase suggests it may play a critical 
regulatory role in herpesvirus replication. The protein kinases found within the UL region 
appear to belong to a novel class of protein kinase and may therefore be good candidates 
for the development of an antiviral, effective against all herpesviruses. To date, protein 
kinase activity has been demonstrated for UL13 of HSV-1 (Cunningham et a l, 1992, 
Purves and Roizman 1992; Coulter et al, 1993); for VZV ORF47 (Ng and Grose, 1992) 
and for the PRV UL13 homologue (de Wind et al, 1992).
a) HSV-1 UL13
A protein kinase activity associated with this gene was first described by Cunningham et 
al, (1992). Nuclear extracts form mock or HSV-1 infected cells were assayed in vitro for 
kinase activity, a major phosphoprotein of 57kDa unique to infected cell nuclear extracts 
was observed. This phosphoprotein was first observed at 2-3 hr post-infection and levels 
peaked at 5 hr post-infection, remaining constant after 5 hr.
HSV-l/HSV-2 intertypic recombinants mapped the gene encoding the 57kDa 
phosphoprotein, to between UL9 and UL15. Immunoprecipitations using an anti-UL13 
fusion antisera, followed by in vitro kinase assays produced a 57kDa band unique to 
precipitates from infected cells (Coulter et al, 1993). The UL13 protein kinase is 
associated with the virion, disruption of pure virion preparations followed by in vitro 
kinase assays produces a major phosphoprotein which co-migrates with the 57kDa 
observed in infected cell nuclear extracts. Immunoprecipitation of disrupted virion preps 
followed by in vitro kinase assays provided further proof that this major virion-associated 
phosphoprotein was identical to the 57kDa product of the UL13 gene observed in the 
nuclei of infected cells (Coulter et al, 1993).
Two mutants in UL13 have been described; an insertion mutant in which the open reading 
frame was destroyed by insertion of a lacZ expression cassette (Coulter et a l, 1993) and a 
deletion mutant in which the entire UL13 locus was deleted (Purves and Roizman, 1992). 
These mutants were used to characterise substrates of this kinase activity. Comparisons of
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nuclear and virion-associated phosphoprotein profiles from cells infected with either the wt 
or the UL13 mutant virus were made. Two major phosphoproteins were altered by 
destruction of the UL13 gene; the UL13 gene product itself (57kDa) and a virion- 
associated 38kDa protein The 38kDa phosphoprotein in cells infected with wt virus shows 
an almost identical kineticsof phosphate incorporation to the UL13 encoded 57kDa protein. 
Intertypic recombinants were used to identify the UL13 38kDa substrate, the gene 
encoding the 38kDa phosphoprotein was found to be UL49 (VP22) which encodes a major 
tegument protein previously described by Elliot and Meredith, (1992).
The deletion mutant in which the entire UL13 ORF is removed was used by Purves and 
Roizman, (1992) to characterise potential substrates for the UL13 protein kinase. In 
addition, the possible relationship between the UL13 and US3 protein kinase activities of 
HSV-1 was investigated using a mutant in which both open reading frames were deleted. 
Several phosphoproteins were altered in whole cell, in vitro labelled, extracts from BHK 
cells infected with the UL13 deletion mutant. The most striking difference was observed 
in the pattern of phosphorylation of a viral associated 70kDa band. In the absence of the 
UL13 protein kinase this band accumulates and higher Mwt phosphoproteins of ~80kDa 
are reduced, in contrast to in vitro labelled extracts from cells infected with wt HSV-1 in 
which the higher Mwt bands are more predominant than the lower Mwt 70kDa 
phosphoprotein. Western blot analysis was used to identify the viral protein 
phosphorylated by the UL13 kinase, antisera specific to ICP22 (IE68) reacted with both 
the 70kDa and the higher Mwt species. It has been proposed that the UL13 protein kinase 
is essential for post-translational modification of the ICP22 protein. Confirmation that 
ICP22 is the 70kDa came from analysis of a mutant in the ICP22 locus, the 70kDa and 
associated species were absent in extracts from cells infected with this mutant (Purves and 
Roizman, 1992).
In both studies the effect of the mutations in the UL13 locus on viral replication was 
investigated, in both cases the mutations did not appear to have a profound effect on viral 
replication. To date, two separate viral proteins have been proposed as substrates for the 
UL13 kinase activity; one an immediate early protein, ICP22 (IE68), whose function is, at 
present, unknown and the other, a virion tegument protein |UL49 (Elliot andjMeredith, 
1992).
b) VZV ORF 47
The VZV homologue of HSV-1 UL13, open reading frame 47, a gene of the unique long 
region of VZV was identified as a possible protein kinase (Smith and Smith, 1989). 
Immunoprecipitation, followed by in vitro kinase assay, using an anti-ORF47 fusion 
antisera demonstrated that the 54kDa product of ORF47 is a functional protein kinase (Ng
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and Grose, 1992). Phosphoamino acid analysis showed that VZV ORF 47 predominantly 
phosphorylates serine residues and to a lesser extent threonine. The intracellular 
localisation of VZV ORF47 appears to differ from HSV-1 UL13, showing a cytoplasmic 
localisation with a strong perinuclear association Like HSV-1 UL13£)RF 47 is associated 
with the virion (Stevenson et al., 1994).
Co-immunoprecipitation experiments using ant-ORF47 specific antisera and antisera to 
known VZV phosphoproteins (ORFs 4,61,66 and 63) identified a substrate for the ORF47 
protein kinase in infected cells. Co-precipitation of ORF62 with ORF47 followed by in 
vitro kinase assays demonstrated that ORF62 is a substrate of the ORF47 protein kinase, 
ORF62 is the Vmwl75 homologue of VZV, it is a major transcriptional activator in VZV.
c) PRV UL13 Homologue
Unlike HSV-1 and VZV, the complete genomic sequence of PRV has not been 
determined. A UL13 homologue in PRV was identified by random mutagenesis of a 
49Kbp region of the UL segment, cloned into a cosmid vector (de Wind et al., 1992). The 
mutagenesis method, first described by de Wind et al., (1990), randomly inserts 
oligonucleotides, containing translational stop codons in all three reading frames and an 
EcoRl site (no EcoRl site in T1W genome), throughout the region of interest. Viral 
mutants were constructed by co-transfecting the linearised mutated DNA with wt viral 
DNA. Using an HSV-1 UL13 probe, and low stringency conditions, two Icosmids 
containing the mutated PRV UL13 homologue were isolated, one in 5 ' region and the 
other in the 3' region. The PRV homologue was in vitro transcribed and translated and 
found to produce a protein within the predicted Mwt range (41kDa). Transient transfection 
assays were performed to show that the PRV UL13 homologue possesses protein kinase 
activity. Using a VSV glycoprotein epitope the PRV UL13 open reading frame was 
tagged allowing the protein to be easily immunoprecipitated, and assayed for kinase 
activity in vitro. To show that kinase activity was a function of UL13 homologue from
I was constructed
PRV, and not a minor contaminating kinase, a mutant^n wmch the putative lysine 
involved in phosphotransfer (lys 103) was mutated to a methionine; this mutant 
immunoprecipitated but failed to autophosphorylate.
(d) HCMVUL97
Unlike the alpha-herpes homologues of UL13, the HCMV UL97 does not act as a protein 
kinase (Littler et al, 1992; Sullivan et al., 1992). Phosphorylation of an antiviral 
nucleoside analogue, ganciclovir, is observed in vitro by the recombinant UL97 gene 
product (Littler et al., 1992), truncation of the N-terminal region of the UL97 ORF did not 
effect ganciclovir phosphorylating activity, confirming that the region with protein kinase 
homology is sufficient for activity. Marker rescue experiments of HCMV isolates resistant
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to ganciclovir identified UL97 as the gene responsible for ganciclovir phosphorylation 
(Sullivan et al, 1992). A region important for UL97 phosphorylation of ganciclovir is 
located at a site homologous to the nucleotide binding site of PKA (Sullivan et al, 1992).
1C.2 Vaccinia virus protein kinase
B1R
Vaccinia virus genes with regions of homology to known protein kinases were first 
described by Howard and Smith, (1989). Several reports have described a protein kinase 
activity associated with vaccinia virions (Paoletti and Moss, 1972; Kleiman and Moss, 
1973, 1975, 1975). The vaccinia virus protein kinase is tightly associated with the virus 
core, two virus proteins in heat inactivated extracts, of llkD a and 37kDa, are 
transphosphorylated. The B1R ORF shows homology to protein kinases with residues 
characteristic of a serine/threonine kinase.
The B1R gene has been overexpressed and its in vitro protein kinase activity characterised 
(Banham and Smith, 1992; Lin et al, 1992). Lin et al, (1992) expressed the B1R gene as 
a glutathionine-S-transferase fusion, affinity-purified protein autophosphorylates, and in 
addition, transphosphorylation of the exogenous substrates casein andfhistones was 
observed Confirmation that the kinase activity was a function of the B1R gene product 
was provided by assaying a mutant in which a lysine, predicted to be involved in phosphate 
transfer, was mutated to a glutamine; neither autophosphorylating or transphosphorylating 
activity was observed. Preferred sites of phosphorylation by the B1R kinase activity have 
been determined; in autophosphorylation the preferred site is a threonine, in 
transphosphorylation both serine and threonine were phosphorylated. Purified virions 
extracted and fractionated into envelope and core fractions were found, by Western 
analysis, to contain the B1R protein kinase. Two proteins, both components of the 40S 
ribosomal subunit, are transphosphorylated by B1R (Banham et a l, 1993). 
Phosphorylation of these proteins is observed early in infection.
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Figure 1C.1 Comparison of viral protein kinases. Comparison was carried out using 
University of Wisconsin GCG pileup program. The protein kinases belonging to the unique short region of 
alphaherpesviruses (HSVlUs3, VZV ORF 66) are compared to the UL13 family of protein kinases conserved 
throughtout the herpesvirus classes (a: HSV1 UL13; VZV 47; 0: HCMV UL97; HHV6 15R; y: EBV Bglf4), 
the vaccinia virus protein kinase B10R, the proposed vaccinia protein kinase B12R and the large subunit of 
HSV-1 ribonucleotide reductase (HSV-1 Rl). Pileup shows that there is limited conservation of residues 
between viral protein kinases. The large subunit of ribonucleotide reductase shows little similarity to other 
viral protein kinases. Residues involved in catalysis, where identified, are bolded.
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Figure 1C.1 continued
Hsvlus3 
VZV 66 
H sv lu l13 
VZV 47 
Hcmvul97 
Hhv6_15r 
B g lf 4 
W  BIOR 
W  BI2R 
HSV-1 Rl
201 250
LDSPPPETPK PSHTTPPSEA ERLCHLQEIL AQMYGNQDYP IEDDPSADAA
DTFVGQGKFR GAISTSPSHI MQTCGFIQ................... QMFP VEMSPGIESE
LASYVHSNPH GASGRPSGPS LQDAAVSRSS HGSRHRSGLR ERLRAGLSRW
 HHNTD GHEPNATAAD QQERESTNPT HGCVNHP...............WANPSTA
LVSLARTPLC RRRVGGVDAV LEENDVELRA E................. S QDSAVASGPG
VKS EC ESRSASLDES FGKCKHEIAC DCSAIEELLC HESLLDS. PM
 MDVNMAA ELSPTNSSSS GELSVSPEPP
.MASRPAASS PVEARAPVGG QEAGGPSAAT QGEAAGAPLA HGHHVYCQRV
Hsvlus3 
VZV 66 
H sv lu ll3  
VZV 47 
Hcmvul97 
Hhv6_l5r 
Bgl f 4 
W  BIOR 
W  BI2R 
HSV-1 Rl
Hsvlus3 
VZV 66 
H sv lu ll3  
VZV 47 
Hcmvul97 
Hhv6_15r 
B glf 4 
W  BIOR 
W  BI2R 
HSV-1 Rl
Hsvlus3 
VZV 66 
H sv lu ll3  
VZV 47 
Hcmvul97 
Hhv6_15r 
B glf 4 
W  BIOR 
W  BI2R 
HSV-1 Rl
251 300
DDVDEDAPDD VAYPEEYAEE LFLPGDATGP LIGANDHIPP PCGASPPGIR
DDPNYDVNMD IQSFNIF................................................................................
RMSR..SSHR RASPETPGTA AKLNRPPLR. RSQAALTAPP SSPSHILTLT 
TCME..SPER SQQTSLFLLK HGLTRDPIHQ RERVDVFPQF NKPPWVFRIS 
RIPQPLSGSS GEESATAVEA DSTSHDDVHC TCSNDQIITT SIRGLTCDPR 
KLSNAHTIFS SNKWKLELEK IIASKQIFLD MSENAELAAY G. . ETLCNLR 
RETQAFLG...............KVTVID YFTFQHKHLK VTNIDDMTET........................
NGVMVLSDKT PGSASYRISD SNFVQCGSNC TMIIDGDWR GRPQDPGAAA
301
RRSRDEIGAT
RIRKLCSPVF
KLSRLIVPIF
MFLRLTHPEL
IFEKISSPFL
GFTAEE___
. . . . DG___
. . AINPALHY 
. .TLNEQLCF 
CEL.. .SISY 
FDVQSEERSY
. . . . MDSGIY 
SPAPFVAVTN 
351
MGFTIHGALT 
.GFVILKTFT 
GGYGDVQLIR 
GTYGRVHIYP 
GSFGEVWPLD 
GAYGKVFDLD 
GSYGAVYAHA 
. . .GGLFINN 
DGKKWIIGNT 
PPPPPRFTLG
. . LDAMDREA 
. . VHETEAEA 
TTLEIPGARS 
SKLQIRDRPR 
LLVYVPKEDD 
SWYVPHNKE 
LYVKLPENMT 
VSAVSVNNTI
ARAISRGGKP
SVALCAEARV
FG................
FA................
FCHKICYAVD 
LCGQFCQPEK 
RCDHLPITCE 
FVT..............
350
PSTMAKLVTG
GINKA.........
................. GS
................. GR
MSDESYRLGQ 
TMARV.. LGV 
 YLLGR
ETPINYKKSN 
IGAGSDGGTA WAFGGTPRR SAGTSTGTQT
PGSEGCVFDS 
PGAEGFAFAC 
EHKLAVKTIK 
SSKIAVKTMD 
RYRWKVARK 
. . KVAIKTAN 
DNATVKLYDS 
SNSTIWNNM 
LYSGNSILYK 
GGCCSCRDTR
SHPDYPQRVI 
MDSKTCEHW 
EKEWFAVELI 
SRV.FNRELI 
HSETVLTVWM 
EDESVISAFI 
VTELYHELMV 
EKLDIYKDKQ 
VRKNFTSSFY 
RRSAVFGGEG
VKAGWYTSTS 
IKAGQRQGTA 
ATLL.VGECV 
NAIL.ASEGS 
SGLIR.TRAA 
AGVIR.AKSG 
CDMIQIGKAT 
WSIIEMPMAR 
NYVMKIDHKS 
DPVGPAEFVS
MESFKYCFDN
ADVPTEALGG
400
HEARLLRRLD 
TEATVLRALT 
LRAGRTH.
I RAG ERL. 
GEQQQPP. 
ADLLSHE. 
AEDGQDK. 
VYHGIDS. 
HKPLLSEIRF 
DDRSSDSDSD
401
Hsvlus3 HPAILPLLDL
VZV 66 HPSWQLKGT
H sv lu ll3 . .N I...........
VZV 47 . .G I...........
Hcmvul97 . . SLVGTGVH
Hhv6_l5r . . CVIN. . . .
B glf 4 . .ALVDY. . .
W  BIOR . . TFGMLYFA
W  BI2R YISVLDPLTI
HSV-1 Rl DSEDTDSETL
HWSGVTCL.................VLPK
FTYNKMTCL................. ILPR
RGFIAPLGFS LQQRQIVFPA 
SSIVCLLGFS LQTKQLLFPA 
RGLLTATGCC LLHNVTVHRR 
.NLLISNSVC MSHKVSLSRT
............ LSAC TSCHALFMPQ
GGLSVTEQYG NLEKNNEISC 
DNWTRERGIK YLAIPDLYGI 
SHASSDVSGG ATYDDALDSD
450
YQADLYTYLS R.......... RLNP
YRTDLYCYLA A.......... KRN.
YDMDLGKYIG QLASLRTTNP 
YDMDMDEYIV RLSRRLTIPD
FHTDMFHHDQ W............... KL
YDIDLHKFED W...............DV
FRCSLQDYGH W...............HD
YNPRTNKWFD ISYTIYKISI 
GETDDYMFFV IKNLGRVFAP 
SSSD.....................................
53
Chapter 1. Introduction
Figure 1C.1 Continued
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Figure 1C.1 Continued
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1 C.3 HSV-1 -induced phosphorylation
There are 35 phosphorylated viral specific polypeptides (Wilcox et al, 1980) a few have 
been characterised. Cellular protein phosphorylation patterns are altered by infection with 
HSV-1, HSV-1, like vaccinia virus, alters the pattern of ribosomal protein phosphorylation 
during infection (Kennedy etal., 1981; Masse et al., 1990).
1C.3.1 Phosphorylation of immediate early polypeptides of HSV-1
The immediate early polypeptides Vmwl75 (Pereira et al., 1977), VmwllO (Ackermann et 
a l ., 1984), Vmw63 (Wilcox et al., 1980) and Vmw68 (Wilcox et al., 1980; Purves et al, 
1992) are phosphorylated in vivo. The point at which these proteins exist as 
phosphoproteins in the infected cell was investigated by Wilcox et al., (1980). 
Phosphorylation of Vmwl75 occurs very soon after infection whereas optimal levels of 
Vmw63 phosphorylation is not observed until 2 hr post-infection. It was suggested by 
Wilcox that differences in the pattern of phosphorylation of the immediate early proteins 
were due to different protein kinase requirements; the kinase which phosphorylates 
Vmwl75 being present in an active form early in infection, whereas the protein kinase 
required for Vmw63 phosphorylation only becomes active several hours into the 
productive infection. In addition, Wilcox et al., (1980) showed that the abundance of the
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phosphorylated form of Vmw63 varied throughout infection, phosphate cycling on and off 
this particular protein, a similar situation was suggested for VmwllO.
Of the immediate early polypeptides the importance of phosphorylation in determining 
activity is known only for Vmwl75. The phosphorylation state of Vmwl75 has been 
shown to effect the interaction of Vmwl75 with immediate early, early and late leader 
sequences (Papavassiliou e ta l , 1991). Unphosphorylated Vmwl75 having a greater 
affinity for immediate early leader sequences and phosphorylation appears to be essential 
for complex formation on early and late leader sequences.
1C.3.2 Phosphorylation of non-glycosylated membrane proteins
Two non-glycosylated membrane proteins are phosphoryalted in vivo; UL34 the substrate 
of the US3 protein kinase (Purves et al., 1991; Purves et a l ., 1992) and UL31 (Chang and 
Roizman, 1993). The effects of phosphorylation on UL34 have been discussed (see 
Section 1C. 1.2), briefly, in the absence of UL34 phosphorylation several new 
phosphoproteins are observed, the lack of phosphorylation of UL34 does not however 
appear to impair the replication of the virus. UL31, which contains casein kinase II, cAMP 
kinase and protein kinase C phosphorylation sites is phosphorylated in vivo (Chang and 
Roizman, 1993). This protein associates with the nuclear matrix and is essential for viral 
replication. The importance of phosphorylation on the activity of this protein is presently 
unknown.
1C.3.3 Phosphorylation of capsid proteins
The capsid protein, VP26, the product of the UL35 ORF is phosphorylated, this protein 
appears in three forms depending on its extent of phosphorylation, the phosphorylated 
form is the most abundant in the virion (McNabb and Courtney, 1992). The importance of 
phosphorylation in the localisation of this protein, to discrete areas of the nucleus, and in the 
formation of mature virions is unknown. This protein, although not essential for capsid 
formation, appears to play a role in the formation of a mature virion particle.
The capsid-associated polypeptide, VP22 (ICP35) is phosphorylated in vivo (Braun et al, 
1984). This family of differentially processed polypeptides attaches to mature capsid 
particles, attachment is however completeley dependent on the packaging of the DNA into 
the capsid.
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1C.3.4 Phosphorylation of RNA Pol II in HSV-1 infected cells
The phosphorylation of RNA Pol II is altered in cells infected with HSV-1 (Rice et al,
1994). Instead of the typical phosphorylated form, RNA Pol HO, a new form which 
migrates between the fully | phosphorylated and the unphosphorylated form appears, Rice et 
al., (1994) have called this faster migrating phosphorylated species RNA pol Hi 
(intermediate). The localisation of RNA pol II in infected cells was investigated (Rice et 
al, 1994), pol II co-localised with UL29, the major DNA binding protein involved in the 
formation of HSV-1 replication compartments. Phosphorylation of pol II is thought to be 
important in the removal of histones from promoters allowing the de-repression of the 
promoter (Peterson et al., 1991). Rice et al, proposed that by preventing the full 
phosphorylation of RNA pol II the virus may alter the ability of Pol II to interact with 
normal cellular promoters, allowing the preferential expression of virus genes since in the 
lytic state the viral genome is not associated with histones (Leinbach and Summers, 1980; 
Muggeridge and Fraser, 1986). The aberrant pattern of Pol II phosphorylation was shown 
to require the expression of an immediate early gene (Rice et al., 1994).
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ID Ribonucleotide reductase
1D.1 The need for an HSV-1 encoded enzyme.
The cellular ribonucleotide reductase is active only in actively dividing cells, viral 
replication in terminally differentiated neurons and non-dividing cells is completely 
dependent on the virus enzyme. Mammalian ribonucleotide reductase exists as a tetramer 
composed of dimers of the two subunits, the large subunit (Rl) and the small subunit (R2) 
(Reichard, 1988; Wright et al., 1990; Hurta and Wright, 1992). The activity of the 
mammalian enzyme correlates with the onset of DNA replication during the S-phase of the 
cell cycle (Lewis et al, 1978; Weber, 1983); control of the activity is dependent on the 
synthesis of the small subunit during S-phase (Wright et al., 1992; Bjorkland et al., 1990). 
Once R2 is expressed^ reductase activity is controlled by phosphorylation of R2. 
Phosphorylation is important in the regulation of ribonucleotide reductase iiynammalian 
cell (Albert and Nodzenski, 1989; Hurta and Wright, 1993). Recently, the direct 
phosphorylation of R2 by both p34cdc2 and CDK2 protein kinases has been demonstrated 
(Chan et al., 1993). The activity of both protein kinases is dependent on the cell being in a 
particular phase of the cell cycle.
1D.2 HSV-1 ribonucleotide reductase
A ribonucleotide reductase activity associated with HSV-1 was first suggested when it 
was found that HSV-1 replication was resistant to hydroxyurea, a potent inhibitor of the 
cellular reductase activity (Cohen et al., 1977). The HSV-1 enzyme exists as a tetramer of 
the type 06202, composed of two dimers of each of the subunits, the 136kDa large subunit, 
and the 38kDa small subunit (Frame et al., 1985; Bachetti et a l, 1984; Ingemarson and 
Lankinen, 1987). The activity of the HSV-1 enzyme differs from that of the cellular 
enzyme, it does not have an absolute requirement for Mg2+ or ATP, and it is not 
allosterically regulated (Cohen, 1972; Ponce de Leon et al., 1977; Huszar and Bachetti, 
1981; Langelier et al., 1978). The activities of the other herpesvirus ribonucleotide 
reductases are similar to that of HSV-1; PRV (Lankinen et al., 1982), VZV (Spector et al.,
1987), and EBV (Henry et al., 1978). Comparison of the amino acid sequences of the 
herpesvirus ribonucleotide reductases with the sequences of the mouse, clam T4 and E.coli 
enzymes showed that there is conservation throughout species (Eriksson and Sjoberg,
1988). The reducing power of HSV-1 ribonucleotide reductase is supplied by thioredoxin
58
Chapter 1. Introduction
(Darling et al., 1988), a small cellular protein which contains an oxidation-reduction-active 
disulphide provided by cysteine residues (Holmgren, 1968), the disulphide acts as a 
hydrogen donor for ribonucleotide reductase (see Figure 1D.1).
Figure 1D .1 Catalytic mechanism of ribonucleotide reductase. Ribonucleoside 
diphosphates are reduced to deoxyribonucleosides diphosphates by ribonucleotide reductase (RR). 
Reduction is mediated by the oxidation of sulphydryl groups in ribonucleotide reductase (RR-(SH)2).
1D.3 Ribonucleotide reductase and vims pathogenicity.
Mutants in the HSV-1 ribonucleotide reductase large and small subunits have been used to 
determine the importance of this enzyme in viral replication, both lytic and latent. Its role 
in lytic replication in tissue culture was first determined using two temperature sensitive 
mutants, tsl207 containing a single point mutation in the large subunit (Preston et al., 
1984; Nikas et a l , 1990), and tsl222 which contains a frame shift in the small subunit, R2 
(Preston et al, 1988). The mutant tsl222 fails to produce any detectable viral specific 
reductase activity at both the permissive and the non-permissive temperature. In actively 
dividing cells the growth of tsl222 is essentially similar to that of the wt virus, in contrast, 
growth on serum starved, or confluent cells, is impaired severely. In dividing cells, when 
the cellular enzyme is active, the mutation in the HSV-1 reductase is complemented 
(Preston et al, 1988). A similar phenotype was found for the R1 mutant tsl207 at the 
non-permissive temperature (Preston et al, 1984). In vivo studies using these mutants 
showed that ribonucleotide reductase activity is essential for neuropathogenicity, the 
mutants fail to replicate following intracranial inoculation of mice (Cameron et a l, 1988).
Insertion and deletion mutants in the HSV-1 R1 locus have also been constructed 
(Goldstein and Weller, 1988a; Goldstein and Weller, 1988b). The pathogenicity of both 
mutants has been determined (Jacobson et a l, 1989; Yamada et al, 1991). The deletion 
mutant, ICP6A, in which the entire R1 open reading frame is deleted was tested for its
RR RR
C H2 O P>  O v R a  s  e
K h  H yH + H20
OH OH OH H
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ability to replicate in mice. Explantation of ganglia from mice infected with ICP6A 
followed by co-cultivation of the ganglia with permissive cells failed to produce any 
detectable virus, demonstrating the importance of ribonucleotide reductase in either the 
establishment, maintenance or reactivation of HSV-1 (Jacobson et al., 1989). Using the 
the lacZ insertion mutant (Goldstein and Weller, 1988a), Yamada et al., (1991) showed 
that this reductase null mutant could successfully establish latency, and that it was the 
reactivation of this virus that was specifically impaired; mice latently infected with this 
mutant were superinfected with HSV-2, several days after superinfection, ganglia were 
explanted and the number of reactivating HSV-1 insertion mutants scored by staining 
resultant plaques with P-galactosidase. Blue plaques were detected, indicating that the 
mutant viral genomes were present in the ganglia, and that reductase activity is not 
essential in either the establishment or the maintenance of the virus in the ganglia (Yamada 
et al., 1991). In the guinea-pig epithelial model the R1 mutants show no growth 
impairment when compared to wt virus (Turk et al., 1989), which raises the question of 
which animal model more closely mimics the human situation.
1D.4 Proteolytic cleavage of R1 in infected cells.
The large subunit of ribonucleotide reductase is proteolytic cleaved in certain cell lines 
during lytic replication (Ingemarson and Lankinen, 1987; Lankinen et al., 1989). The 
cleavage of R1 in infected cells was first noted in Vero cells, full length R1 with the 
molecular weight 136kDa degrades to 110, 93 and 81kDa forms (Ingemarson and 
Lankinen, 1987). Cleavage of R1 is inhibited by the protease inhibitor Na -P-tosyl-L- 
lysine chloromethylketone (TCLK), a serine and sulphydryl protease inhibitor. Cleavage 
of R1 in infected Vero cell extracts is inhibited by the addition of 3T3 cell extracts, 
cleavage is therefore cell line specific. Cleavage of R1 is also observed in infected BHK- 
21 cells, multiple bands are observed with antibodies directed against R1 (Preston et al., 
1984;Huszarand Bacchetti, 1983iHuszar^ al., 1983). Ingemarson and Lankinen, (1987) 
proposed that at least one cleavage product, the 93kDa, contains reductase activity: extracts 
in which no full length R1 could be detected, but the 93kDa form was present, contain 
HSV-1 specific reductase activity. Further degradation to the 81kDa product results in no 
detectable reductase activity. The proteolytic fragments of R1 have been mapped using a 
series of antisera raised against fragments of the R1 open reading frame fused to p- 
galactosidase (Lankinen et al., 1989). Sites of proteolytic cleavage map to the region 
between the unique N-terminal region (Nikas et al., 1986) of R1 and the C-terminal portion 
homologous to other R1 proteins, only antibodies which were raised against the conserved 
portion of R1 reacted with the 93kDa and 81kDa fragments, showing that only the N- 
terminal portion of R1 is removed (Lankinen et al., 1989). The cleavage of the R1 to at
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least one fragment, the 93kDa , does not impair reductase activity (Conner et al., 1992a). 
Using pro teases, chymotrypsin and trypsin, to cleave full length R1 expressed in E.coli 
(Furlong et al., 1991) it was shown that the interaction of the C-terminal cleavage 
products, which lack the N-terminal region, with R2 was unimpaired and they possess full 
reductase activity, showing the N-terminal region of R1 does not play a role in the 
reductase activity (Conner et al, 1992a). Conner et al, (1993) mapped minimal regions of 
R1 required for its interaction with R2, and for its dimerisation, using randomly generated 
truncations of Rl. Interaction between R1 and R2 requires a region in R1 between amino 
acids 349 and 373 and the dimerisation of Rl requires amino acids be£v$en 420 and 457, 
although Conner et al, (1993) indicated that other regions of Rl were most likely involved 
in dimerisation. The dimerisation domain of HSV-1 Rl con^ins a stretch of leucines 
which could potentially form a zipper-like structure, the corresponding region in HSV-2 is 
also thought to play a role in Rl dimerisation (Chung et al, 1991).
1D.5 HSV ribonucleotide reductase as an antiviral target
HSV-1 ribonucleotide reductase activity can specifically be inhibited by a synthetic 
peptide, YAGAVVNDL, this peptide represents the extreme C-terminal region of the small 
subunit, R2. The nonapeptide inhibits HSV ribonucleotide reductase activity in vitro 
(Dutia et al, 1986; Cohen et al, 1986), inhibition of reductase activity is specific to the 
HSV enzyme, no affect on the cellular enzyme was observed. Inhibition occurs by 
preventing the interaction of the two subunits of ribonucleotide reductase (McClements et 
a l, 1988; Darling et al., 1988). By linking a photoaffinity tag to the peptide its interaction 
with the large subunit was demonstrated (Paradis et al., 1988). The potential of this 
nonapeptide; as a general inhibitor of all herpesvirus ribonucleotide reductases has been 
demonstrated (Dutia et al., 1986).
1D.6 Expression of Rl
1D.6.1 HSV-1
Like the immediate early genes of HSV (types 1 and 2) the large subunit of ribonucleotide 
reductase is expressed in the presence of cycloheximide (Watson and Clements, 1977). 
Expression of HSV-1 Rl is optimal in the presence of VmwllO (Goldstein and Weller, 
1988a; Sze and Herman, 1992). The Rl gene and upstream regions were transfected with 
the virus transactivators Vmw65, Vmwl75 and VmwllO and expression of R l was 
monitored by immunofluoresence, only when the cell lines were transfected with a
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construct expressing VmwllO was expression of Rl observed (Goldstein and Weller, 
1988a).
Sze and Herman, (1992) analysed Rl promoter activity using HSV-1 mutants in which the 
Rl promoter region was fused to the E.coli lacZ gene allowing expression to be monitored 
by determining p-galactosidase activity. To determine levels of Rl expressed at 
immediate early times, infections were carried out in the presence of cycloheximide the 
cycloheximide block was then removed and the P-gal activity produced by the Rl 
promoter was compared to levels of P-gal produced from a mutant in which P-gal 
expression was driven by the Vmwl75 promoter. The P-gal activity produced by the Rl 
promoter were considerably lower than observed for the Vmwl75 promoter, and it was 
therefore concluded that the Rl promoter is only weakly activated by Vmw65. 
Confirmation of this came from analysis of Rl expression in cell lines containing both the 
Rl promoter/LacZ hybrid gene and Vmw65 under the control of the Imetallothionein: 
promoter. When expression of Vmw65 was induced by the addition of Zn2+ to the 
medium, only moderate increases in P-gal activity were observed. From these analyses it 
was concluded that the weak induction of HSV-1 Rl is mediated by a weak Oct-l/Vmw65 
complex forming on the imperfect TAATGARAT motif (AATGGGAT, see Figure 1D.3).
Further investigations of Rl expression were made in the cell line containing the Rl/lacZ 
hybrid in the absence of Zn2+. Cells were infected with HSV-1 mutants in either Vmwl75 
or VmwllO, and the ability of these mutants to induce expression of P-gal from the Rl 
promoter was compared to levels produced by infection with wt HSV-1. Induction was 
optimal with the Vmwl75 mutant, and greatly reduced in infections with the VmwllO 
mutant, again showing the importance of VmwllO in maximal R l expression and 
confirming the results of Goldstein and Weller, (1988a).
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HSV-2
Figure 1D.3 Comparison of the Rl promoter regions of HSV-1 and HSV-2. Elements 
previously identified, important in Vmw65 induction, the TAATGARAT and GA-rich motifs are shown in 
bold, AP-1 elements and SP-1 elements are also highlighted.
1D.6.2 HSV-2 Rl expression
HSV-2 Rl expression has been analysed by both immunofluoresence and by transient 
transfection analysis (Wymer et al, 1989). Enhanced expression of HSV-2 R l, as 
analysed by immunofluoresence, was observed when plasmids expressing Vmw65 and 
VmwllO were co-transfected with construct containing the entire R l open reading frame 
and upstream promoter region. A region, from -533 to +103, was found to confer the 
response to Vmw65. Co-transfection with a VmwllO expressing construct also increased 
Rl promoter activity. As observed in the analysis of expression by immunofluoresence, 
the Rl promoter failed to respond to Vmwl75. Induction of expression from the Rl 
promoter is dependent on orientation. When placed in the opposite orientation the Rl 
upstream region fails to respond to either VmwllO or Vmw65. In several cell lines 
investigated, Hep2 (human laryngeal carcinoma cells), 293 (adenovirus transformed cells) 
and in primary astrocytes, transactivation by Vmw65 was demonstrated; in contrast, 
induction by Vmwl 10 was found to be cell-type specific.
Wymer et al., (1989) identified several cis-response elements in the Rl promoter; several 
SP-1 binding sites, two AP-1 binding sites, a TAATGARAT-like motif, an octamer motif 
overlapping the putative TAATGARAT, a single GA-rich element and a ATCGTC site,
SP-1 Oct-l/TAATGARAT?
AACGTCCTTTGGGCGGGAGGAAGCCACAAAATGCAAATGGGATACATGGA
II II II I I I I I I I I I I I I I I I I I I I I I I I I I
GTGTGTCTCTGAAATGGCGGAAAC -  -CGACATGCAAATGGGATTCATGGA 
GA-rich 
AP-1
AGGAACACACCCCCGTGACTCAGGACATCGGTGTGTCCTTTTGGGTTTCA
I I I I I I I I I I I I I I I II I I I I I I I I I II I I I I  
CACGTTACACCCCCCTGACTCAGGAGATAGGCATATCCTCCTTAGATTG
AP-1
TATA box
CTGA-AACTGGCCCGCGCCCCACCCCTGCGCGATGTGGATAAAAAGCCAG 
I I I  II I I I I I I I I I I I I I I I I I I I I I I  I I  I I I I  l.l 
CTCAGCACACGATCGCACCCCACCCCTGTGTGCCGGGGAT-AAAAGCCAA
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which may bind Vmwl75. Virus induced proteins were shown to interact with the Rl 
promoter (Wymer et al., 1989). Competition retardation analysis using oligonucleotides 
spanning the Octamer/TAATGARAT with mutations in the Octamer, TAATGARAT, or 
both, demonstrated the importance of the Octamer motif in the formation of the viral- 
specific complexes, oligonucleotides mutated in the Octamer motif failed to compete for 
the virus specific factor(s). Using in vitro translated Oct-1 and Vmw65 the viral-specific 
complexes were shown to contain Vmw65 (Wymer et al, 1989). Further analyses of the 
Octamer, TAATGARAT and GA-rich elements of the Rl promoter were made using 
mutants of a R 1/CAT hybrid construct, allowing the contribution of each element in 
mediating the response to Vmw65 to be investigated, the affect of these mutations is 
shown in table 1D.1.
Wild-type Fold activation M utant Fold activation
GA rich motif GGCGGAAAC 26 GGCTTAAAC 21
Octamer motif ATGCAAAT 26 AGCCAAAT 14
ATGCAAAT 26 ATGCACCT 2
GARAT AAATGGGATTC 26 AAATGGTCTTC 2
Table 1D.1 Analysis of ds-acting sequences in the HSV-2 R l promoter
As shown in the table above, mutation of both the Octamer motif, and the GARAT 
element, reduce Vmw65 transactivation. The GA-rich element mutant showed only a 
slight reduction in activation. In the HSV-2 Rl promoter Vmw65 transactivation is 
mediated by a imperfect TAATGARAT element.
1D.6.3. Analysis of the AP-1 motifs in the HSV-2 Rl promoter
Within the Rl promoters of both HSV-1 and HSV-2 AP-1 sites have been identified, a 
single site in HSV-1 and two in HSV-2 (Wymer et al., 1989). AP-1 (activator-protein 1) 
sites bind the cellular protein c-jun, which exists as a homodimer. C-junl has also been 
shown to exist as a heterodimer with c-fos, the heterodimer is a stronger activator of 
transcription. AP-1 elements in the HSV-2 Rl promoter are functional (Wymer et al.,
1992); transfections of F9 cells (essentially AP-1 negative) with the Rl promoter/CAT 
hybrid, and c-jun, enhanced CAT activity by 20-25 fold, and further increases were 
observed with the addition of c-fos in equimolar concentrations to c-jun. Gel retardation 
analysis using in vitro translated c-jun confirmed the interaction of this protein with the Rl 
promoter.
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1D.7 The unique amino terminal region of HSV Rl
HSV-1 and HSV-2 Rl are unique among the herpesviruses in that they both contain an 
amino terminal extension of around 300 amino acids. The function of this region has been 
extensively studied in HSV-2. The unique N-terminal region of HSV is shown in Figure
1D.2.
Figure 1D.2 Comparison of amino add sequences of HSV (1 and 2) R l with that of 
other large subunits. Comparisons were made using the University of Wisconsin (GCG) GAP 
program. The sequences of HSV-1 and HSV-2 Rl are compared to the sequences of VZV, EBV, HVS, 
HCMV, yeast, vaccinia (VV) and E.coli ribonucleotide reductase large subunits. Residues conserved 
throughout the alphaherpesviruses (HSV-1, HSV-2 and VZV) are shown in bold.
1 50
HSV-1 Rl MASRPAASSP VEARAPVGGQ EAGGPSAATQ GEAAGAPLAH GHHVYCQRVN
HSV-2 Rl MANRPAASAL AGARSPSERQ EPREPEVAPP G................... GDHVFCRKVS
VZV Rl .........................................................................................................................
EBV Rl .........................................................................................................................
HVS Rl .........................................................................................................................
Yeast Rl .........................................................................................................................
W  Rl .........................................................................................................................
E co li Rl .........................................................................................................................
HCMV Rl .........................................................................................................................
51 100
HSV-1 Rl GVMVLSDKTP GSASYRISDS NFVQCGSNCT MIIDGDWRG RPQDPGAAAS
HSV-2 Rl GVMVLSSDPP GPAAYRISDS SFVQCGSNCS MIIDGDVARG HLRDLEGATS
VZV Rl .........................................................................................................................
EBV Rl .........................................................................................................................
HVS Rl .........................................................................................................................
Yeast Rl .........................................................................................................................
W  Rl .........................................................................................................................
E co li Rl .........................................................................................................................
HCMV Rl .........................................................................................................................
101 150
HSV-1 Rl PAPFVAVTNI GAGSDGGTAV VAFGGTPRRS AGTSTGTQ..........................T
HSV-2 Rl TGAFVAISNV AAGGDGRTAV VALGGTSGPS ATTSVGTQTS GEFLHGNPRT
VZV Rl .........................................................................................................................
EBV Rl .........................................................................................................................
HVS Rl .........................................................................................................................
Yeast Rl .........................................................................................................................
W  Rl .........................................................................................................................
E co li Rl .........................................................................................................................
HCMV Rl .........................................................................................................................
151 200
HSV-1 Rl ADVPTEALGG PPPPPRFTLG GGCCSCRDTR RRSAVFGGEG DPVGPAEFVS
HSV-2 Rl PEPQGPQAVP PPPPPPFPWG HECCARRDAR............. GGAE KDVGAAESWS
VZV Rl .........................................................................................................................
EBV Rl .........................................................................................................................
HVS Rl .........................................................................................................................
Yeast Rl .........................................................................................................................
W  Rl .........................................................................................................................
E co li Rl .........................................................................................................................
HCMV Rl .........................................................................................................................
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Figure 1D.2 Continued
201 250
HSV-1 Rl DDRSSDSDSD DSEDTD SETLSHAS SDVSGGATYD DALDSDSSSD
HSV-2 Rl DGPSSDSETE DSDSSDEDTG SGSETLSRSS SIWAAGATDD DDSDSDSRSD
VZV Rl .........................................................................................................................
EBV Rl .........................................................................................................................
HVS Rl .........................................................................................................................
Yeast Rl .........................................................................................................................
W  Rl .........................................................................................................................
E co li Rl .........................................................................................................................
HCMV Rl  MNPA DADEEQRVSS
HSV-1 Rl 
HSV-2 Rl 
VZV Rl 
EBV Rl 
HVS Rl 
Yeast Rl 
W  Rl 
E co li Rl 
HCMV Rl
251 300
DSLQIDGPVC RPWSNDTAPL .................DV CPGTPGPGAD AGGPSAVDPH
DSVQPDVWR RRWSDGPAPV AFPKPRRPGD SPGNPGLGAG TGPGSATDPR
VPAHRCRPGR IPSRSAETET EESSAEVAAD TIGGDDSELE EGPLPGGDKE
301 350
HSV-1 Rl APTPEAGAGL AADPAVARDD AEGLSDPRPR LGTGTAYPVP LELTPENAEA 
HSV-2 Rl AS...ADSDS AAHAAAPQAD VAPVLDSQPT VGTDPGYPVP LELTPENAEA
VZV Rl .........................................................................................................................
EBV Rl .........................................................................................................................
HVS Rl .........................................................................................................................
Yeast Rl .........................................................................................................................
W  R l  ..................................................................................................................................................................................
E co li Rl .........................................................................................................................
HCMV Rl ASAGNTNVSS GVACVAGFTS GGGWSWRPE SPSPDGTPSV LSLTRDSGPA
351 400
HSV-1 Rl VARFLGDAVN REPALMLEYF CRCAREETKR VPPRTFGSPP RLTEDDFGLL
HSV-2 Rl VARFLGDAVD REPALMLEYF CRCAREESKR VPPRTFGSAP RLTEDDFGLL
VZV Rl ......... MEFKR IFNTVHDIIN RLCQHGYKEY
EBV R1
HVS R1
Yeast Rl . . . MFVYKRD GRQEKVAFDK ITARVSRLCY GLDSDHVDPV
W  Rl . . .MFVIKRN GYKENVMFDK ITSRIRKLCY GLNTDHIDPI
E co li Rl .................. M NQNLLVTKRD GSTERINLDK IHRVLDWAAE GLHNVSISQV
HCMV Rl VPSRGGRVSS GLSTFNPAGA TRMELDSVEE EDDFGASLCK VSPPIQATRM
401 450
HSV-1 Rl NYALVEMQRL CLDVPPVPPN AYMPYYLREY VTRLVNGFKP LVSRSARLYR
HSV-2 Rl NYALAEMRRL CLDLPPVPPN AYTPYHLREY ATRLVNGFKP LVRRSARLYR
VZV Rl ......... IIPPE STTPVELMEY ISTIVSKLKA VTRQDERVYR
EBV Rl .................. M ATTSHVEHEL LSKLIDELKV KANSDPEADV
HVS Rl ___ MSQETI ISNLIDMLKV SAGWDREANE
Yeast Rl EITQKVISGV YPGVTTIELD NLAAETAATM TTKH.PDYAI LAAR............
W Rl KIAMKVIQGI YNGVTTVELD TLTAEIAATC TTQH. PDYAI LAAR............
E co li Rl ELRSHI. .QF YDGIKTSDIH ETIIKAAADL ISRDAPDYQY LAAR............
HCMV Rl LMGKKCHCHG YWGKFRFCGV QEPARELPSD RNALWREMDT VSRHSAGLGS
451 500
HSV-1 Rl ILGVLVH... . LRIRTREAS FEEWLRSKEV ALDFGLTERL R......... EH. E
HSV-2 Rl ILGILVH... . LRIRTREAS FEEWMRSKEV DLDFGLTERL R......... EH. E
VZV Rl CCGELIH.. . . CRINLRSVS METWLTSP.. . . ILCLTPRV R......... QAIE
EBV Rl LAGRLLHRLK AESVTHTVAE YLEVFSDKFY DE. . EFFQMH R......... DELE
HVS Rl ISGRLFHKLM DMSSTETISQ YMSLFGPLLE PHILEFIQNY E......... QEID
Yeast Rl IAVSNLHKQT EKVFSTWQQ LHDYVNPKTD KPAPMISDKI Y......... DIVM
W Rl IAVSNLHKET KKLFSEVMKD LFNYVNPKNG KHSPIISSIT M......... DWN
E coli Rl LAIFHLRKKA YGQFEP..PA LYDHV. VKMV EMGKYDNHLL E......... DYTE
HCMV Rl FRLFQLIMRH GPCLIRHSPR CDLLLGRFYF KANWARESRT PLCYASELCD
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Figure 1D.2 Continued
HSV-1 Rl
501
AQLVILAQAL DHYDCLIHST PHTLVERGLQ SALKYEEFYL
550
. . . KRFGGHY
HSV-2 Rl AQLMILAQAL NPYDCLIHST PNTLVERGLQ SALKYEEFYL . . . KRFGGHY
VZV Rl GRRDEIRRAI . . LEPFLKDQ YPALATLGLQ SALKYEDFYL . . .TKLEEGK
EBV Rl TRVSAFAQSP A.................. YERIVSSGYL SALRYYDTYL YVGR.. . SGK
HVS Rl EVCLEYRASY D.................. FMCLRNCGIL PAKRFYDTYV LPPRTEMNGK
Yeast Rl KHKDELDSAI IYDRDFTYNF F.................. •GFKTLERSY L L .. RIDGKV
W Rl KYKDKLNSVI IYERDFSYNY F.................. .GFKTLEKSY LL..KINNKI
E coli Rl EEFKQMDTFI DHDRDMTFSY A.................. .AVKQLEGKY LVQNRVTGEI
HCMV Rl ESVRRFVLRH MEDLPKLAEE TARFVELAGC WGLYAAILCL DKVCRQLHGQ
1D.7.1 HSV-2 Rl kinase activity
Kinase subdomains were identified within the unique N-terminus of both HSV-1 and 
HSV-2 Rl with varying degrees of conservation between the two (Chung et a l, 1989). 
Regions located to the C-terminal part of the unique N-terminus show greater homology to 
the residues described by Hanks et al, (1988). Probably one of the most striking features 
of the N-terminal domain is the apparent lack of the lysine involved in phosphate transfer 
from the nucleotide binding site to the substrate. In HSV-1 no lysines are found in the 
region downstream of the proposed nucleotide binding site, and in HSV-2 the spacing of 
the lysine initially proposed (lys 177) is some 60 amino acids downstream of the 
nucleotide binding site, greatly exceeding the average spacing of between 14-23.
A kinase activity associated with HSV Rl was first demonstrated by Chung e ta l  (1989). 
Using monoclonal antibodies against HSV-2 Rl Chung et al, (1989) demonstrated that 
kinase assays of immunoprecipitates from either infected or transiently transfected cells 
produced a phosphoprotein of a Mwt identical to that of R l. Confirmation that the 
observed phosphoprotein was HSV-2 Rl came from comparisons of phosphoproteins 
immunoprecipitated from cells containing a frame shift mutation in R l, only cells 
containing the wild-type expression vector produced the 140kDa phosphoprotein. 
Phosphoamino acid analysis showed that HSV-2 Rl belongs to the serine/threonine class 
of protein kinase. In autophosphorylation reactions serine is the favoured site of phosphate 
transfer. The kinase activity was shown to be a feature of the unique N-terminal region of 
HSV-2 Rl, expression of the first 446 amino acids followed by immunocomplex kinase 
assay produced a phosphoprotein of 65kDa, this phosphoprotein was competed for using 
the peptide against which the monoclonal antibody used to precipitatewas raised. It was 
concluded that the phosphorylation of Rl occurs either in the absence of external factors, 
or that the activity phosphorylating Rl must be strongly associated.
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It has been reported that HSV-2 Rl is myristylated (Chung et al., 1990).
Immunoprecipitation of Rl from either infected or transfected cells grown in the presence
of [3H] myristic acid demonstrated that Rl was labelled with [3H]. The myristylation of
Rl lead Chung and colleagues to propose that the HSV-2 Rl activity may associate with
the plasma membrane, and that it may be related to the growth factor receptor family of
protein kinases which are also myristylated. Within the N-terminus of HSV-2 Rl (and
. j. This.HSV-1 Rl) there is a region nch in acidic ammo acids " is a feature common to the
growth factor receptor kinases and is important in the control of their activity (Morrison et
a l, 1989). Polylysine activation of growth factor receptor kinases is thought to be 
I theirmediated by ^  interaction with the highly acidic stretches of amino acids (Gatica et al, 
1987; Morrison et al, 1989). Increases in the kinase activity of HSV-2 Rl were observed 
in the presence of polylysine, but only in the presence of manganese. HSV-2 Rl 
transphosphorylates exogenous substrates, but only in the presence of polylysine and 
manganese.
iof
Regions important in the kinase activity of HSV-2 Rl were mapped by analysis^deletion 
mutants of HSV-2 Rl expressed in E.coli (Luo et al, 1991). The mutations made are 
shown in the table below (Table 1D.2).
Amino adds Activity
expressed
1-445 ++
1-416 ++
1-340 ++
Table 1D.2 Analysis of truncations of the HSV-2 R l N-terminal region.
Kinase assays were performed on immunoprecipitates of lysed E.coli extracts. The 
immunoprecipitates produced a phosphoprotein of a Mwt substantially smaller than 
predicted, 29kDa compared to the predicted 53kDa. The 29kDA product was shown to be 
HSV-2 Rl specific by performing competition experiments, immunoprecipitation of [35S] 
labelled methionine protein from E.coli extracts was effectively competed by the addition 
of infected cell extracts, but not mock infected cell extracts. Assays for 
autophosphorylating activity and transphosphorylating activity using deletions of the N- 
terminus from its C-terminus showed that only the first 340 amino acids were required for 
activity. Investigation of conditions optimal for autophosphorylation and 
transphosphorylation of the 29kDa showed that manganese was absolutely required for 
both activities.
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Mutations were introduced into the predicted subdomain I (nucleotide binding region) and 
II (essential lysine) to investigate the importance of these regions in HSV-2 Rl kinase 
activity (Luo and Aurelian, 1992). To determine if the nucleotide binding region is 
important, a glycine positioned in the middle of this proposed site, was converted to a 
proline. The role of the lysine located more than 70 amino acids downstream of the 
nucleotide binding region was investigated by converting this residue to a leucine. Internal 
deletions in the Rl open reading frame were also made; between amino acids 106-178 
removing the proposed subdomains I and n  (mentioned above), amino acids 86-106 
removing the region proposed by Chung et al, 1990 to be transmembrane, and amino acids 
106-445. Mutants were assayed for autophosphorylating activity and the Km value for 
each determined. Both the site directed mutants autophosphorylated and their Km values 
were slightly increased. Deletion of residues 86-106, and 106-445, destroyed activity and 
the deletion removing amino acids 106-178 was greatly impaired although 
autophosphorylation was observed. Further analysis of this mutant showed that the 
activation of the kinase activity by manganese had been destroyed it was proposed that this 
region mediates the interaction with manganese.
1D.7.2 Intracellular localisation of the HSV-2 R l/ amino terminal region
The intracellular localisation of HSV-2 Rl from infected cells was first determined by 
crude subcellular fractionation (Chung et al., 1989). Cells were labelled with [35S] 
methionine and fractionated into soluble, cytoskeletal and nuclear fractions. The amount 
of R l in each fraction was determined by immunoprecipitation, the majority of R l was 
located within the soluble or cytoskeletal fractions and was only observed in the nuclear 
fraction at later times post-infection. Rl localising to purified plasma membrane fractions 
was demonstrated by immunoprecipitation. All samples of R l localising to the soluble, 
cytoskeletal and plasma membrane fractions were shown to possess autophosphorylating 
activity.
Immunofhiorescenceshowed the large subunit localising to the cytoplasm in cells infected 
with HSV-2 (Wymer et al., 1989). Stably transformed cell lines expressing the large 
subunit showed Rl localising to the plasma membrane as well as the cytoplasm (Luo and 
Aurelian, 1992).
1D.7.3 Autophosphorylation of HSV-1 Rl
Autophosphorylation of HSV-1 Rl has been demonstrated (Conner et al., 1992b). Several 
truncations in Rl were used to localise both the site of phosphorylation, and the intrinsic
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protein kinase activity. A truncation in which the amino terminal 245 amino acids were 
removed shows no ability to autophosphorylate, indicating that either the site of 
phosphorylation or part of the active site of the kinase was contained within the amino 
terminal 245 amino acids. Using the truncation described in section 3A (Results and 
Discussion), dC449, expressing the first 449 amino acids of HSV-1 R l it was 
demonstrated that this region contains both the site of phosphorylation and all the residues 
required for autophosphorylation. Conditions optimal for autophosphorylation have been 
determined, activity is almost completely dependent on the presence of Mn^+, a divalent 
cation which like Mg^+ interacts with residues involved in phosphate transfer, by correctly 
orienting the phosphate to be transferred (Zheng et al, 1990). A 10-fold increase in 
activity is observed in the presence of the basic polypeptide protamine, the exact 
mechanism by which this basic polypeptide acts to stimulate activity is unknown. Both 
ATP and GTP can act as a source of phosphate for Rl autophosphorylation; GTP 
effectively inhibits 32p uptake. The dual nucleotide specificity of this enzyme is a feature 
shared with the UL13 protein kinase of HSV-1. Non-hydrolysable ATP analogues such as 
5 ' adenylylimidophosphate (AMP-PNP) and 5 ' fluorosulfonylbenzoyladenosine (FSBA) 
inhibit Rl autophosphorylation, FSB A inhibits protein kinase activity by inactivating the 
lysine residue involved in phosphate transfer, normally FSBA labels protein kinases at this 
residue (Kamps et al., 1984; Russo et al, 1985). FSBA inhibits the autophosphorylating 
activity of HSV-1 Rl but does not appear to bind to Rl, this has been observed for another 
protein kinase, the BCR protein kinase (Maru and Wittle, 1991).
Analysis of the kinetics of R l autophosphorylation demonstrated that Rl
autophosphorylation is an intramolecular reaction, other molecules of Rl are not
phosphorylated. In addition, by analysis of phosphate incorporation it was shown that there
is only one site of phosphorylation (Conner et al, 1992b). To determine the ability of
HSV-1 Rl to transphosphorylate, exogenous substrates, as used for HSV-2 Rl (Chung et
al, 1989) were added to pure preparations of HSV-1 R l. Initially, histone
transphosphorylation was demonstrated but further analysis showed that a truncation in
which the first 245 amino acids of Rl were removedtalso contained transphosphorylating
activity. This indicated that the transphosphorylating activity of full length Rl was most
likely a contaminant. The transphosphorylating activity was separated from the
autophosphorylating activity by FPLC. The transphosphorylating activity problems
highlight the problems encountered in the analysis of a protein kinase even when expressed
in E.coli and purified to apparent homogeneity. It is possible that a transphosphorylating 
1 is
activity^associated with the HSV-1 Rl but the substrate is highly specific or, a co-factor is 
required for the activity.
70
Chapter1. Introduction
IE. Aims of research
The initial aim of the work presented in this thesis was to locate and mutate regions of the 
HSV-1 Rl large subunit which are important in the autophosphorylating activity. The 
autophosphorylating activity was mapped to the unique N- terminus and found to reside 
within the first 449 amino acids of Rl. Insertional mutation of this region was carried out, 
it was hoped that these analyses would help to identify key catalytic regions or residues of 
th eautophosphorylating activity.
To directly compare the autophosphorylating activities of HSV-1 and HSV-2 R l, HSV-2 
Rl was overexpressed in Ecoli and purified to apparent homogeneity using the same 
purification scheme that had been determined for HSV-1 Rl.
Cell lines were constructed which express the N-terminal region of HSV-1 Rl to 
complement mutations introduced into this region in the virus. The importance of the N- 
terminal region in virus replication will be determined by the construction of an HSV-1 
mutant lacking this region.
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Chapter 2. Materials and Methods
2A Materials
2A.1 Cells 
2A.1.2 Eukaryotic cells
(a) BHK-21 clone 13 cells (McPherson and Stoker, 1962), a fibroblast cell line derived 
from baby hamster kidney cells were used for the growth and assay of HSV-1 strain 17 
svn+.
(b) Rat-1 cells, a rat fibroblastoid 3T3-like cell line (Botchan et al, 1976) were used for 
both stable and transient transfections.
2A.1.2 Bacterial cells
E. Coli strain DH5 (supE AA,hsdR 17, recA 1 ,endA 1, gyrA 96, th i-1 relA 1), a 
recombination deficient strain (Hanahan, 1983)were used for the growth of plasmid DNA 
Strain JM101 (supE, thi A (lac-proAB ) F ' [traD 36 proAB+ lac N lacZ AM15] were used 
for the selection of recombinants into vector containing amber mutations (Messing, 1979). 
Expression of proteins was carried out in strain BL21(DE3) QisdS gal (X Its 857 ind 1 S am 
7 nin 5 lac UV5-T7 genel), a strain containing a copy of T7 RNA polymerase carried on X 
DE3 integrated into the chromosome of BL21 (Studier and Moffat, 1986)
2A.2 Viruses
HSV-1 Glasgow strain 17 svn+. which forms non-syncytial plaques on BHK cells (Brown 
et al, 1973) and the temperature sensitive mutant tsK, which has a temperature sensitive 
lesion in Vmwl75, produces five functional polypeptides; VmwllO, Vmw63, Vmwl36, 
Vwm68 and Vmwl2 at the non-permissive temperature (39°C) (Marsden et al, 1976) were 
obtained from department stocks maintained by Mary Murphy.
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2A.3 Tissue culture medium
a) BHK cells were grown in Glasgow Modified Eagle’s medium (Busby et al., 1964) 
supplemented with 100 units/ml streptomycin, 100 units/ml penicillin, 0 .0 0 2 % (w/v) 
phenol red. The growth medium used (ETC 10) consisted of 80% Eagles, 10% tryptose 
phosphate and 10% newborn calf serum.
b) Rat-1 cells were grown in Dulbecco’s medium (DMEM, Gibco laboratories) 
supplemented with lOOunits/mlipenicillin lOOunits/ml streptomycin, and 20mM glutamine. 
Foetal calf serum was added to a final concentration of 10%.
2A.4 Medium used for harvesting cells
a) PBS, which contained 170mM NaCl, 3.4mMKCl, 10mMNaHPO4, 2mM KH2PO4  (pH 
7.2).
b) versene, PBS supplemented with 0.6mMEDTA and 0.0015% (w/v) phenol red.
c) Trypsin, 25% Difco trypsin dissolved in Tris-saline (140mM NaCl, 30mM KC1, 280mM 
Na2 HPO4 , lmg/ml dextrose, 25mM Tris-HCl (pH7.4), 0.005% (w/v) phenol red 
supplemented with 100 units/mljpenicillin and 100 units/ml streptomycin).
2A.5 Bacterial culture medium
DH5 and JM101 strains of bacteria were grown on L-broth (10g/l NaCl, 10g/l Difco 
bactotryptone and 5g/l yeast extract pH 7.5 ). The BL21 (DE3) strain used for protein 
expression were grown in 2YT (5g/l NaCl, 6g/l difco Bactotryptone, 10g/l yeast extract).
2A.6 Plasmids
pET8C: plasmid carries the bacteriophage T7 0  10 promoter and 0  terminator, plasmid 
contains a unique BamHl cloning site.
pYNl: (Nikas, 1986). The HSV-1 Rl open reading frame contained on a Xhol /Hindm 
fragment derived from the Hindlll K fragment of the HSV-1 genome.
pRRl: (Nikas, 1986). The HSV-2 Rl open reading frame cloned on a Sstl/Xhol fragment 
from HSV-2 strain HG52 cloned into a pUC vector.
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2A.7 Reagents
Oligonucleotides were synthesised in this department by Dr. John McLauchlan using a 
Biosearch 8600 DNA synthesizer.
Most analytical grade chemicals were purchased from BDH Chemicals UK or Sigma 
Chemical Co.; ammonium persulphate and TEMED were obtained from Bio-Rad 
Laboratories; boric acid from Koch-Light Laboratories; cesium chloride from Melford 
Laboratories Ltd.; nitrocellulose paper from Scleicher and Schuell Inc.; nylon membrane 
(Hybond-N), ECL Western detection reagents and megaprime random priming kit from 
Amersham LKB Ltd; dNTPs from Pharmacia; G418 (Geneticin) from Gibco; DOTAP 
transfection reagent from Boehringer Mannheim; Geneclean kit from Bio 101 inc; IPTG 
from Promega; polylysine, protamine and histones from Sigma..
2A.8 Radiochemicals
All radiochemicals were obtained from Amersham at the following specific activities
5 ' [a-3 2P] dNTPs, 3000Ci/mmol 
5' [y-32P] ATP, 5000Ci/mmol 
L-3 3 S-methionine, around lOOOCi/mmol
2A.9 Enzymes
Proteinase K, DNA polymerase holoenzyme, T4 polynucleotde kinase, T4 DNA ligase 
were purchased from Boehringer Mannheim; restriction enzymes were purchased from 
either Boehringer Mannheim or New England Biolabs; RNase A and lysozyme were 
purchased from Sigma; Klenow fragment polymerase was expressed by Dr. E. Telford and 
purified in the department. Sequenase™ T7 polymerase and sequenase kits were obtained 
from United States Biochemical.
2A.10 Antibodies
2A. 10.1 Polyclonal and Monoclonal
Both the polyclonal and the monoclonal antibodies used were a kind gift from members of 
lab 106 in this institute. The polyclonal antibodies FI and F3, prepared by fusing various 
regions of the Rl ORF to p-galacosidase were prepared by Dr. H. Lankinen (Lankinen et 
al., 1993). Polyclonal antibodies 77 and 106 raised against full length HSV-1 Rl and a
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truncated Rl polypeptide (AA 245-1037), were prepared by Jill Murray. The monoclonal 
antibody, mabl026, raised against full length Rl was also prepared by Dr. H. Lankinen 
(Lankinen et al, 1993), the epitope for this monoclonal maps to between AA 289 and 313.
2A.10.2 Commercial antibodies
Anti-mouse-FITC conjugated antibodies and Protein-A sepharose were both obtained from 
Sigma immunochemicals.
2A.11 Commonly used buffers
Coomassie brilliant Bluestain 2mg/ml Coomassie Brilliant Blue
SDS tank buffer
SGB (stacking gel buffer)
20x SSC
20x TBE
TE
5x TBS
Blotting buffer (Westerns)
RGB (resolving gel buffer): 
SDS boiling mix
Hybridisation Solution:
2xPK
Denaturing solution: 
Neutralising solution:
2xHBS:
50x Denhardt’s 
5x gel loading buffer:
2xCSK
lOx Mung bean buffer
in methanol:H2 0 :acetic adic (200:200:28).
1% Polyvinylpyrrolidone, 1% BSA, 1% Ficol. 
lx TBE, 1% SDS, 50% glycerol, bromophenol 
blue.
300mM sodium acetate (pH 4.5), 500mM NaCl,
lOmM ZnCl2, 50% glycerol
200mM NaCL, 600mM sucrose, 20mM pipes
(pH6 .8), 6mM MgCl2, 2mM EDTA
0.5M NaOH, 1.5M NaCl.
1.5M NaCl, 0.5M Tris-HCl (pH7.2), 0.001M .. 
EDTA.
280mM NaCl, 50mM Hepes, 1.5mM Na2HP0 4  
(pH 7.1).
6x SSC, 5x Denhardt’s, 0.1% SDS, 50|ig/ml calf 
thymus DNA.
lOOmM Tris-HCL (pH8.0), 20mM EDTA 
(pH8.0), 20mM NaCl, 0.4% SDS.
181.5g Tris, 4g SDS, 11H20, (pH8.9). 
lml SGB, 0.8ml 25%SDS,
0.5ml p-mercaptoethanol, bromophenol blue. 
6.32g Tris, 4g glycine, lg SDS, 11H2 0.
59g Tris, 4g SDS, 11H20 , (pH6.7).
174g/l NaCl, 8 8 .2g/l Trisodium Citrate.
2.5M Tris, 800mM boric acid, 54mM EDTA. 
lOmM Tris (pH 7.5), ImM EDTA (pH8.0).
24.2g Tris, 292.4g NaCl, 21H2 O (pH 7.5).
25mM Tris, 192mM glycine,
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20% methanol (pH8.3).
TTBS 20mM Tris, 500mM NaCL,
0.05% Tween (pH 7.5).
Blocking Solution (Westerns) 20mM Tris, 500mM NaCl, 5% marvel.
Solution 1
Solution 2 
Solution 3
50x TAE
50mM glucose, 25mM Tris (pH8.0), 
lOmM EDTA (pH8.0).
0.2M NaOH, 1% SDS.
6ml 5M potassium acetate, 1.15ml glacial acetic acid, 
2.85ml dH20.
242g Tris, 57.1ml glacial acetic acid, 100ml 0.5M 
EDTA (pH8.0).
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2B Methods
2B.1 Preparation of DNA 
2B. 1.1 Small scale 'miniprep'
An overnight culture was prepared by inoculating 2mls of LB supplemented with 
ampicillin (100|ig/ml) with a single colony and incubating at 37°C. The overnight culture 
was pelleted by brief centrifugation at 15000 rpm (benchtop microcentrifuge). Pellets were 
resuspended in lOOpl of solution 1 and incubated for 5 min on ice, 200|il solution 2 was 
added, carefully mixed, and incubated for a further 10 min at room temp. Finally, 150j l x 1 
solution 3 was added, mixed and cell debris was pelleted by centrifugation at 15000 rpm 
for 15 min. Supernatants were removed and the DNA precipitated by adding 2 volumes of 
100% ethanol, pellets were washed in 70% ethanol and dried under vacuum. Dry DNA 
pellets were routinely resuspended in 50pl of dH20.
2B.1.2 Large scale preparation of DNA
A starting culture was prepared by inoculating 10ml of LB-amp with a stab from a glycerol 
stock and incubating overnight at 37°C. The 10ml overnight culture was used to inoculate 
300ml of LB-amp and grown for 6 hr; jchloramphenicol! was added to a final 
concentration of 50pg/ml and the culture was grown overnight. Bacteria were pelleted by 
centrifugation at 9000 rpm (Sorvall GS3 rotor) for 10 min at 4°C. Pellets were 
resuspended in 10ml of ice cold solution 1 containing lysozyme at a final concentration of 
1 mg/ml and incubated for 10 min on ice. Solution 2 was added (20mls), carefully mixed 
and incubated for a further 15 min at room temp. Finally, 15ml of solution 3 was added 
and incubated for a further 10 min on ice. The lysate was centrifuged at 15000 rpm 
(Sorvall SS34 rotor) to remove cell debris. Nucleic acids were precipitated from the lysate 
supernatant by the addition of an equal volume of isopropanol (propan- l-ol) and 
incubating for 30 min at room temp, followed by centrifugation at 3000 rpm (Beckman 
benchtop) to pellet. Pellets were drained and air dried for 30 min. The nucleic acid pellets 
were then resuspended in 10.5ml of dH2 0 . Cesium chloride was added to a final 
concentration of 1 mg/ml, 0.5ml of ethidium bromide (lOmg/ml) was added and debris 
removed by centrifugation at 3000 rpm (Beckman benchtop) for 10 min. The resulting 
solution was centrifuged for 48 hr at 44000 rpm. Supercoiled DNA was isolated and 
ethidium bromide removed by several extractions with water saturated butan-l-ol. DNA
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was dialysed against TE and its concentration was determined byjspectrophotometry OD26O 
1.0=50p,g DNA/ml).
2B.2 Cloning methods
2B.2.1 Restriction digests
a) Vector digests
In the preparation of vector backbone the plasmid was digested using the specified
manufacturers’ buffers, to reduce vector background routinely lu of calf intestinal
the
phosphatase was added to the digest and incubated for 2 hr ayecommended temperature 
The phosphatase was inactivated by the addition of an equal volume of 2xPK buffer 
containing proteinase K (lOOpg/pl). DNA was then purified by 2 phenol extractions 1 
chloroform extraction and ethanol precipitation (2.5 volumes ethanol, 1/10 vol 3M sodium 
acetate pH7.0).
b) Miniprep Digests
Miniprep digests; typically 5|il of total DNA isolated was digested with lu of enzyme, 
again using the manufacturers specified buffers, RNase A was added to the digest to a final 
concentration of lOpg/ml to remove contaminant RNA. Digests were carried out for 1 hr 
at the recommended temperature.
c) Partial restriction digests
A starting mix containing routinely 15p,g of plasmid DNA in a total volume of 150|il (lx 
concentration of restriction enzyme buffer) was aliquoted between 9 1.5ml eppendorf 
tubes. Restriction enzyme was added, 0.5u, to the first tube (total volume 30pl) mixed 
gently by(pipetting, 15(il of this mix was removed and added to tube 2, again the contents 
were mixed and 15p,l removed and added to tube 3, this was repeated till final tube. Tubes 
1-9 were incubated at 37°C, tube 10 was incubated on ice, after 30 min all reactions were 
stopped by the addition of 0.2M EDTA. Agarose gel loading buffer was added to the 
digests and the partial digests were resolved on a 1% agarose gel (lx TAE). Linear bands 
were identified by comparing the partial digests to linear and uncut plasmid DNA.
2B.2.2 Isolation of restriction fragments from agarose gels
Slab gels of 0.8-1.5% agarose in lxTAE containing EtBr at a final concentration of 
0.5p,g/ml were run submerged at up to 12V/cm. Samples were loaded in 1/5 vol loading 
buffer. Gels were run for 1-3 hr, till bromophenol blue almost ran off the end and 
examined and photographed with long-wave uv illumination. Bands were removed and
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DNA eluted using geneclean. DNA was eluted from glassmilk beads into a final volume 
of 2 0pl.
2B.2.3 Blunt-ending DNA
a) End filling with Klenow
DNA cut with a restriction enzyme which produced a 5 ' overhang was precipitated, dried 
and resuspended in 16(0,1 of dH2 0 ; 2j l l 1 of the appropriate restriction buffer, 1|l l 1 of 2mM 
dNTPs and 0.5u of Klenow were added and the reaction incubated at room temperature for 
30 min. If further restriction digestion was to be carried out the Klenow was inactivated at 
65°C for 20 min and the reaction mixture was cooled before the addition of the appropriate 
restriction enzyme.
b) Mung bean exonuclease
DNA was resuspended in 16pl dH2 0 , 2pi of lOx mung bean buffer and 20u of mung bean
exonuclease were added. The reaction was incubated at 30°C for 30 min, the reaction
I after 2.0M NaClvolume was then made up to lOOpl / \  was added to a final concentration of 0.2M. 
The reaction mix was then extracted twice with phenol chloroform and ethanol 
precipitated.
2B 2.4 Ligations
a) 'Sticky ends'
Ligation of 'sticky' ended DNA ( typically ratio insert to vector 5:1) was carried out in the 
manufacturers specified buffer, to improve efficiency of ligation fresh ATP was added to a 
final concentration of ImM, lu of ligase was used per ligation. Ligations were incubated 
at 16°C overnight.
b) Blunt ends
Ligations of blunt end DNA (typically ratio of insert to vector 1:1) was performed in the 
presence of polyethylene glycol 6000 which was added to a final concentration of 4%. 
Ligations were incubated overnight at 16°C.
c) Ligation o f Oligonucleotides
Phosphorylated oligonucleotides were heated to 100°C for 5 min and left to cool to room 
temperature for 20 min. The oligonucleotides were added to the phosphatased vector DNA 
and ligated overnight at 16°C. Oligonucleotide linkers being blunt-end ligated were 
precipitated prior to ligation by the addition of 2 vol 100% ethanol and 1/10th vol 3M 
sodium acetate (pH 7.0); precipitated DNA was washed in 70% ethanol and dried by
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speedvac. DNA was resuspended in dH2 0  and digested with an excess of the linker site 
enzyme. DNA was again precipitated and ligated (in the absence of extra PEG).
2B.2.5 Preparation and transformation of competent Kcoli
2B.2.5.1 Preparation of Competent cells
A 100ml culture was prepared by inoculating 2YT-amp with 1ml of an overnight culture of 
E.coli (routinely E.coli strain DH5) and grown till the OD (A,=600nm) reached 0.5 (usually 
between 2-2.5 hrs). Cells were pelleted by centrifugation at 3000 rpm (Beckman 
benchtop) for 5 min, the pellet was then resuspended in 1/2 the original culture vol of 
lOOmM CaCl2, ImM MgCl2 and incubated for 40 min on ice. Cells were re-pelleted and 
resuspended in 1/50 of the original culture vol of lOOmM CaCl2/lmM MgCl2- Cells were 
left on ice for 4 hr before being used for transformations. Competent E.coli were kept for 
several days at 0°C.
2B.2.5.2 Transformation of competent Ecoli
Competent E.coli, 150|il, were transformed with various dilutions (1/10, 1 and 10) of the 
ligation mixes (vector alone, insert alone ± phosphotase(if used)), incubated on ice for 45 
min, heat shocked at 42°C for 40 seconds and incubated a further 5 min on ice before 
being plated onto LB-amp (lOOpg/ml) plates. Plates were incubated at 37°C overnight.
2B.3 DNA Sequencing
2B.3.1 Preparation of template DNA
Template DNA was prepared essentially as described in 2B.1.1. Miniprep DNA was 
denatured by adding 4jil 2M NaOH and 4|il 2mM EDTA(pH 8.0) and incubating at 90°C 
for 5min. Denatured DNA was precipitated by adding 1/10th vol 3M sodium acetate 
(pH5.0) and 2.5 vol 100% ethanol, precipitation was carried out at room temp. After 10 
mins the DNA was pelleted by centrifugation at 15000 rpm (benchtop microfuge) for 20 
min. Pellets were washed in 70% ethanol and vacuum dried.
2B.3..2 Purification of primers (oligonucleotides)
Oligonucleotides were received in a concentrated ammonia solution, the oligonucleotides 
were heated to 55°C for 5 hr to deprotect. Ammonia wasthen removed by spinning the
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oligonucleotide solutions overnight in a speedvac. Pellets were resuspended in 40fil of 
denaturing loading buffer (- dyes) heated to 100°C for 5 min and cooled on ice, 1/4 of the 
total oligonucleotide synthesised was then loaded onto a 15% denaturing polyacrylamide 
gel (loading buffer containing dyes was run alongside the oligo to monitor the progress) 
and run at 35 watts till the bromophenol blue was near the bottom of the gel. 
Oligonucleotides were visualised by UV shadowing, bands were isolated and the gel slice 
was sheared by spinning through a perforated 0.5 ml eppendorf into a 1.5 ml eppendorf. 
The oligonucleotide was eluted by adding 1ml of dH2 0  and incubating overnight at 37°C. 
Polyacrylamide fragments were removed by spinning the solution through a spinex tube. 
The oligonucleotide solution was phenol/chloroform extracted twice and ethanol 
precipitated. Pellets were resuspended in dH2 0  and the yield determined by measuring 
optical density at 260 and 280.
2B.3.3 jAnnealing of primer to denatured template
Denatured DNA was resuspended in 7pl of dH2 0 . 2\i\ of annealing buffer and 2|il of 
primer solution (9ng/reaction) was added to the template DNA and incubated for 30 mins 
at 37°C. Annealed DNA was used directly for sequencing.
2B.3.4 Sequencing (T7)
Method essentially as described by Sanger, (1977). To the annealed DNA 2p,l of labelling 
mix (20pM dGTP, 20^tM dCTP, 20*iM dTTP), l\i\ 0.3M DTT, lO^Ci [a-35s] dATP, and 
3u T7 DNA polymerase was added, mixed gently and incubated for 5 min at room temp. 
Termination mixes ( 15pM of each of the four ddNTP 150|iM dNTPs) were aliquoted into 
a microtitre plate (2.5fil per well) and warmed to 37°C for lmin. Labelling reactions were 
then added to each of the four termination reactions and incubated for 10 min at 37°C. 
Reactions were stopped by the addition of 5pl of stop solution (acrylamide gel loading 
buffer). The reaction mixtures were heated to 100°C for 2 min prior to loading on a single 
strength denaturing polyacrylamide gel (8%).
2B.3.5 Electrophoresis of sequencing reactions
All sequencing reactions were run through a 8% denaturing polyacrylamide gel which had 
been pre-run at 70 watts prior to loading of samples. Once loaded the samples were run at 
80 watts for the estimated period of time to give the sequence of interest between 50-100 
nucleotides from the bottom of the gel. The gel was then removed and in the case of 35_S 
dATP no prior fixing was given before drying.
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2B.4 Southern blot analysis and hybridisation 
2B.4.1 Preparation of DNA from mammalian (cells
A large tissue culture flask, (750ml) ~5 xlO7 cells per flask, was washed twice with 
versene, cells harvested by trypsinisation. Cells were pelleted and washed twice in ice- 
cold PBS and resuspended in 1 vol of digestion buffer (lOOmM NaCl, lOmM Tris-Cl (pH 
8.0), 25mM EDTA (pH 8.0), 0.5% SDS and O.lmg/ml proteinase K). All samples were 
incubated at 50°C with rotation in a hybridisation oven for 16 hrs. Nucleic acids were 
extracted by phenol/chloroform/isoamyl alcohol extraction. DNA was then precipitated by 
adding 1/2 vol 7.5M ammonium acetate and 2 vol ethanol, DNA was pelleted immediately 
and washed in 70% ethanol. Pellets were resuspended in TE and gently shaken at 65°C to 
facilitate solubilisation RNA was then removed by adding 0.1% SDS and RNase A 
(10p.g/ml) and incubating at 37 °C for 1 hr.
The quality of the DNA was determined by runing a small sample on a 0.7% agarose gel, 
any samples which produced DNA which had a greater electrophoretic mobility than uncut 
phage X were discarded. Restriction digests were carried out using lOpg DNA.
2B.4.2 Transfer of DNA onto nylon membranes
The gel was treated for 10 min with 0.2M HC1 to denature the DNA. After acid treatment 
the gel was rinsed several times in dH2 0  to remove all traces of acid and incubated for 2x 
45 min in neutralising solution The gel was then placed on a piece of 3MM pre-wetted in 
2xSSC on a support allowing the 3MM to contact the transfer buffer. The gel was 
surrounded with nescofilm to ensure that buffer can only pass through the gel. The nylon 
membrane cut to be slightly larger than the gel was soaked in transfer buffer (lOx SSC) 
and placed on top of the inverted gel, two pieces of 3MM cut to the same size as the gel 
and soaked in 2xSSC were placed on top of the membrane. A stack of paper towels were 
then placed on top and weighted to improve transfer. Transfer was carried out overnight.
The nylon membrane was removed and rinsed in 6xSSC, DNA was UV crosslinked to the 
membrane using a $tratalinker,
2B.4.3 Preparation of random primed probe
The appropriate fragment was purified from a lxTAE agarose gel using geneclean. The 
Amersham megaprime kit was used for the production of high specific activity probes.
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Purified DNA, 25ng, was mixed with random primers and heated to 100°C for 5 min the 
mix was cooled to room temperature the three 'cold' dNTPs were added to a final 
concentration of 0.5 mM. The fourth dNTP was added as 50|i Ci [oc32‘P] dCTP 2 u of 
Klenow was added and the reaction incubated for up to 30 min at 37°C, l|il 0.2M EDTA 
(pH8.0) was added to terminate the reaction.
Unincorporated label was removed by purification of the probe through a 1ml G50 
sepharose column. Samples were collected and each fraction cherenkov counted to 
determine position of probe elution. Samples were pooled and usually the whole probe 
was used for a hybridisation.
2B.4.4 Hybridisation of Southern blot
Blots were incubated with 5ml of prehybridisation solution at 65°C for 2 hr. The probe 
was denatured by boiling for 5 min and placed on ice. The probe was mixed with 0.5 ml of 
prehybridisation solution and carefully added to the hybridisation tube. Hybridisations 
were typically carried out overnight. Blots were then washed for 20 min in 2xSSC/0.1% 
SDS, 20 min in lxSSC/0.1 %SDS and for 20 min in 0.1xSSC/0.1% SDS. Blots were air 
dried, wrapped in clingfilm and autoradiographed.
2B.5 Overexpression of proteins
2B.5.1 T7 Expression system
The T7 expression system is completely selective, T7 RNA polymerase recognises 
promoter sequences completely different from those recognised by E.coli RNA 
polymerase. In some cases (Studier and Moffat, 1985) transcription by T7 polymerase is 
so active that the majority of transcription in the host is carried out by the T7 RNA 
polymerase. The T7 expression vector chosen for expression of HSV R1 and truncations 
of this gene is one of the pET (plasmid for expression by T7 RNA polymerase) vector 
series which contains a T7 promoter (from the phage gene 10), unique cloning site and the 
T7 terminator sequence. A modified bacterial strain, BL21 (F“ ompT, Rb~, mB~) a B strain, 
which as a B strain lacks the Ion protease and in addition lacks the ompT outer membrane 
protease was used for protein expression. The particular derivative of BL21 used, 
BL21(DE3), contains an integrated copy of phage 'k in which the int gene of the phage has 
been disrupted by insertion of the T7 RNA polymerase gene under the control of the UV5 
promoter allowing selective induction of RNA polymerase expression upon addition of 
isopropyl-B-D thiogalactopyranoside (IPTG) (Studier and Moffat, 1986).
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2B.5.2 Small scale induction of protein synthesis
E.coli strain BL21 were transformed with the expression vector, colonies were picked and 
grown overnight in 10ml of 2YT. Glycerol stocks were made from the fresh overnight 
cultures and stored at -70°C. For small scale inductions a stab of the glycerol stock was 
used to inoculate 1ml of 2YT-amp the culture was grown for 1 hr at 37°C and the culture 
was used to streak a fresh LB-amp plate. The LB-amp plate was incubated overnight at 
37°C to allow colonies to develop. Colonies were used to inoculate 5ml of 2YT-amp 
(150pg/ml) this culture was grown at 37°C till the optical density (X=600) of the culture 
reached between 0.4-0.5 . IPTG was added to a final concentration of 150|ig/ml to induce 
protein expression. E.coli were pelleted and resuspended in 1ml dH2 0  and 0.5ml 3x 
boiling mix. Protein expression was analysed by Western blotting or Coomassie staining 
SDS-PAGE.
2B.5.3 Large scale induction of protein synthesis
As for small scale induction except the 5ml starter culture was used to inoculate 300ml of 
2YT amp. Again, the culture was grown at 37°C till the optical density reached 0.5, at this 
point IPTG was added and the culture was transferred to 26°C. Cultures were grown for a 
further 2 hr post-induction. Bacteria were pelleted by centrifugation at 2000 rpm (Sorvall 
GS3 rotor) for 10 min at 4°C. Pellets were resuspended in 10ml of 25mM Hepes (pH 7.6)/ 
ImM DTT (in some cases the protease inhibitor PMSF was added) and stored overnight at 
-70°C prior to lysis.
2B.5.4 Lysis of Bacteria
Lysozyme was added to the 10ml prep of whole E.coli to a final concentration of 
250pg/ml and incubated on ice for 30 min or till lysis was obvious. The lysates were then 
spun at 18000 rpm (Sorvall SS34 rotor) for 20 min at 4°C Lysates were then ammonium 
sulphate precipitated.
2B.6 Protein purification
2B.6.1 Ammonium sulphate precipitation of protein
Ammonium sulphate was added to the desired final concentration, precipitations were 
carried out over a period of 30-45 min the salt being added gradually over this time. All 
precipitations were carried out on ice with constant stirring. Precipitates were pelleted by 
centrifugation at 15000 rpm (Sorvall SS34) for 20 min at 4°C. Supernatants were carefully
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removed and the pellets were re-spun for a further 5 min to remove any traces of 
supernatant. Pellets were carefully resuspended in 1ml of 25 mMHepes/lmM DTT and 
stored at -70°C.
2B.6.2 FPLC
Ammonium sulphate fractions were in 1ml aliquots were spun for 1 min to remove all 
debris prior to loading on the column. The column was loaded in 2x500|il samples. 1ml 
fractions were collected and tested for protein by Western blot analysis, for further FPLC 
analysis all positive fractions were pooled.
2B.7 Analysis of proteins
2B.7.1 Coomassie stained gels
Protein samples were mixed with 3x boiling mix and heated to 100°C for 3 min. Samples 
were then loaded onto an SDS-polyacrylamide gel and run till the bromophenol blue of the 
boiling mix ran off the gel. Commonly 10 or 12.5% resolving gels were run. Gels were 
treated with Coomassie stain for 15 min and destained till the majority of background 
staining was removed (only protein bands being visible).
2B.7.2 Western blot analysis
Protein samples were resolved by electrophoresis and proteins were electroblotted onto 
nitrocellulose for 2 hr at 250 mA. The nitocellulose filter was then blocked using a 5% 
marvel solution (in lxTBS) for 1 hr at room temp. Blocking solution was removed and 
primary antibody ( typically diluted at 1/100 or 1/200) in TTBS (0.5% tween TBS 
solution) was added and the blot incubated for a minimum of 2 hr. Blots were then washed 
2x 5 min in TTBS to remove any excess primary antibody before adding the secondary 
antibody: protein A-peroxidase conjugate in the case of polyclonal antibodies and an anti- 
mouse-peroxidase conjugate in the case of monoclonal antibodies, and incubated for 1 hr at 
room temp. Excess secondary antibody was removed and the blot washed 2x5 min in 
TTBS and 2x 5 min in TBS. Bands were visualised by adding a mixture of 100ml TBS 
containing 60|il of 30% H2O2 and 20ml ice cold methanol containing 60mg of horse radish 
peroxidase colour development reagent (Bio-Rad). Bands were developed over 30 min 
maximum.
The Amersham ECL detection method used in several blots, using this method of detection 
the blots were treated as above but the final TBS washes were emitted. Blots were mixed
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with equal volumes of the two developing reagents for 1 min at room temp. The blot was 
then sandwiched between cling film at autoradiographed.
2B.7.3 Immunoprecipitation
Antigens in ammonium sulphate fractions were immunoprecipitated and analysed for 
kinase activity. Crude extracts were mixed with 5-10p,l of primary antibody (~10 mg) and 
incubated for 3 hr at 4°C using an end over end rotator. Protein-A sepharose (CLB4) was 
added and incubation carried out for a further hour at 4°C. The protein A sepharose- 
antigen complex was pelleted by brief centrifugation at 1000  rpm and the supernatants 
removed. Pellets were washed 2x 20 min in 200|il of dilution buffer (lOmM Tris-Cl 
(pH7.6), 150mM NaCl, 0.5% NP40) and given a final was in TS solution. An equal 
volume of boiling mix (lx) was added to sepharose pellets and heated to 100°C for 10 min. 
Eluted proteins were then analysed by SDS-PAGE.
2B.8 In  vitro kinase assays
2B.8.1 Partially purified protein
Fractions from FPLC columns were assayed by adding Mn2+ to a final concentration of 
ImM. 10pCi 7^2-pATP was added and reactions were incubated for 20 min at room 
temperature. Reactions were terminated by adding 1/2 sample vol of 3x Boiling mix and 
heating to 90°C for 3 min. Samples were resolved by SDS -PAGE and gels were routinely 
Coomassie stained for 10 min and destained overnight to reduce background. Gels were 
vacuum dried and bands were visualised by autoradiography.
2B.8.2 In vitro kinase assays on immunocomplexed antigen
The protein A-sepharose bound antigen after washing several times in 25mM hepes 
(pH7.6) was resuspended in 50p,l of kinase reaction buffer (25mM hepes pH 7.6, ImM 
Mn2+ , O.lmg/ml protamine and 20|iCi Y^ 2"PATP) reactions were incubated for 20 min at 
room temperature and excess isotope was removed by washing several times in 25mM 
hepes. Proteins were eluted from the sepharose in lx boiling mix and resolved by SDS- 
PAGE.
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2B.9 Tissue Culture
Cells were routinely maintained in 750 ml flasks. Rat-1 cells when 90% confluent were 
sub-cultured; monolayers were washed in versene (2x20ml) and trypsinised by adding 5ml 
of diluted trypsin solution, trypsinisation was carried out at 37°C for 5 min. Cells were 
dispersed by repeated pippetting and added to 20ml of DMEM.
2B.10 Infections
2B.10.1 Preparation of stocks of infectious virus
An 80% confluent monolayer of BHK cells was seeded with 106 pfu of wt HSV-1 per 
roller bottle in 40ml of GMEM ( a moi of 0.003pfu/cell) and incubated for 2-4 days until 
cells exhibited obvious cpe. The cells were shaken into medium and pelleted at 3000 rpm 
(Beckman benchtop) for 15 min at 4°C. Cell associated virus (CAV) was prepared by 
sonicating the pellet in 2ml of medium. Cell released virus (CRV) was pelleted from 
supernatant at 1200 rpm (Sorvall GSA rotor) for 2 hr at 4°C and gently resuspended in 2ml 
supernatant and sonicated in a sonibath. Sterility checks were performed by streaking 
blood agar plates and incubating at 37°C for 5 days. Virus stocks were stored at -70°C.
2B.10.2 Titration of virus stocks
Virus samples were serially diluted in 10-fold dilutions to a final dilution of 10'9. 
Duplicate plates of BHK cells were infected with lOOfil of 10-4 to 10'9 . The virus was left 
to adsorb for 1 hr at 37°C before the inoculum was removed and the plates were overlaid 
with methylcellulose medium (containing 1.5% methylcellulose) and incubated for 3-5 
days at 37°C. Giemsa stain was then added to the methylcellulose medium, left for 1 hr 
and washed off. The plaques could then be counted and the virus titre established.
2B.10.3 Virus growth curves
Tissue culture plates (30mm) were seeded at a density of 5xl05 cells per plate and 
incubated overnight. The following day, the cells (lx l0 6/plate) were infected with 
5pfu/cell in a total volume of 200p.l. The virus was left to adsorb for 1 hr at 37°C before 
the medium was removed. Cells were washed twice with medium (without serum) and 
overlayed with 1.5ml growth medium. Cell released virus was harvested at appropriate 
times by removing medium, pelleting cell debris and harvesting supernatant. Virus 
samples were stored at -70°C till virus production was analysed by titration on BHK 
monolayers.
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2B.11 Transfections 
2B. 11.1 Transient transfections
Rat-1 cells were seeded at 4xl06 cells per 10cm plate and left overnight. The DNA 
solution (10p,g total) was diluted with 2x HBS. DOTAP (lipofection reagent) transfection 
reagent was diluted in a separate vial, the DNA solution was then added to the DOTAP 
solution, mixed by vortexing and left at room temp for 10 min. After the 10 min 
incubation the solution was added carefully to the monolayers. The transfection reagent 
was left on cells overnight. Monolayers were washed several times in serum free DMEM 
and finally lOmls of medium was added to the monolayers. Cells were left for a further 48 
hr before harvesting and analysis
2B.11.2 Cell lines
Rat-1 cells were transfected using the method outlined above. Once the monolayers 
became confluent neomycin resistant cells were selected for; 400|ig/ml G418 was added to 
the cells and selection was continued until individual colonies appeared which could be 
isolated easily using a cloning ring (4mm), Individual clones were grown in multiwell 
plates and then expanded, neomycin was maintained in the medium throughout expansion.
2B.12 Immunolocalisation
2B.12.1 Preparation of cells
Sterile coverslips were placed in a 5cm plate and cells were seeded at 105/plate to give a 
sub-confluent covering the next day. Coverslips were removed and washed several times 
in PBS. Cells were fixed in 3.7 % paraformaldehyde in CSK for 10 min at room 
temperature. Cells were permeabilised by incubation in CSK/TritonX-100 for 15 min at 
room temperature.
2B.12.2 Labelling cells
Coverslips were washed several times in ice-cold PBS. The primary antibody was then 
added and incubated for lhr at 37°C. Excess primary antibody was removed by washing 
in PBS, secondary antibody was then added and incubated at 37°C for 1 hr. Excess 
antibody was again removed by washing in PBS, coverslips were then mounted onto slides 
using 50% glycerol (in PBSA).
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3 A Overexpression of the HSV-1 R1 unique amino terminal 
region and characterisation of autophosphorylating activity
The amino terminal region of HSV-2 R1 exhibits protein kinase activity (Chung et a l ., 
1989). Comparison of the unique amino terminal regions of HSV-1 and HSV-2 shows this 
region is the least conserved part of the HSV R1 (Nikas et a l ., 1988; Chung et a l ., 1989; 
see Figure 3A.1).
HSV-1 1 MASRPAAS S PVEARAPVGGQEAGGPSAATQGEAAGAPLAHGHHVYCQRVN 
1 1 1 1 1 1 1 I I I  II I I I  1 1 1 1 1
MANRPAASALAGARSPSERQEPREPEVAPPG GDHVFCRKVS
50
HSV-2 1 41
HSV-1 51 GVMVLSDKTPGSASYRISDSNFVQCGSNCTMIIDGDWRGRPQDPGAAAS 
1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I  
GVMVLSSDPPGPAAYRISDSSFVQCGSNCSMIIDGDVARGHLRDLEGATS
10 0
HSV-2 42 91
HSV-1 101 PA PF VAVTNI GAGS DGGTAWA FGGT PRRS AGTS TGTQ T
III 1 1 I I  I I  1 II 1 1 II 1 1 1 1 1 1 1 1
TGAFVAISNVAAGGDGRTAWALGGTSGPSATTSVGTQTSGEFLHGNPRT '
139
HSV-2 92 141
HSV-1 140 ADVPTEALGG P P P P PR FTLGGGCC SC RDTRRRSAVFGG EG D PVG PA E FVS 
1 1 1 1 1 1 1 II 1 1 II 1 1 1 1 1 
PEPQGPQAVPPPPPPPFPWGHECCARRDAR GGAEKDVGAAESWS
189
HSV-2 142 18 5
HSV- 1 1 9 0 DDRSSDSDSDDSEDTD SETLSHASSDVSGGATYDDALDSDSSSD 
1 1 1 1 1 II 1 II 1 1 1 II 1 1 I I  1 1 1 1 1 1 1
233
HSV-2 186 DGPSSDSETEDSDSSDEDTGSGSETLSRSSSIWAAGATDDDDSDSDSRSD 23 5
HSV-1 234 DS LQIDGPVCRPWSNDTAPL DVCPGTPGPGADAGGPSAVDPH 
1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 
DSVQ PDVWRRRWSDG PAPVAF PK PRRPGDSPGNPGLGAGTG PGSATDP
27 5
HSV-2 236 28 5
HSV-1 276 APTPEAGAFLAADPAVARDDAEGLSDPRPRLGTGTAYPVPLELTPENAEA 
1 1 II 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
AS ADSDSAAHAAA PQADVA PVLDSQ PTVGTD PGYPVPLELT PENAEA
325
HSV-2 286 332
Figure 3A.1 Comparison of the amino acid sequences of the amino terminal regions 
of HSV-1 and HSV-2. Comparisons were made using the University of Wisconsin GCG Gap program, 
the upper sequence is HSV-1 R1 and the lower sequence is HSV-2 Rl. The comparison shows that the 
amino terminal regions are more divergent than the rest of the protein which shows homology to the 
sequences of other herpesvirus ribonucleotide reductase large subunits which have been sequenced. Up to 
amino acid 300, the sequences show only 38% homology whereas the rest of the protein shares 90% 
homology.
Within the amino terminal region of HSV-2, putative protein kinase subdomains, a feature 
common to even the most divergent protein kinases (Hanks et al., 1988), were identified.
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As shown in Figure 3A.2, the conservation of these subdomains in the HSV-1 amino 
terminal region is less than observed for the amino terminal region of HSV-2.
Subdomain I II
src 267/ ESLRLEVKLGQGCFGEVWMGTW 293/ RVAIKTL
raf 346/ SEVMLSTRIGSGSFGTVYKGKW 370/ DVAVKIL
HSV-US3 189/ MGFTIHGALTPGSEGCVFDSSH 216/ RVIVKAG
HSV-UL13 149/ EIPGARSFGGSGGYGDVQLIRE 
G G G V
172/ KLAVKTI 
A K
HSV-2 R1 96/ VAISNVAAGGDGRTAWALGGT 172/ GGAEKDV
HSV-1 R1
EBVR1 
VZVR1  
mouse R1 
E.coli R1
jl06/ VAVTNIGAGSDGGTAWAFGGT 1176/ GGEGDPV
HI IV V
src 309/ FLQEAQV 321/ HEKLVQL 334/ EPIYIVIEYMSKGSLLDFLKGETGK
raf 389/ FRNEVAV 301/ HVNLLLF 314/ DNLAIVTQWCEGSS LYKHIMVQETR
HSV-US3 227/ TSHEARL 239/ HPALLPL 253/ GVTCLWLPKYQ-DLYLSRRLNP-
HSV-UL13 190/ ATLLVGE
E
SGSETLS
208/ IRGFIAP 221/ QRQ--1VF PAYDMLGKYIGQLASLR
HSV-2 R1 206/ 241/ DVWRRR 260/ PRPGDSPGNPGLGAGTGPGSATDPR
HSV-1 R1
EBVR1 
VZVR1 
mouse R1 
E.coU R1
(205/ TDSETLS 2 39 / DGPVCRP 25 0 / APLDVCPGTPGPGADAGGPSAVDPH
VI \ v n
src 384/ YVHRDLRAANILVG 403/ KVADFGLAR 422/ AKFPIKWTAPEAA
raf 363/ IINRDNKSNNIFLH 382/ KIGDFGLAT 404/ PTGSVLWMAPEVI
HSV-US3 300/ IIHRDIKTENIFIN 319/ CLGDFGAAC 340/ REGDCEYIAPEVL
HSV-UL13 274/ ISHLDIKCANILVM 299/ VLADFSLVT 348/ GHGY--NQPPELL
DLKPEN DFG G Y APE
HSV-2 R1 320/ PVPLELTPENAEAV 375/ TEDDFGLLN 401/ PNAYTPYHLREYA
HSV-1 R1 313 / PVPLELTPENAEAV 368 / TEDDFGLLN (394 ^ PNAYMPYYLREYV
EBVR1 1/ MATTSH
VZVR1 9/ TVM-------- 28/ PESTTPVELMEYI
mouse R1 16/ DKITSRIQK 42/ KVIQGL--VTTVE
E.coU R1 20/ DKIHRVLDW 46/ H-IQF----IKTSD
Figure 3A.2 Alignment of the amino terminal regions of HSV-1 R1 and HSV-2 R1 
with other protein kinase subdomains R1 is aligned with protein kinases from both the 
serine/threonine kinase family (the cellular kinase raf and two other HSV-1 protein kinases US3 and UL13) 
and the tyrosine kinase family (src). In addition, the sequences of HSV-1 and HSV-2 R1 were compared to 
the sequences of other ribonucleotide reductase large subunits (of other herpesviruses, the mammalian protein 
and to the E.coli protein)
To determine if the amino terminal region of HSV-1 contained protein kinase activity, even 
in the apparent absence of certain conserved regions, full length R1 overexpressed in Rcoli 
and purified to apparent homogeneity was assayed for protein kinase activity. The ability of 
pure R1 to either autophosphorylate or to transphosphorylate was determined (Conner et
90
Chapter 3. Results and Discussion
al., 1992b). Under the assay conditions used, autophosphorylation but not 
transphosphorylation was observed.
3A. 1 Over-expression of the amino terminal region of HSV-1
The amino terminal region of R1 from HSV-1 strain 17+ was subcloned from a pUC based 
vector, pYNl, containing the entire R1 open reading frame (see Figure 3A.3).
t r l  u l  i r l  IRS U s  t r
i—
0.54
—r~
0.56
— I-
0.58
—r~
0.60
H indffllt----------------------------------------
R1 ORF R2 ORF
Xhol HindHI
^ ^
Fragment cloned into pYNI
Figure 3A.3 Locus of both the large and small subunits of HSV-1 RR in the HSV-1 
genome. The large and small subunit genes are both located in the unique long region of the HSV-1 
genome, transcript mapping showed the mRNAs of the two subunits as 3' co-terminal. Restriction sites used 
to clone the R1 open reading frame are indicated, the entire R1 open reading frame contained in the HindHI 
fragment k was removed using Xhol and Hindm sites located 5' and 3' respectively.
To determine whether the amino terminal region of HSV-1 R1 contains the intrinsic protein 
kinase activity (Conner et a l ., 1992b.), a vector was constructed for the expression of a N- 
terminal truncation in E.coli. A vector containing the HSV-1 R1 open reading frame, 
pYNl, from the HSV-1 Hind III k fragment of strain 17+ was initially converted to pYNl- 
SD a plasmid in which the Shine-Dalgamo region of E.coli leader sequences were placed 
within the optimal spacing for efficient translation from the initiating methionine of R1 
(Shine and Dalgamo, 1974). The oligonucleotides inserting the Shine-Dalgamo sequences 
upstream of the R1 initiating methionine were inserted between a Ball site in the R1 gene 
located between the first and second codons and an EcoRl site located in the pUC vector 
polylinker (Figure 3A.4)
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The truncation in the R1 ORF was then made by digesting pYNl-SD with the enzyme 
BstXl, this site was then rendered blunt using mung bean exonuclease prior to digestion 
with HindHI (Figure 3A.4). To ensure that translation terminated at the predicted amino 
acid in the R1 ORF, oligonucleotides containing translational termination codons, in all 
three reading frames, were ligated into the BstXl/Hindin cut plasmid, the oligonucleotides 
contained a half HindO site at their 3' end ensuring they were orientated correctly.
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EcoRl
Xhol
Ball
pYNl
Ori HSV-1 R1 BstXI
EcoRl
Xbal
Ball
SD oligosHindffl
pYNl-SD
HSV-1 R1Ori BstXI
HindIU 
1/2 BallShine Dalgamo1/2 EcoRl
AATTCTAGAAATAATTTTGTTTGAACTAAGAAGGAGATATACATATGG 
GATCTTTATTAAAACAAACTTGATTCTTDCTCTATATGTATACC 
" L— I
Xbal Initiator ATG
Translational stop codons
EcoRl
GCTTAGTTAGTTAGGCA
CGAATCAATCAATCCGTTCGA/  X bal 
^  Ball
AA1
SD oligos
pYNl-SD
(dC449)
HSV-1 
NH2 domaii
Ori
T  A A 449
/  BstXI 
HindHI
Figure 3A.4 Construction of pYNl-SD (dC449). The vector pYNl-SD (dC449) was 
constructed by producing an altered pUC vector pYNl-SD in which oligonucleotides containing the E.coli 
Shine-Dalgamo sequence were placed at a distance optimal for initiation of translation from the R1 initiation 
codon. A BstXI site located at codon 449 was utilised to make the truncation. Both the Shine-Dalgamo and 
the translational termination oligonucleotides are shown.
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The truncated R1 open reading frame was subcloned into a pET (T7) expression vector in 
which the unique BamHl cloning site had been converted into a unique HindHI site. The 
unique HindHI site was used to clone the truncated R1 ORF, containing AA’s 1-449 on an 
Xbal/Hindm fragment (Figure 3A.5).
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Figure 3A.5 Construction of pETdC449. The pET expression vector, pET(HindIH) was 
constructed by first removing the vector HindHI site by end-filling with Klenow. The new HindHI 
cloning site was made by end filling the BamHI site and ligating HindHI linkers. The truncation 
expression vector, finally pETdC449 was made by ligating the 1.4Kb Xbal/HindHI fragment of the R1 
ORF from pYNI-SD(dC449) into pET(Hindlll) cut with Xbal and HindHI.
95
Chapter 3. Results and Discussion
3A.2 Induction o f synthesis of the HSV-1 R1 truncation
To determine whether pETdC449 expresses the amino terminal region of HSV-1 Rl, a 
small scale culture (5ml) was grown till the O.D.(^= 600) reached 0.5, IPTG was then 
added to a final concentration of 150|ig/ml and the culture was grown for a further 2 hr. 
The induction of expression of the HSV-1 truncation can be seen in the Coomassie stained 
gel in Figure 3A.6 (a), in the extracts which have been induced (lane 1) unique bands are 
visible, the upper band indicated falls into the Mwt range predicted for the truncation 
(predicted Mwt ~46kDa). Confirmation that this band is the truncated HSV-1 Rl 
polypeptide came from Western blot analysis (Figure 3A.6 (b)). Small scale induction of 
single colonies of E.coli transformed with vector alone (lane 2) or with the vector 
expressing the HSV-1 truncation (lanes 3 and 4, two separate isolates) were subjected to 
SDS-PAGE and transferred onto nitrocellulose and analysed by Western blot. The blot 
was incubated with a monoclonal antibody (mAb 1026), an antibody raised against full 
length HSV-1 Rl whose epitope maps to an exposed loop located between amino acids 289 
and 323, a region spanned by the truncated polypeptide (Lankinen et al, 1993). The blot 
shows the appearance of unique bands in the induced E.coli containing pET dC449 
(lanes 3 and 4 Figure 3A.6 (b)). The lower band observed in the induced track in the 
Coomassie gel is most likely related to the amino terminal region of HSV-1 R l as this 
region contains several sites for proteolytic cleavage, and as will be discussed later, this 
truncation is very susceptible to cleavage. The absence of the lower band in the Western 
blot can be explained by the loss of the monoclonal antibody epitope which maps to an 
unstable loop structure, that has been predicted to separate the unique region of Rl from 
the region at which homology to other reductase large subunits begins. Lower Mwt 
cleavage products will most likely lack this epitope and therefore will not be recognised by 
this antibody. The truncated Rl polypeptide will be referred to as dC449, this 
nomenclature identifies the amino acid at which the Rl open reading frame is truncated, dC 
indicates that the truncation was made from the carboxy end of Rl.
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Figure 3A.6 Induction of expression of truncated Rl (first 449 amino acids of HSV-1 
Rl)
a) Coomassie stained gel (10%) showing the protein profiles from E.coli strain BL21 (DE3) transformed with 
the vector pETdC449. Lane 1 shows the profile for induced E.coli (IPTG added to a final concentration of 
150|ig/ml) and lane 2 shows the profile for uninduced E.coli. The bands unique to the induced extract are 
indicated.
b) Western blot of whole extracts of E.coli either uninduced (lane2),or induced (lanes 3 and 4), probed with 
monoclonal antibody 1026, lane 1 is the positive control, R l. The bands unique to induced extracts is 
indicated.
3 A.3 Optimisation of induction conditions
Levels of expression of proteins in the T7 expression system vary with each protein, in 
particular, the length of induction and the temperature at which induction is carried out can 
determine the amount of protein synthesised. For full length R l, the optimal level of 
expression was observed at 2 hr post-induction carried out at 26°C (Furlong et al., 1991) . 
Optimal times and temperatures for harvesting the cultures expressing dC449 were 
determined. Small scale cultures were induced at either 26°C or 37°C and aliquots were
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removed at various time points and after the final aliquot was collected samples were 
subjected to SDS-PAGE, transferred onto nitrocellulose and probed with the polyclonal 
106 (raised against AA245-1137 of HSV-1 Rl), see Figure 3A.7. The optimal temperature 
for induction was found to be 26°C (blot a, Figure 3A.7), dC449 has increased stability at 
26°C (lanes 4 and 5, blot (a)), whereas at 37°C after 2 hr dC449 becomes unstable (lanes 4 
and 5, blot (b)). Levels of dC449 expression peak between 1 and 2 hr post-induction 
(compare lanes 4 and 5 of blot a, Figure 3A.7). The optimum conditions for dC449 
expression are similar to those described for the full length protein (Furlong et al, 1991).
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Figure 3A.7 Western blots showing optimal induction conditions. Western blots of small 
scale inductions, 1ml aliquots of the starting culture were removed at various times indicated after the 
addition of IPTG to the culture.
a) Blot of extracts from E.coli (BL21 (DE3)) transformed with pETdC449 and induced with IPTG at 26°C, 
lane 2 is E.coli transformed with the control plasmid pET8C, lanes 2 to 6 are pETdC449 transformed E.coli 
harvested at 0, 0.5, 1.0, 1.5 and 2.0 hr post-induction and lane 7 is a positive control, full length R l, for the 
antisera.
b) Blot of extracts from E.coli induced at 37°C, lanes are as described above for the induction at 26°C. 
Induced bands specific to E.coli containing pETdC449 are indicated.
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3A.4 Partial protein purification of HSV-1 truncation
The solubility of dC449 was determined by lysing E.coli prepared from a large scale 
induction (300ml culture). Samples of the lysate were subjected to SDS-PAGE, transferred 
to nitrocellullose and analysed by Western blot (Figure 3A.8, lane 2). Lysates were 
ammonium sulphate precipitated to concentrate the protein, the final concentration optimal 
for precipitation of the truncation was determined by precipitating aliquots of lysate from a 
large scale preparation. The final concentration of ammonium sulphate added for optimal 
precipitation was 45%, Figure 3A.8 shows the increase in precipitation (compare lanes 4, 6, 
8 and 10) of dC449 with increasing ammonium sulphate.
30% 35%
H 1  I--------------- ' ------------Su % S P S P
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40% 45%
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Figure 3A.8 Western blot showing solubility of dC449 and optimisation of 
ammonium sulphate precipitation. E.coli cells transformed with pETdC449 were lysed, insoluble 
material was removed by centrifugation and the lysate was ammonium sulphate precipitated by adding 
various concentrations of ammonium sulphate from 30% (lane 3) to 45% (lane 10). Precipitates (lanes 4, 6, 8 
and 10) were compared to the supernatants (lanes 3, 5, 7 and 9), 5pg of protein from extracts was loaded 
onto a 12.5% SDS-PAGE.
Following precipitation, initial attempts at purification of dC449 used the protocol 
determined for full length R l (Furlong et al., 1991), the ammonium sulphate fraction was 
passed through a heparin Affi-gel FPLC (Bio-Rad) column. This purification method was 
unsuitable for the truncation as it had no affinity for this matrix. Because the amino 
terminal region carries a high negative charge, a mono-Q FPLC anion exchange column 
was used to partially purify the truncation; no further purification steps were attempted. 
The mono-Q elution profile for dC449 is shown by Western blot (Figure 3A.9), the blot
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was probed with the N-terminus specific antibody FI, raised against amino acids 1 to 145. 
Elution of the truncation is first clearly observed in fraction 19 (lane 5) and peaks in 
fraction 23 (lane 9). Bands highlighted are the full length dC449 (the upper band) and 
major truncated products (two lower bands).
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Figure 3A.9 Western blot showing FPLC purification of dC449. Ammonium sulphate 
concentrated protein was partially purified by FPLC using a mono-Q column. Fractions from the column 
were tested for the presence of the truncation : 20pl samples from each fraction were subjected to SDS- 
PAGE, transferred to nitrocellulose and analysed by Western blot using a polyclonal antisera (FI) raised 
against the amino terminal 145 amino acids of R l. Lane 2 is the unbound (flow-through) fraction and lanes 
3- 9 are samples from the mono-Q run. Major bands unique to the mono-Q fractions are highlighted.
3A.5 Assay for autophosphorylation of dC449 
3A.5.1 In ammonium sulphate precipitates
Initial screening for autophosphorylation of dC449 was carried out using ammonium 
sulphate precipitates from large scale cultures. Assays were carried out by adding 
manganese to a final concentration of ImM and protamine, a basic polypeptide which 
stimulates the autophosphorylation of the full length protein (Conner et al., 1992b), see
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Figure 3A. 10. The optimal ammonium sulphate concentration for precipitation dC449 was 
found to be 45% (Figure 3A.8). Comparison of autophosphorylation assays (Figure 3A.10) 
carried out on both uninduced (lane 1) and induced extracts (lane 2) shows that there are 
phosphoproteins unique to induced extracts which are equivalent to dC449 and two of its 
degradation products, previously observed by Western analysis of dC449 extracts, shown 
in Figure 3A.9. Contaminating bands are visible in uninduced extracts, one band co- 
migrates with band b (lane 2), explaining the higher level of autophosphorylation observed 
in the induced lane where the contaminant E.coli band and dC449 co-migrate. Although 
phosphorylation of dC449 can be observed in crude ammonium sulphate fractions 
contamination by E.coli kinases is a problem.
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Figure 3A.10 Autoradiograph of in vitro kinase assays of crude ammonium sulphate 
fractions. Large scale preparations of induced and uninduced E.coli transformed with pETdC449, were 
lysed and ammonium sulphate precipitated. Precipitated protein was resuspended in 25mM Hepes pH7.6. 
Equal amounts of precipitated protein (5pg) were assayed for autophosphorylating activity by adding Mn^+ 
(0.5mM), protamine (O.lmg/ml) and 10 pCi y^PA TP. Lanes 1 shows the phosphoprotein profile for 
uninduced E.coli precipitated with 45% ammonium sulphate and lanes 2 shows the phosphoprotein profile 
for induced E.coli precipitated with 45% ammonium sulphate. Bands related to dC449 are indicated.
3A.5.2 In partially purified mono-Q fractions
In addition to W estern blot analysis, to determ ine the position of dC449 
autophosphorylating activity eluting from the mono-Q column, kinase assays were 
performed on the fractions shown to contain dC449 by Western analysis. Equal volumes
102
Chapter 3. Results and Discussion
(2 0 pl of a 1ml fraction) of each fraction were assayed for their ability to 
autophosphorylate. As described in 3A.5.1, assays were carried out in the presence of ImM 
manganese and O.lmg/ml protamine. Figure 3A.11 shows the increase in a major 
phosphoprotein (band a), activity peaking at fraction 20 (lane 6 ). Lower Mwt bands (b and 
c) are also observed, although the level of autophosphorylation is low in comparison to 
band a, the peak elution activity of these bands differ from that of band a; peak elution of b 
is observed in fractions 18 and 19 (lanes 4 and 5) and, peak elution of band c is observed in 
fractions 19 to 21 (lanes 5 to 7). A higher Mwt phosphoprotein, previously observed in 
crude ammonium sulphate fractions co-elutes with dC449, and its phosphorylating activity 
peaks in the same fraction as full length dC449 (fraction 20, lane 6). The full length Rl 
sample used as a control in this assay has undergone severe proteolytic cleavage most 
likely due to several freeze-thaws; storage at -70°C rapidly increases Rl degradation 
(Ingemarson and Lankinen, 1987). Proteolytic cleavage products of R l which co-migrate 
with those produced by dC449 degradation are observed (most obvious with bands a and b, 
although in the Rl sample band a migrates slightly faster because band a in dC449 extracts 
represents the full 449 amino acid Rl truncation). The autophosphorylation activity of 
dC449 does not therefore appear to directly correlate with the fraction at which optimal 
elution of the truncation is observed as determined by Western blot analysis (Figure 3A.9). 
Assays were carried out on untreated fractions, the final concentration of NaCl in each 
fraction may affect the activity of the truncation in an autophosphorylation assay; full 
length Rl autophosphorylation is inhibited by NaCl at concentrations greater than 250mM.
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Figure 3A.11 Autoradiograph showing kinase assays of mono-Q fractions. Lanes 3 to 9 
are fractions from an FPLC mono-Q column assayed for kinase activity in the presence of Mn^+(0 5mM) and 
protamine(0.1 mg/ml). Lane 3 is a sample from the unbound fraction and lanes 4 to 9 are fractions 18 to 23 
from the column and represent the fractions across which the elution of the truncation is observed by Western 
blot analysis. Samples are compared to a pure preparation of HSV-1 Rl in lane 2. Bands which represent 
the autophosphorylated dC449 and its cleavage products are indicated (a to c).
Confirmation that phosphoproteins observed above are related to dC449 came from a 
comparison of Western blot analysis of FPLC fractions with kinase assays carried out on 
immunocomplexed dC449 from fractions spanning the peak elution fraction. Bands which 
react with the antisera 106 (raised against amino acids 245 to 1137) in the fractions 
(fractions 22 to 28, lanes 4 to 10 Figure 3A. 12(a)) are also phosphorylated in the 
immunocomplex kinase assay (lanes 5 and 6, Figure 3A. 12(b)). The autophosphorylating 
activity of dC449 correlates with its elution profile, the greatest level of 
autophosphorylation is observed in the peak elution fraction, fraction 24.
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Figure 3A.12 Western blot and autoradiograph comparing dC449 positive FPLC 
fractions with phosphoproteins produced in an immunocomplex in vitro kinase assay
Fractions from an FPLC mono-Q run were analysed for peak elution of dC449 by Western blot assay of 
fractions
a) Shows Western blot using polyclonal antibody 106, FPLC fractions (lanes 4 to 10) are compared to the 
ammonium sulphate fraction (lane 3) and to extracts from E.coli containing the control plasmid pET8C (lane 
2). Fractions were also assayed for their ability to autophosphorylate by immunocomplex kinase assav
b) Shows the autoradiograph of such an assay of Mono-Q FPLC fractions (lanes 3 to 6, fractions 12, 16, 20 
and 28), on ammonium sulphate fractions from dC449 expressing E.coli (lane 2) and from E.coli 
transformed with the control plasmid pET8C (lane 1).
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3A.6 Discussion
The first 449 amino acids of HSV-1 Rl autophosphorylate showing that this region 
contains both the intrinsic protein kinase activity of HSV-1 Rl and the site of 
autophosphorylation. This region,dC449, when expressed in E.coli is proteolytically 
unstable. Several bands unique to induced extracts are observed in Western blots of 
fractions eluted from a mono-Q anion exchange column. Cleavage is a feature of HSV-1 
R l, occurring in infected cells (Ingemarson and Lankinen, 1987). Sites of proteolytic 
cleavage have been mapped, all were found to be located within the amino terminal 1/3 of 
the protein (Lankinen etal., 1988; Conner et al, 1992a). Cleavage of the Rl molecule 
does not affect the reductase activity (Conner et al, 1992a), demonstrating that the amino 
terminal region plays no role in the in vitro reductase activity. That the truncation dC449 
expressed in E.coli was unstable was not therefore a surprise. Protease inhibitors used to 
reduce cleavage were ineffective suggesting that, as found for an HSV-2 amino terminal 
truncation expressed in E.coli (Luo et al., 1991), that cleavage occurs in vivo. The 
cleavage sites located within the amino terminal region of HSV-1 Rl which have been 
mapped (Conner et al., 1992a) are shown in Figure 3A.13.
1137
449
dC449
306
Tryptic cleavage product
247
Chymotryptic cleavage product
Figure 3A.13 Proteolytic cleavage sites in HSV-1 Rl. The unique N-tenninus of HSV-1  Rl is 
shown as the lighter shaded areas. Sites of cleavage with respect to dC449 are shown.
Three main, novel, phosphoproteins are observed in in vitro kinase assays of crude extracts 
from E.coli expressing the amino terminal 449 amino acids of HSV-1 R l; the full length 
5 lkDa, and two cleavage products of 45kDa and 25kDa respectively. Both the full length 
dC449 and the 25kDa cleavage products are obvious in ammonium sulphate extracts, 
whereas further mono-Q purification is required to clearly observe the 45kDa cleavage 
product, which in ammonium sulphate fractions is probably co-migrating with an E.coli 
phosphoprotein. Problems encountered with contaminating E.coli phosphoproteins in
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kinase assays of ammonium sulphate fractions were overcome by both FPLC fractionation 
and immunoprecipitation.
Comparisons of phosphoproteins produced from fractions assayed from an FPLC column 
with the same fractions analysed by Western blot analysis showed that the peak 
phosphoprotein fraction differed from the peak elution fraction. That the phosphoproteins 
are related to the dC449 truncation and its cleavage products was shown by assaying 
immunocomplexed polypeptides from the fractions spanning the peak elution fraction. 
The activity was greatest in the peak fraction, differences observed by the two methods of 
analysis can in part be explained by the different assay conditions. In an immunocomplex 
kinase assay the proteins are assayed in a buffer containing equal concentrations of 
manganese and salt, unlike crude assays in which the salt concentration is varied across the 
gradient used to elute the proteins. Exact kinetic analysis and comparison of the dC449 
truncation with the full length HSV-1 R1 was attempted but problems were encountered in 
the quantification of the truncation because of its impurity and its instability.
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3B Mutagenesis of the HSV-1 amino terminal region
3B.1 Introduction
Little is known about the regions of the R1 amino terminal domain which are critical for 
the kinase activity. Regions of potential importance were first identified using amino acid 
sequence comparison by Chung et al., (1989). However, data from this group suggest that 
the regions initially thought to be important for substrate binding, in particular the putative 
nucleotide binding region, when mutated did not significantly reduce HSV-2 R1 
autophosphorylating activity (Luo and Aurelian, 1992). To locate possible regions of 
importance for the HSV-1 activity, mutants of the N-terminal region were constructed.
3B.2 Construction of mutations
Mutations throughout the amino terminal region were made by inserting a 12 base pair 
oligonucleotide (pCCCGAATTCGGGp), containing an EcoRl site, into blunt restriction 
sites located throughout the amino terminal 449 amino acids. The wild type expression 
vector, pETC449, contains an EcoRl restriction site located in the vector backbone in a 
non-essential region; this site was destroyed by end filling with Klenow. Partial digests 
were made in the EcoRl-negative plasmid using three different restriction enzymes; Nael, 
Rsal and Smal. The three blunt restriction enzymes chosen have several recognition sites 
in the 1.4Kb fragment of the R1 truncation Partial digestion was carried out as described 
in Materials and Methods. Digests were resolved through a 1% Tris-acetate agarose gel, 
linear bands were isolated, gene cleaned and treated with calf intestinal phosphatase to 
reduce vector background. Oligonucleotides were annealed, phosphorylated and ligated 
into the linearised plasmids. Sites of insertion into the R1 open reading frame are 
summarised in Figure 3B.1.
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Figure 3B.1 Location of insertion/deletion mutants in the unique amino terminal 
region of HSV-1 Rl. Amino acid residues at which oligonucleotides were inserted are indicated by 
triangles, the restriction site used to create the insertion is colour coded for each triangle. Insertion into Nael 
sites are shown as grey triangles; into Rsal as white triangles and into Smal sites as black triangles.
Clones containing insertions were screened for by restriction digestion with EcoRl. The 
site of insertion was crudely mapped by double digestion with Xbal/EcoRl or 
HindlD/EcoRl, and the exact location of the insertion confirmed by double-stranded 
dideoxy DNA sequence analysis.
3B.3 Expression of insertion and deletion mutants
Insertion and deletion mutant plasmids were transformed into BL21 (DE3) and colonies 
expressing mutants were screened for by small scale induction. Large scale preparations of 
each mutant were lysed and proteins were concentrated by ammonium sulphate 
precipitation. The level of expression of each mutant was then assessed by Western blot 
analysis of equal amounts of ammonium sulphate precipitated protein. Levels of 
expression of each mutant varied, with the lowest expression level observed for the
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insertion mutant Ini 12 (Figure 3B.2(a), lane 4), expression of the other insertion mutants is 
comparable to levels observed for dC449 (lane 2). Expression of the deletion mutants, also 
compared to dC449 (Figure 3B.2 (b)), was also varied. The truncations have an increased 
stability compared to dC449, with fewer cleavage products observed, compare lanes 4 and 
5 with lane 2. The antibody used to analyse the expression of the truncations was raised 
against an R1 truncation in which the amino terminal 245 amino acids had been deleted, 
the expression of dl257 appears to be very low, with only a weak band being apparent, this 
deletion must therefore lack most of the epitopes for the antibody used and it is possible 
that the amount of protein expressed is not accurately determined by Western analysis with 
this particular antibody.
110
Chapter 3. Results and Discussion
a)
i% S'
Jo
£ S '
$4 S
Figure 3B.2 Expression of insertion and deletion mutants. Levels of expression of both 
insertion and deletion mutants were compared by Western blot analysis of ammonium sulphate fractions, 
equal final concentrations of protein, 3jig, were resolved by SDS-PAGE, transferred onto nitrocellulose and 
probed with the polyclonal antibody 106
a) Shows Western blot of insertion mutants lanes 3 to 9 were compared to that of dC449 (lane 2) and lane 1 is 
E.coli transformed with the control vector pET8C.
b) Shows Western blot analysis of deletion mutants, lanes 3 to 5, compared to dC449 (lane 2), lane 1 as in
(a).
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3B.4 Developing an assay for analysis of mutants 
3B.4.1 Immunoprecipitations
To easily assay the mutants, a method for rapid determination of kinase activity was 
developed. Several polyclonal antibodies raised against HSV-1 R1 were screened for their 
ability to immunoprecipitate full length R1 and truncations of Rl. The antisera chosen for 
precipitations, antibody 106, was raised against a truncation of Rl in which the first 245 
amino acids are removed, the epitopes for this antibody will all therefore map downstream 
of amino acid 245, the interaction between this antibody and the mutants is unlikely to 
affect the autophosphorylation reaction.
Conditions for precipitation were optimised using full length Rl; varying concentrations of 
antibody, from 5 |il to 50 |il were incubated with ammonium sulphate precipitated 
fractions of Rl and the ability to immunoprecipitate Rl was then assessed by Coomassie 
staining an SDS-PAGE (10%) of the precipitates (shown in Figure 3B.3). Figure 3B.3 
shows that immunoprecipitation of full length Rl using the polyclonal antibody 106 is 
optimal with as little as 10pl (compare lane 7 with 8 to 10 in 3B.3(a)) of the antibody 
serum. With 5pl of antibody, Rl precipitation is observed, but levels are not optimal when 
compared to other Ab concentrations (compare lane 6 with lanes 7 to 10). By limiting the 
amount of antibody in immunoprecipitations, the amount of antigen precipitated will be 
less than optimal for the amount of antigen added, this allows differences in the levels of 
the mutants expressed to be compensated for, as in most cases the antigen should always 
be in excess. Because of the lack of a suitable purification scheme for the N-terminus the 
immunoprecipitation assay is the most accurate way to determine the affect of the mutation 
on the ability of this region to autophosphorylate.
In addition, the ability of the polyclonal antibody to precipitate a truncated form of R l, 
dN245, which lacks the amino terminal region (deleted from amino acids 1 to 245), was 
determined, fhis particular deletion shows no ability to autophosphorylate (Conner et al., 
1992b) and can therefore act as a control In the immunoprecipitatioh/kinase assay’ 
Precipitation of the truncation in the immune serum is shown in Figure 3B.3 (b) (see lane 
9), the amount of protein precipitated from the 33% ammonium sulphate fraction is 
comparable to the amount of Rl precipitated from the ammonium sulphate Rl fraction 
(lanes 6  and 7).
* The deletion mutant dN245 is precipitated by pre-immune serum, this is probably 
due to a non-specific interaction with the sepharose matrix to which protein A is 
coupled (J. Conner, personal communication).
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Figure 3B.3 Optimisation of immunoprecipitations.
a) Shows a Coomassie stained gel of the titration of the polyclonal antibody 106. Lanes 1 to 5 are 
precipitations of 35% ammonium sulphate fraction of HSV-1 R l using 5pl (lane 1) to 50 pi (lane 5) of pre- 
immune serum, the exact amount of serum used is indicated at the top of the lanes. Lanes 6 to 10 are 
precipitations carried out with serum after immunisation with the truncated Rl polypeptide dN245 , as with 
the pre-immune serum the amount of serum used ranged between 5pl (lane 6) and 50pl (lane 10).
b) Shows a Coomassie stained gel of immunoprecipitations carried out with different ammonium sulphate 
fractions of full length R l for both HSV-1 and HSV-2 and with an ammonium sulphate fraction of the 
truncation dN245 in which the amino terminal 245 amino acids of HSV-1 R l are deleted. Lanes 1 to 5 are 
precipitations carried out with pre-immune serum and lanes 6 to 10 are precipitations carried out with 
immune serum (106). Lanes 1 and 6 and lanes 2 and 7 are precipitations of two different ammonium 
sulphate fractions of full length HSV-1 R l, lanes 3 and 8 are precipitations of an ammonium sulphate 
fraction of HSV-2 R l. The precipitation of dN245 is shown in lanes 4 and 9.
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Kinase assays were carried out on immunoprecipitates from ammonium sulphate fractions 
from E.coli expressing full length R l, the amino terminal truncation dN245 and the 
carboxy terminal truncation dC345 (first 345 amino acids of HSV-1 are expressed). Equal 
volumes of ammonium sulphate precipitated protein fractions were immunoprecipitated 
with the polyclonal antibody 106, and the precipitates were assayed for 
autophosphorylating activity, see Figure 3B.4.
(136kDa )R1
dC345 (37kDa)
Unique amino terminal 
region
1137 Rl
AA245 1137 dN245
dC345
Figure 3B.4 Autoradiograph of immunoprecipitation/kinase assay of ammonium 
sulphate fractions for Rl and truncated Rl. Ammonium sulphate fractions of full length Rl 
(lane 1), N-terminal truncated Rl (lane 2) and C-terminal truncated R l (lane 3) were precipitated with 5pl of 
polyclonal antisera 106. Following precipitation and washes to remove non-specific proteins the 
immobilised antigen was incubated in kinase assay buffer for 30 min at room temp. Samples were resolved 
by 10% SDS-PAGE. The truncations are shown, residues of Rl expressed are for dC345 (AA1-345) and for 
dN245 (AA245-1037)
Only samples from ammonium sulphate fractions of full length R l and dC345 show strong 
phosphoprotein bands following kinase assay, compare lanes 1 and 3 to the amino 
terminal truncation in lane 2. Bands common to full length R l and dC345 are observed, 
indicating that cleavage occurs at the same sites in both. This assay provides further 
evidence that the ability of Rl to autophosphorylate resides in the amino terminal region.
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3B.5 Assay for autophosphorylation of insertion mutants
Equal volumes of total ammonium sulphate fractions were used for immunoprecipitations 
and the optimal amount of antibody determined by precipitation of full length R l, was 
used for all mutants. Precipitates were assayed for kinase activity using the method 
developed for the full length protein.
Mutations which both decrease and increase the kinase activity of the amino terminal 
region of HSV-1 Rl were isolated. Sites of insertion which decreased activity include an 
insertion at amino acid 22 (In22, lane 3, Figure 3B.5(a)) and insertions at 112 (Ini 12, lane 
4 , gel (a)). Further downstream, insertions at amino acids 292 and 343 (Figure 3B.5 (b) 
lanes 4 and 5) also decreased activity when compared to wild-type (lane 2, both gels). A 
significant increase in the autophosphorylation of the immunocomplexed truncation was 
observed when insertions were made at amino acids 257 and 262, compare lanes 6 , gel(a) 
and lane 3, gel (b) to the initial construct in lanes 2 of both gels. In addition, a deletion 
mutant which removes amino acids 257 to 434 of the truncation open reading frame shows 
a significant increase in the ability to autophosphorylate. That the increased 
autophosphorylation of this particular deletion is probably a direct result of the deletion 
and not enhanced resistance to proteolysis can be seen by comparing this particular 
truncation with two other deletions which show decreased sensitivity to proteolysis 
(compare D1 257 (Figure 3B.5 lane7, gel (b )), with D1 292 (lane 8 , gel (b)), and D1 345 
(lane 9, gel (b)). The internal deletion mutant D143-136 (lane 6 , gel (b)), is completely 
inactive.
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Figure 3B.5 Autoradiographs of immunoprecipitation/ kinase assays of insertion and 
deletion mutants in the HSV-1 Rl amino terminal region.
a) Shows an autoradiograph of an SDS-PAGE (12.5%) of immunoprecipitates from ammonium sulphate 
fractions of insertion mutants assayed for their ability to autophosphorylate. Sites of insertion for each 
mutant are indicated at the top of the gel, phosphoproteins highlighted are those unique to extracts containing 
dC449 and dC449 mutants.
b) shows an autoradiograph of both insertion (lanes 3, 4 and 5) and deletion mutants (lanes 6, 7, 8 and 9), 
again bands unique to extracts expressing the amino terminal region of HSV-1 R l are highlighted.
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The ability of the insertion mutants to be precipitated by the antibody 106 was 
determined by analysing the immunoprecipitates by Western blot. Precipitates were 
resolved by SDS-PAGE, transferred onto nitrocellulose and the membrane was 
probed with the Rl N-terminal specific antibody FI (raised against AA1-145 of HSV- 
1 Rl). Figure 3B.5(b) shows the Western blot, all insertion mutants which showed an 
altered activity are precipitated by 106; those which decrease activity, In i 12 and 
In 136 (lanes 5 and 6, respectively); those which increase activity, In 257 and In262 
(lanes 7 and 8, respectively) and those which do not appear to affect activity, In 22, In 
43 and In292 (lanes 3, 4 and 9 respectively). This analysis confirms that the 
differences observed between mutants is in fact due to the mutations created rather 
than an altered ability to be precipitated.
ngure B^.5(b). Western blot showing the amount of protein precipitated for 
each insertion mutant. The precipitation of each insertion mutant (lanes 3 to 9) is compared to 
the amount of protein precipitated from the wild-type (dC449, lane 2). Lane 1 is the negative control, 
extracts from pET8C transformed E. coli.
1 2 3 4 5 6 7 8 9
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3B.6 Discussion
The sites | of insertion into the amino terminal domain with respect to the localisation of 
regions potentially important in catalysis is shown below (Figure 3B.6).
1 MASRPAASS PVEARAPVGGQEAG^PSAATQGEAAGAPLAHGHHVYCQRVN
I n 2 2  GQEAGDFPGGPS I n 4 3  GHHVWGNSPCQRVN
51 GVMVLSDKTPGSASYRISDSNFVQCGSNCTMIIDGDWRGRPQDPGAAAS
Subdomain 1 y
101 PAPFVAVTNIGtfJGSDGGTAWAFGGTPRRSAGSTGTQTADVPTEALGGPP
I n l l 2  NIGAGDPPGSDG I n l 3  6 STGGDFPTQTA
Subdomain 2
151 PPPRFTLGGGCCSCRDTRRRSAVFGGEGDPVGPAEFVSDDRSSDSDSDDS
Subdomain 3 Subdomain 4
2 0 1  SETDSETLSHASSDVSGGATYDDALDSDSSSDDSLQIDGPVCRPWSNDTA
^ubdcynain 5 ^
2 5 1  DLPVCPGTPGPGADAGGPSAVDPHAPTPEAGAGLAADPAVARDDAEGLSD
I n 2 5 7  PVCPGDFPGTPG I n 2 9 2  PAVARGNSPDAEG
I n 2 6 2  TPGPGNSPGADAG
Subdomain 6
3 0 1  PRLGTGTAYPVPLELTPENAEA
Figure 3B.6 Insertions into the amino terminal region of HSV-1 R l compared to the 
localisation of sites potentially important in catalysis. Regions important in catalysis in protein 
kinase, subdomains, and their predicted location in the amino terminal region are shown. Insertions into the 
amino terminal region and the sequences created by these insertions are also shown below and bolded.
Mutations were constructed throughout the N-terminal domain of HSV-1 Rl to locate
potential regions of importance in the Rl autophosphorylating activity. A 12 base pair
oligonucleotide was inserted into blunt restriction sites located within the 449 amino acid
/  ofopen reading frame of HSV-1 Rl. To analyse the autophosphorylating activity^the mutants 
an immunoprecipitation assay was developed using a polyclonal antibody raised against a 
truncation of HSV-1 Rl. Optimal precipitation of full length Rl was used to determine the 
amount of antisera required for effective precipitation whilst keeping the antibody in 
limiting amounts' so that differences in'the levels of expression of the mutants could be 
compensated for in the assay.
Mutants were isolated with a variety of phenotypes; 1) with no affect on the activity; 2) 
those which impair but do not completely destroy activity and 3) those which significantly 
increase activity. Mutations which decrease activity map upstream and within the 
proposed nucleotide binding site located around amino acid 111 to 123. Insertion at amino 
acid 22  reduces activity, this may be a region important in the formation of a structurally
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stable kinase domain, this region has been predicted to form a hydrophobic p-sheet 
structure (Nikas etal., 1986). The insertion into the predicted nucleotide binding site at 
amino acid 112 did not destroy activity, as found for the insertion at amino acid 2 2  the 
activity was significantly reduced, this may however be due to reduced expression of this 
particular mutant. That activity is not completely destroyed by mutation of the predicted 
nucleotide binding site may in part be explained by the conservation of a glycine in the 
construction of this mutant (Figure 3B.7). Mutation of the HSV-2 nucleotide binding site 
leads to decreased autophosphorylating activity (Luo and Aurelian, 1992). It is possible 
that this site in both HSV-1 and HSV-2 is not the actual nucleotide binding site. No other 
conserved nucleotide binding site is located within the first 449 amino acids of HSV-1 Rl. 
It is however possible that Rl has a non-consensus nucleotide binding site, as has been 
observed for other protein kinases, a protein kinase with no apparent nucleotide binding 
site has been reported (Herman et al, 1991). The role of the region located upstream of 
the nucleotide binding site in the autophosphorylating activity is unknown, this region in 
the HSV-2 Rl N-terminal domain is thought to be important in the stability of this domain, 
deletions in this region lead to the instability of the N-terminal domain when expressed in 
E.coli and in eukaryotic cells (Luo et al., 1991). It was proposed by Luo et al., (1991) that 
this region is important in the formation of a structurally stable protein kinase domain.
A A  104 VAVTNGAGSDGGTAWA
In i 12 VAVTNGAGDFPPGSDG
*
Figure 3B.7 Mutation of the proposed nucleotide binding site in the HSV-1 amino 
terminal region. The sequence of the proposed nucleotide binding site is shown above, the glycine triad 
is highlighted. The residues inserted into die nucleotide binding site in the mutant Ini 12 are shown below, 
the glycine which could in part complement this mutation is highlighted by an asterix.
Mutations around amino acid 257 lead to a several fold increase in activity, a mutation 
located at amino acid 262 also shows an increase in activity but not as large as observed for 
the insertion at 257. Both these insertion sites are located close to or within the predicted 
kinase subdomain 5, a region in protein kinases of, as yet, unknown function. The amino 
acids inserted into both sites are similar to those inserted into another site located at amino 
acid 292, that these particular insertions create another phosphorylation site, thereby 
increasing the observed phosphorylation, is unlikely. That a region involved in the down- 
regulating of the protein kinase exists is not surprising as it is rarely of benefit for a protein 
kinase activity to be optimal without some means of regulation. A region in the insulin 
receptor has been identified which controls autophosphorylation, mutation of this region 
leads to increased autophopshorylation (Sung et al., 1994). The down-regulatory region in
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leads to increased autophopshorylation (Sung et al, 1994). The down-regulatory region in 
the HSV-1 Rl protein kinase may simply act to mask either the site catalytically important,\ or 
it could be speculated that a co-factor interaction with this region is required in vivo to 
overcome the inhibitory effect of this region. There are several well documented cases 
where a protein kinase structure is altered upon interaction with a stimulatory co-factor, 
such an interaction may be important in the N-terminus activity.
Deletion mutants, both internal, between amino acids 43 and 136, and carboxy terminal to 
amino acid 257 and 292 were also produced and analysed for their autophosphorylating 
activity. As found with the insertion mutant at amino acid 257, the deletion from 257 ] led 
to an increased autophosphorylating activity. This mutant has increased stability, with 
fewer cleavage products observed. A comparison of the 257 deletion with the mutant in 
which the carboxy terminal amino acids from amino acid 292 were deleted, which also has 
increased stability shows that the deletion from amino acid 257 does appear to have a 
direct affect on the kinase activity. It appears that the deletion mutations are removing 
amino acids located downstream of 257 which are involved in down-regulating activity. 
Deletion of amino acids 43 to 136 leads to a complete loss in activity indicating that within 
this region residues crucial for Rl autophosphorylating activity are located.
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3C Overexpression of HSV-2 Rl and characterisation of 
kinase activity
3C.1. Introduction
To compare accurately the protein kinase activities associated with HSV-1 and HSV-2 Rl, 
both proteins were expressed in E.coli and purified using a similar purification scheme. 
The HSV-1 Rl protein kinase activity would appear to differ from that ol HSV-2, in that 
unlike HSV-2 which has previously been shown to transphosphorylate exogenous 
substrates (Chung et al, 1989), there does not appear to be a similar activity associated 
with HSV-1 Rl (Conner et a l ., 1992b).
The HSV-2 Rl kinase activity was characterised using the full length Rl 
immunoprecipitated from infected human epidermoid 2 cells (Hep2) and from cells 
transiently transfected with a construct constitutively expressing HSV-2 Rl: the kinase 
activity was shown to be stimulated by manganese and polylysine (Chung et al, 1990). 
Recently, mutations in HSV-2 have shown that the site proposed to be involved in 
nucleotide binding and the lysine residue thought to be involved in phosphate transfer are 
dispensable, mutants in this region showed a significant but not a complete loss in activity 
(Luo and Aurelian, 1992).
A transphosphorylating activity, originally thought to be associated with HSV-1 Rl was 
shown to be a contaminant when truncations which lacked the N-terminus and the ability 
to autophosphorylate were shown to transphosphorylate. It was therefore possible that the 
transphosphorylation activity associated with HSV-2 Rl was also a contaminant, or, that 
the purification scheme used for HSV-1 removed a co-factor essential for this activity. To 
determine if the differences reflected the different assay conditions used, HSV-2 R l was 
overexpressed in E.coli purified to near homogeneity and assayed for both 
autophosphorylating and transphosphorylating activity under the same conditions used to 
characterise HSV-1 Rl.
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Fragment cloned into pRRl
Figure 3C.1 Locus of HSV-2 Rl and R2. The loci of the large and small subunits of HSV-2| RR 
are shown. Both map to the unique long region of the genome, and like HSV-1, the transcripts for Rl and 
R2 are 3' co-terminal. Sites used to initially clone the entire Rl open reading frame into the pUC vector, 
pRRl are indicated.
3C.2 Construction of vector for the overexpression of HSV-2 Rl in E.coli
The strategy for the construction of the expression vector for HSV-2 Rl was essentially 
the same as described for pYNl-SD (Figure 3A.2). Oligonucleotides containing the E.coli 
Shine-Dalgamo sequence were placed upstream of the HSV-2 Rl initiation codon within 
the predicted optimal spacing for efficient translation. The entire reading frame of HSV-2 
Rl in the pUC based vector pUCRRl was digested with Ball (site falls within the second 
codon of Rl) and EcoRl (a site within the pUC polylinker). The oligonucleotides were 
cloned into this blunt Ball/sticky end plasmid. Insertion of the oligonucleotides was 
determined by screening minipreps with Xbal and dideoxy DNA sequencing confirmed 
the oligonucleotides were correctly positioned. The entire open reading frame of HSV-2 
Rl was then cloned into a pET vector (Figure 3C.2). The Rl open reading frame was 
removed from the plasmid pRRl-SD on a Xbal/BamHl fragment and ligated into the T7 
expression vector pET8C cut with Xbal and BamHl.
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EcoRV
Eco Rl 
Xba I
Bal I (R l ATG)
Bam HI 
,  Ncol
Xbal 
Bgl IIT7 termAp
T7 prom
SD Oligos
pET8C i f  Ori
pRRlXho I
Ori
Ncol (R2ATG)Bam HI
EcoRV 
Bam HI
Ori pETRl(2)
T7 prom
Bal I (Rl ATG)
Bgl II
Figure 3C.2 Construction of HSV-2 T7 expression vector. Plasmid pRRl-SD was 
constructed essentially as described for pYNl-SD (Figure 3A.2). Shine-Dalgamo oligonucleotides were 
ligated into pRRl which had been cut with Xbal and Bal I. The Rl open reading frame was then removed 
on an Xbal/BamHl fragment, the Xbal site was created by the ligation of the Shine-Dalgamo 
oligonucleotides and the BamHl site located downstream of the termination codon of Rl, and ligated into 
pET8C cut with Xbal and BamHl.
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3C.3 Induction of expression of HSV-2 R l
Plasmid pETRl(2) was transformed into E.coli strain BL21 (DE3) and expression of R l 
was induced by the addition of IPTG (150ug/ml final concentration). A time course of a 
small scale preparation was carried out to determine the optimal hr post-induction to 
harvest cultures. Expression was determined by Western blot analysis using a polyclonal 
antibody (22029) raised against HSV-1 Rl which cross-reacts with HSV-2 (see Figure 
3C.3). Induction of expression can be detected by Western blot analysis within 1 hr post­
induction, as observed for HSV-1 R l (Furlong et al., 1991), the level of expression peaks 
at 2 hr post-induction (lane 6) and decreases by 3 hr post-induction (lane 8). Additional 
background bands were also detected.
uooHW
Hours post-induction
a  0 0.5 1 1.5 2.5 3
140kDa
4 5 8 9
Figure 3C.3 Induction of expression of HSV-2 R l. E.coli, strain BL21 (DE3) transformed 
with pETRl(2), were grown to an optical density of 0.5. IPTG was added to the culture to a final 
concentration of 150pg/mland cultures were grown at 26°C. Samples (1ml) were then removed at 30 min 
intervals up to 3 hr post-induction. Samples were subjected to SDS-PAGE (10%) transferred to 
nitrocellulose and analysed by Western blot using an antisera (20209) initially raised against HSV-1 R l but 
which cross reacts with HSV-2 R l. Lanes 2 to £ are samples of E.coli removed from 0 min post-induction 
(lane 2) to 3 hr post-induction (lane ^). An uninduced control is shown (lane 1) and an HG52 extract was 
used for a positive control (lane 9).
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3C.4 Purification o f HSV-2 R l
The concentration of ammonium sulphate optimal for precipitation of HSV-2 Rl was 
determined, like HSV-1 Rl precipitation was optimal at a final concentration of 35% 
HSV-1 Rl was purified to apparent homogeneity using a heparin Affi-gel column 
(Furlong et al, 1991), this column was tested for its ability to bind HSV-2 Rl. A 101 
starting culture was used for the purification of HSV-2 R l, ammonium sulphate 
precipitates were loaded onto a heparin Affi-gel column, the elution of HSV-2 Rl from 
this column is shown in Figure 3C.4. The Coomassie stained gels show that Rl is the 
major protein interacting with the matrix, like HSV-1 Rl (Furlong et al, 1991), HSV-2 
Rl was purified using a single column.
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R l
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Rl
Figure 3C.4 Purification of HSV-2 R l. Coomassie stained gels of elution profile of ammonium 
sulphate fractions from E.coli expressing HSV-2 Rl. The starting ammonium sulphate fraction is shown in 
the upper gel, the rest of the gel represents fractions from the heparin Affi-gel column, the elution of R l is 
shown in the final fractions in the lower gel. R l is highlighted.
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3C.5 Assay for autophosphorylating activity associated with HSV-2 Rl
HSV-2 R l preparations purified using a Heparin Affi-gel FPLC column were assayed for 
autophosphorylation. Samples were assayed under the conditions found to be optimal for 
HSV-1 kinase activity (25mM Hepes pH 7.6, ImM Mn2+, O.lmg/ml protamine) although 
no NaCl was added. The results of such an assay are shown in Figure 3C.5. Of particular 
interest are the two bands which co-elute from the FPLC column, most apparent in lane 4; 
the lower molecular weight band showing a greater activity than the full length upper 
band. It is likely that the lower Mwt band is a degradation product, similar analyses of 
HSV-2 R l by Chung et al., (1991) showed a 55kDa major cleavage product in HSV-2 R l 
kinase assays.
[NaCl]
140kDa
55kDa
Figure 3C.5 Autoradiograph of kinase assays of FPLC (heparin Affi-gel column) 
fractions. Samples of equal volume from each 1ml fraction eluted from the heparin Affi-gel column were 
assayed for autophosphorylating activity. Samples were assayed in the presence of Mn2+ (ImM) and 
protamine (0. lmg/ml). Bands which are HSV-2 R l associated are indicated.
3C.5.1 Optimisation of HSV-2 autophosphorylation
Full length HSV-1 Rl autophosphorylation is optimal in 250mM NaCl and ImM M n2+. 
Activity is further stimulated by the addition of the basic polypeptide protamine to a final 
concentration of O.lmg/ml (Conner et al., 1992). The effect of salt and manganese on 
HSV-2 Rl autophosphorylation was investigated and compared to the effect of salt and 
manganese on HSV-1 R l autophosphorylation (see Figure 3C.6). Various concentrations
1 2 3 4 5 6
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of NaCl were assayed for the affect on autophosphorylation (Figure 3C.6 (a)); no 
significant affect on the autophosphorylation of HSV-2 Rl was observed, compare lanes 
3, 5, 7 and 9, although the pattern of the phosphoproteins associated with HSV-2 Rl 
(55kDa and 25kDa) appears to be altered by the final salt concentration in the assay, the 
55kDa band becomes more predominant as the salt concentration is increased (lane 9), 
explaining the differences observed in the kinase assays of the heparin Affi-gel fractions 
(Figure 3C.6), where the 55kDa band is more active than the full length protein; 
autophosphorylation of the 55kDa band is optimal in high salt. The 25kDa bands 
observed in both HSV-1 and HSV-2 Rl autophosphorylation assays are unaffected by the 
salt concentration in the assay; this band probably represents a stable amino terminal 
domain cleavage product. A band of a similar Mwt is observed in kinase assays of 
dC449. The relationship between the 25kDa band and HSV-2 R l could not be 
conclusively determined due to the lack of amino terminal specific antisera for HSV-2 Rl. 
A 29kDa HSV-2 Rl cleavage product is observed in extracts from E.coli expressing the 
HSV-2 amino terminal truncation (Luo et al, 1991); it is therefore likely that the 25kDa 
protein observed in assays with full length Rl is also Rl specific . The full length HSV-1 
Rl activity in this analysis, like that of full length HSV-2 R l, did not appear to be 
significantly altered by salt concentration, but was optimal in the absence of salt. A band 
observed in HSV-2 assays of between 90-110kDa, highlighted by an asterix, may be an 
intermediate cleavage product.
There is an absolute requirement for manganese for protein kinase activity, that 
autophosphorylation of both HSV-1 and HSV-2 Rl is observed in the absence of added 
Mn^+ (Lanes 1 and 2, gel b, Figure 3C.6) indicates that there are trace amounts of either 
Mn^+ or Mg2+ in ths samples. Large increases in the autophosphorylating activity of 
HSV-1 Rl are observed by the addition of relatively low concentrations of Mn^ + 
(0.5mM). Figure 3C.6 (b) shows a comparison of the effect of Mn^+ on the 
autophosphorylating activity of HSV-2 (lanes 2 ,4 , 6  and 8 , gel b) and HSV-1 Rl (lanes 1, 
3, 5 and 7). Both are stimulated by the addition of Mn^+ to a final concentration of 
0.5mM (lane 3, HSV-1 Rl; lane 4, HSV-2 Rl). The autophosphorylation of the HSV-2- 
specific 55kDa cleavage product is also dependent on manganese, this band only becomes 
apparent upon the addition of manganese to the assay (lane 4). Both the HSV-1 and HSV- 
2 25kDa cleavage products show a stimulation by the addition of manganese to the assay, 
for HSV-2 compare lanes 2 and 4, the activity of the 25kDa band is increased by the 
addition of Mn^+; the increase observed is not as large as the increase detected with the 
full length R l, it is possible that the 25kDa fragment has a higher affinity for Mn^+ or 
M g2+.
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Figure 3C .6  A utoradiographs showing optim isation of HSV-2 R l 
autophosphorylation, compared to HSV-1 R l.
a) Shows the autoradiograph of phosphoproteins produced in various final concentrations of NaCl by in vitro 
kinase assays of HSV-1 and HSV-2 R l resolved by SDS-PAGE (10%). Lanes 2, 4, 6 and 8 are HSV-2 R l 
autophosphorylation assays carried out in OmM, 250mM, 500mM and 1M NaCl, and lanes 3, 5, 7 and 9 are 
HSV-1 R l autophosphorylated in the same final salt concentrations as HSV-1 R l. Bands highlighted in this 
autoradiograph are full length R l, upper band (both HSV-1 and HSV-2), and several lower Mwt cleavage 
products.
b) Shows an autoradiograph of the phosphoproteins resolved by SDS-PAGE (10%) in various final 
concentrations of manganese. Lane 1, 3, 5 and 7 are HSV-1 R l autophosphorylated in assay buffer 
containing a final concentration of manganese of OmM, 0.5mM, l.OmM and 2.0mM respectively. Lanes 2, 
4, 6 and 8 are HSV-2 Rl related phosphoproteins assayed in the same final concentrations of manganese as 
described for HSV-1. Again, phosphoproteins highlighted represent full length Rl (HSV-1 and HSV-2) and 
several lower Mwt cleavage products. sizes were determined using reference markers
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3.C.5.2 Stimulation of HSV-2 autophosphorylation by basic polypeptides
Basic polypeptides stimulate the autophosphorylating activity of growth factor receptor 
protein kinases (Gatica et a l , 1987; Rosen and Lebwohl, 1988; Morrison et al., 1989). 
HSV-2 Rl purified from infected or transfected cells by immunoprecipitation 
autophosphorylates and transphosphorylates; both activities are stimulated by polylysine 
(Chung et al., 1990). In contrast, HSV-1 Rl overexpressed in E.coli and purified to 
homogeneity is not stimulated by polylysine, although the basic polypeptide protamine 
has been shown to stimulate activity as much as 10-fold (Conner et al., 1992b). To 
determine whether HSV-2 Rl overexpressed in E.coli can be stimulated in a similar 
fashion, both polylysine and protamine were assayed for their ability to stimulate 
autophosphorylation. Various concentrations of both poly lysine (from 0 to ImM) and 
protamine (from 0 to 0 .2mg/ml) were added to the standard kinase reaction buffer. 
Phosphoproteins were subjected to SDS-PAGE and bands were visualised by 
autoradiography (see Figure 3C.7). Polylysine showed no stimulation of 
autophosphorylation of either the full length (140kDa) or the intermediate truncation 
(55kDa) at any concentration tried, see lanes 1 to 6 of Figure 3C.7 (a). At a concentration 
greater than 0.05mM (lane 3) the autophosphorylation of both the full length HSV-2 Rl 
and the 55kDa fragment was inhibited significantly. In contrast, the phosphorylation of 
the 25kDa fragment is observed at concentrations of polylysine as high as [ l.OmM. 
Protamine stimulates the autophosphorylation activity of both the full length HSV-2 Rl 
and the 25kDa fragment; for full length Rl stimulation is observed (upper band indicated) 
at concentrations between 0.05mg/ml (lane 2) and O.lmg/ml (lane 3), and inhibition of 
activity at a concentration of 0.2mg/ml (lane 4). The lower band indicated, 25kDa, shows 
an initial increase in activity at a concentration of 0.05mg/ml (lane 2) and decreases at 
higher concentrations of protamine (O.lmg/ml, lane 3) to an activity comparable to that 
observed in the absence of protamine (lane 1). Protamine, a basic polypeptide, may 
mediate the stimulation of activity of a protein kinase by making the sites of 
phosphorylation more accessible to phosphorylation. Autophosphorylation of the 
intermediate 55kDa cleavage product is inhibited by protamine, in this polypeptide the 
sites of either autophosphorylation or catalytic residues may be readily accessible 
compared to either the full length or the 25kDa product. In the 25kDa, fragment the active 
site may be masked by C-terminal sequences, or the 29kDa fragment could be structurally 
more stable. The basic polypeptides will have a greater effect on the ability of either the 
full length or 25kDa product to autophosphorylate.
Alternatively, since the pattern of phosphorylation for the 25kDa fragment and the full 
length protein is similar, the 25kDa may result from the cleavage of full length Rl after
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autophosphorylation has occurred, indeed phosphorylation could stimulate the proteolytic 
cleavage.
Polylysine Protamine
a) (mM) b) (mg/ml)
0 0.01 0.05 0.5 1.0 0 005 Q1 0 .2
140kDa
^  55kDa
^  25kDa
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Figure 3C.7 Stimulation of HSV-2 autophosphorylation. HSV-2 R l autophosphorylation 
was assayed in the presence of two basic polypeptides, polylysine and protamine to determine their effects 
on autophosphorylation. Bands related to HSV-2 R l are highlighted equal volumes of a pure HSV-2 Rl 
preparation were used in each assay.
a) Shows the effect of polylysine on the autophosphorylation activity. Lane 1 is R l in the absence of 
poly lysine, lanes 2 to 5 are Rl assayed in the presence of poly lysine; OmM (lane 2), 0.0 ImM (lane 3), 
0.05mM (lane 3), 0.5mM (lane 4) and l.OmM (lane 5).
b) Shows the effect of protamine on HSV-2 R l. Lane 1 is R l in the absence of protamine and lanes 2 to 4 
contain protamine at a final concentration of 0.05mg/ml, O.lmg/ml and 0.2mg/ml. Activity is stimulated at 
concentrations of 0.05mg/ml (lane 2) and O.lmg/ml (lane 3) and severely inhibited at 0.2mg/ml (lane 4).
3C.6 Assay for transphosphorylation by HSV-2 Rl
A transphosphorylating activity associated with HSV-2 R l has previously been described 
(Chung et al., 1989). To determine whether HSV-2 Rl expressed in E.coli contains a 
similar activity, transphosphorylation assays were carried out under various conditions 
found previously to promote the transphosphorylation of exogenous substrates commonly 
used to characterise a protein kinase. As shown above, the autophosphorylation of HSV-2 
R l can been enhanced by the addition of protamine to the assay, optimal levels of 
autophosphorylation were observed when protamine was added to a final concentration of 
3.05mg/ml To determ ine whether protam ine or polylysine can stim ulate a 
transphosphorylating activity of HSV-2 R l, in transphosphorylation assays both basic
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polypeptides were included, and compared to the ability of HSV-2 R1 to 
transphosphorylate in their absence. Transphosphorylation assays were carried out with 
histones as a potential substrate, a substrate which has previously been shown to be 
transphosphorylated by HSV-2 R1 purified by immunoprecipitation from infected cells 
(Chung et ai, 1989). Equal amounts of an FPLC purified preparation of HSV-2 R1 were 
incubated in a kinase assay mixture, in certain reactions the basic polypeptides protamine 
(see lanes 2 and 5) and polylysine (lanes 3 and 6 ) were added to determine whether these 
act to stimulate the transphosphorylation of histones (lanes 4, 5 and 6 ), reactions were 
incubated for 20 min at room temperature. Phosphoproteins were resolved by SDS-PAGE 
(10%), see Figure 3C.8. Comparison of lanes 1,2 and 3 with those which contain histones, 
lanes 4 ,5 and 6 , shows there is no differences in the phosphoprotein profile, if histones had 
been transphosphorylated new bands of between 25-35kDa would have been observed. 
There is, however, a slight increase in phosphorylation of the HSV-2 polypeptides in the 
presence of histones, most notably for the truncated species in the absence of a basic 
polypeptide, see lane 4 (compare to lane 1) and for full length R1 in the presence of 
protamine (O.lmg/ml), compare lane 5 to lane 2. Histones, like protamine are basic 
polypeptides, so the stimulation of the autophosphorylating activity of HSV-2 R1 may be 
similar to that observed for protamine, but dependent on protamine for the stimulation of 
full length Rl.
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^  140kDa
55kDa
Figure 3C.8 Autoradiograph of assay for transphosphorylation of histones by HSV-2
Rl. HSV-2 R1 was assayed for transphosphorylating activity under various conditions which are known to 
stimulate the autophosphorylating activity of this protein. Lane 1 and 4 shows the assay in the absence of 
basic polypeptides, lane 4 also contains histones (0.1 mg/ml, histone type III) at a final concentration of 5pg 
per reaction , lanes 2 and 5 are transphosphorylation assays carried out in the presence of protamine 
(O.lmg/ml), lane 5 also contains histones. Lanes 3 and 6 are transphosphorylation assays carried out in the 
presence of polylysine (40mM). Bands highlighted are those related to HSV-2 R l.
3C.7 Discussion
The kinase activity of the HSV-2 Rl was originally thought to differ from that of HSV-1 
(Chung et al., 1989). To make an accurate comparison of the activities of the two, HSV-2 
R l was over-expressed in E.coli using the T7 expression system used for the full length 
HSV-1 R l (Furlong et al., 1991). HSV-2 Rl was then purified to apparent homogeneity 
using the heparin Affi-gel matrix that was successful in the purification of the HSV-1 R l. 
Previously, HSV-2 R l purified by immunoprecipitation from infected cells was shown to 
be completely dependent on manganese for activity (Chung et al., 1989; Chung et al., 
1990), analysis of the HSV-1 R l kinase activity showed it was also dependent on 
manganese (Conner et al., 1992b). The HSV-2 R l autophosphorylating activity was 
compared to HSV-1 Rl autophosphorylating activity over a variety of salt and manganese 
concentrations. In the experiments comparing the effects of sodium chloride on both HSV- 
1 R l and HSV-2 R l, the activity showed no significant differences over the range of salt 
concentrations tried. Both full length HSV-1 and HSV-2 R l showed an absolute
- Histones + Histones
Protamine
Polylysine
+
+
1 2 3 4 5 6
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requirement for manganese as did the 55kDa HSV-2 specific polypeptide. Both the HSV-1 
and HSV-2 25kDa polypeptide autophosphorylated in the absence of exogenous Mn^+ 
suggesting that trace amounts of either Mn^+ or Mg2 + is enough to promote its 
autophosphorylation. The divalent cation may interact strongly with the 25kDa 
polypeptide.
The effects of basic polypeptides on the autophosphorylation of HSV-1 and HSV-2 Rl 
were found to differ; the basic polypeptide polylysine has previously been shown to 
stimulate HSV-2 Rl kinase activity (Chung et al, 1990), whereas protamine was found to 
stimulate the activity of the HSV-1 Rl (Conner etal., 1992b). The stimulation of the E. 
coli expressed HSV-2 activity was investigated, unlike previously, the only basic 
polypeptide which showed stimulation of the autophosphorylation of full length HSV-2 
was protamine, polylysine showed no effect at low concentrations and at higher 
concentrations inhibited autophosphorylation. As found for the amino terminal region of 
HSV-1 Rl and for the full length HSV-1 Rl, the HSV-2 enzyme degrades, two main 
cleavage products are commonly observed; of 55kDa and 25kDa. The affect of basic 
polypeptides on the phosphorylation of these cleavage products is varied; for the 55kDa 
cleavage product, neither polylysine or protamine were found to have a stimulatory affect, 
and for the 25kDa cleavage product autophosphorylation is stimulated by both protamine 
and polylysine. Cleavage products associated with HSV-2 Rl have been previously noted; 
55kDa (Chung et al, 1989) and the smaller 25kDa product (Luo et al, 1992). Differences 
in the autophosphorylation pattern of these cleavage products when compared to full length 
R l may represent different accessibility’s of either the active site or the site of phosphate 
transfer in these truncations. The interaction of protamine or polylysine with the 55kDa 
cleavage product does not affect the autophosphorylation of this polypeptide, this cleavage 
product may have adopted a structure which allows the autophosphorylation to be optimal 
and failure of either polylysine or protamine to stimulate autophosphorylation suggests that 
interaction with these sites can not be made more accessible, optimal phosphorylation is 
observed in the absence of the basic polypeptides. Formation of the 25kDa cleavage 
product, which may be the stable protein kinase domain of Rl may lead to a more tightly 
complexed molecule in which, as proposed for the full length, molecule 
autophosphorylation can be stimulated by basic polypeptides.
HSV-2 Rl differs from that of HSV-1 Rl in that it can transphosphorylate exogenous 
substrates (Chung et al, 1989; Chung et al, 1990). The substrate chosen for this assay of 
the E.coli expressed HSV-2 R l, histones, was previously used to analyse the 
transphosphorylating activity of HSV-1 Rl (Conner et a l, 1992b). Initially 
transphosphorylating activity associated with HSV-1 Rl was shown to be a contaminant 
when the amino terminal truncated R l dN245 was also shown to have
133
Chapter 3. Results and Discussion
transphosphorylating activity. The transphosphorylating assay of HSV-2 Rl expressed in 
E.coli showed that HSV-2 R l did not posses any transphosphorylating activity with 
histones as a substrate. The autophosphorylation of the HSV-2 R l was however affected 
by the addition of histones to the assay, in the presence of protamine histones lead to an 
even greater increase in autophosphorylating activity. Whereas in the absence of basic polypeptides, 
in the presence of polylysine, histones acted to inhibit autophosphorylation. Histone inhibition of 
HSV-2 R l autophosphorylation has been noted previously for a 29kDa amino terminal 
truncation of HSV-2 Rl expressed in E.coli (Luo et al., 1991). In contrast to the full 
length R l autophosphorylation, the phosphorylation of the 55kDa cleavage product was 
not affected by histones, which raises the obvious question of whether or not this 
phosphoprotein is directly related to HSV-2 R l. Without any HSV-2 amino terminal 
specific antisera this protein can not conclusively be shown to be related to HSV-2 R l. 
Comparison of the profiles of type 1 and type 2 R l purified by the same purification 
scheme suggests that the 55kDa protein is not a contaminant E.coli protein which also 
binds to the column, as this protein would also be observed in the HSV-1 preparations. It 
is, however, possible that it is an E.coli protein which specifically interacts with HSV-2 
R l. The 25kDa cleavage product is a feature of both HSV-1 and HSV-2 R l In the case of 
HSV-1 that this protein is a cleavage product was shown by Western blot analysis, this 
product is observed in preparations of both the dC449 truncation and with full length R l.
The 25kDa protein may be a result of Rl cleavage after phosphorylation has occurred.
Stimulation of protein kinase activity by both histones and protamine has been noted for 
the cellular protein kinase, caesin kinase II (Palen and Traugh, 1991). For icasein kinase II 
it has been proposed that transient interactions between this protein kinase and specific 
intracellular compounds stimulate the autophosphorylating activity of casein kinase II, 
autophosphorylation leading to the up-regulation of the transphosphorylating activity of 
this enzyme.
Comparison of the activities of the type 1 and type 2 R l in vitro shows that they are 
similar, it is possible they also play a similar in vivo function.
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3D Construction and analysis of cell lines expressing the 
HSV-1 Rl unique amino terminal region
3D.1 Construction of expression vector
To constitutively express the HSV-1 Rl N-terminal region, the unique amino terminal 
region was cloned into a retroviral vector. The vector chosen contains two copies of the 
Moloney murine leukaemia virus LTR. Transcription is initiated from a TATA box in the 
U5 region of the retroviral LTR and a polyadenylation signal is located in the repeat (R) 
region of the downstream LTR. The truncated Rl open reading frame, amino acids 1-564 
was cloned into the vector on a Xbal/Sal-1 fragment. The original vector was cut with 
BamHl and Hindlll, both sites were rendered blunt using Klenow; the vector was then 
treated with calf intestinal phosphatase to reduce vector background in ligation. The Rl 
truncation was prepared by Xbal/Sal-1 digestion of pYNl-SD (Figure 3A.4) (Xbal site 
located within the T7 promoter, Sail site located between amino acids 564 and 565), see 
Figure 3D.1.
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Bal-1 (R1 ATG)
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Rl BamH1
Xba1
Figure 3D.1 Construction of vector for the expression of HSV-1 Rl in mammalian 
cells.
a) Shows the Moloney murine leukaemia virus long terminal repeat region. In the unique 5 ' region, sites for 
upstream activator binding are located, these include the glucocorticoid response element (GRE), nuclear 
factor 1 (NF1) and the leukaemia virus specific binding factors (LVa, LVb and LVc). The TATA box is also 
located within the unique 5 region and the polyadenylation signal is located within the repeat (R) region of 
the LTR.
b) Shows the region of HSV-1 cloned into the retroviral vector, this region includes the unique amino 
terminal region (AA 1-325) and the leucine repeat region located downstream of the unique region in die 
region which shows the greatest conservation to the HSV-2 enzyme (98%), and where homology to the 
mammalian R l enzyme begins.
c) Shows the vector used to express the amino teminal region in mammalian cells, the truncated Rl open 
reading frame was cloned into this vector on an Xbal/Sall fragment derived from pYNl (see Figure 3A.4).
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3D. 2 Construction o f cell lines
Expression from the plasmid containing the amino terminal region of HSV-1 Rl was first 
confirmed by Western blot analysis, cell lines were then constructed. Plasmid 
pMLVdCRl was co-transfected into Rat-1 cells with p61, a plasmid in which the 
neomycin gene is expressed from an HSV-1 tK promoter (see Figure 3D.2). Transfections 
were carried out with varying concentrations of plasmid; ratio of pMLVdCRl:p61 ranging 
from 1:10 to 1:103. DNA was transfected overnight, plates were then washed with serum- 
free medium. Once plates became confluent, G418 (Gibco) was added to the plates at a 
final concentration of 400p,g/ml; the concentration of G418 used was determined by 
optimising the amount required to kill Rat-1 cells within 7 days, at this concentration, 
resistant colonies are able to proliferate with minimum impairment caused by G418. 
Colonies were grown until it was possible to pick them easily using a cloning ring 
(typically 7-14 days). Clones were expanded and frozen stocks made prior to analysis.
HSV-1
tk
promoter
E.coli aminoglycoside 3'- 
phosphottansferase 
(Neo9
HSV-1 
tk polyA
Figure 3D.2 Neomycin resistant cassette in plasmid p61. The neomycin resistance gene, from 
the E.coli transposable element Tn5, aminoglycoside 3’-phosphotranferase was expressed from the HSV-1 tk 
gene promoter, downstream processing was mediated by die HSV-1 tk polyadenylation sequences.
3D.3 Analysis of cell lines
3D.3.1 Expression of truncation in neomycin resistant cell lines
Each cell line was screened for the expression of the truncation by Western blot analysis. 
Cells were seeded on 10cm culture plates and allowed to reach confluence. To determine 
whether expression could be enhanced by a synthetic glucocorticoid, (MLV LTR U5 
region contains a glucocorticoid response element), dexamethasone was added to the 
medium at a final concentration of 10|ig/ml. Cells were incubated with dexamethasone for 
24hr prior to harvesting. Monolayers were harvested as described in Materials and 
Methods and extracts were resolved by SDS-PAGE. Proteins were transferred to 
nitrocellulose and the blot was probed with the polycolonal antisera 77 raised against full 
length Rl expressed in E.coli. The Western blot (using Amersham ECL detection (Figure 
3D.3a,b)) shows bands unique to cell lines when compared to the parental cell line, Rat-1,
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within the predicted Mwt range of 65kDa. The majority of cell lines do not show induced 
levels of expression in the presence of dexamethasone suggesting that in the majority of 
cases the GRE element does not respond to dexamethasone (see Figure 3D.3a,b). Two 
lines are stimulated by dexamethasone, line 1A and 3A (lanes 5 and 9, gel a). The high 
precentage of positives is probably due to the efficiency of the transfection reagent used, a 
lipofection reagent DOTAP and the final ratio of pMLVdCRl:p61 used was 1:103. *
* Two independently transfected plates of Rat-1 cells were used for the isolation of the cell 
lines. The isolated clones, a and b, refer to the different plates transfected.
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R l Rat-1 1A 2A 3A 7A 8A
dexamethasone I -  +  1^ -  +  ■+■ If"- +  H -  +  H -  +  Ia
64kda
1 2 3 4 5 6 7 8 9 10 11 12 13
b)
Rl Rat-1 IB 2B 4B 10B 1 IB
dexamethasone H"  ^ “ H" M ~ "t“ H -  +  H -  ~h I
64kda
1 2 3 4 5 6 7 8 9 10 11 12 13
Figure 3D.3 Western blot of extracts from cell lines. Neor cell lines, ten shown above, were 
plated out on lOOmM plates and grown till confluent, the synthetic glucocorticoid dexamethasone was added 
to a final concentration of 10|ig/ml (samples shown in lanes 3, 5, 7, 9, 11 and 13) 24hr prior to harvest. 
Plates were washed twice in ice cold PBS and harvested in 500fil of lx boiling mix, 100|il of each sample 
was loaded onto a 10% SDS-PAGE, transferred to nitrocellulose and probed with a polyclonal antibody, 77, 
raised against full length E.coli expressed HSV-1 R l. a) Shows Western blot of A isolates, b) Shows 
Western blot of B isolates
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3D.3.2 Copies of Rl truncation integrated into the cellular genome
Genomic DNA was prepared as described in Materials and Methods. DNA, 10|ig, was 
digested overnight with Xbal or EcoRl. Xbal sites are located within the LTRs flanking 
the truncated R l, digests with Xbal will give an indication of whether the promoter and 
downstream regions are intact and how the plasmid has integrated into the genome. 
EcoRl has a single site in the vector backbone, digests with EcoRl should therefore give 
an indication of the number of copies of insert/cell and also whether the plasmid has 
inserted into the genome as concatamers. Concatameric DNA will produce a band of 
5.6Kb, the size of the plasmid, in an EcoRl digest. Digests were resolved overnight on a 
0.8% lxTBE gel. The gel was photographed to determine the extent of digestion and then 
transferred onto a nylon membrane. The blot was hybridised overnight with an Rl specific 
DNA probe (see Figure 3D.4).
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5.6Kb EcoRl 
fragment
2.8Kb Xbal 
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1 2 3 4 5 6 7 8 9 10 11 12
MLV LTR R1 reading frame M Ly L JR  
AA 1-564
i::::::::::::::
M  I  M  t
EcoRl Xbal BamHl BamHl Xbal
BamHl
2.8 Kb Xbal fragment
0.58 Kb BamHl probe
Figure 3D.4 Southern blot of genomic DNA isolated from cell lines. Genomic DNA, 
lOpg, was digested with the restriction enzymes Xbal(X) or EcoRl(E). Lanes 5 and 6 are DNA isolated 
from line 2A and digested with Xbal or EcoRl respectively, lanes 7 and 8 are line 3A, lanes 9 and 10 are 7A 
and lanes 11 and 12 are line 8A. Transformed cell lines are compared to control Rat-1 cells, lanes 2 and 3. 
Lane 4 (R) is a reconstruction containing 1 genome equivalent of pMLVdCRl DNA. The location of 
restriction sites, EcoRl and Xbal with respect to their location in the R l truncation and LTRs, used to digest 
genomic DNA is shown, as are the BamHl sites used for the 0.58Kb probe.
The Southern blot shows that several cell lines contain the Rl insert in multiple copies. 
The highest plasmid copy number of the four lines analysed is observed in line 3 A (lane 7,
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Xbal digest and lane 8, EcoRl digest); when compared to the genome equivalent 
reconstruction in lane 4 it is apparent that in this cell line the plasmid has integrated as 
multiple copies; other lines analysed, 2A (lanes 5 and 6), 7A (lanes 9 and 10) and 8A 
(lanes 11 and 12) are positive but the copy number is not as high as in 3A. The restriction 
enzymes used, EcoRl and Xbal, cleave once or twice per plasmid respectively. In lines 
2A, 3A and 7A bands of 2.8Kb are produced in an Xbal digest, indicating that in these 
lines the plasmid has integrated in such a way that the upstream and downstream LTR 
sequences are maintained at least partially. In an EcoRl digest of these lines both 2A and 
7A contain one major band, this indicates that in these lines the plasmid has integrated into 
a single site, that a band of 5.6Kb is absent in both these lines suggests that the plasmid has 
not integrated as a concatamer. From the restriction analysis of 2A and 7A it appears that 
there is only one copy of the truncated Rl open reading frame integrated per cell. The 
patterns of restriction digests for 2A and 7A are similar, the EcoRl fragments co-migrate 
(Lane 5, line 2A and lane 9, line 7A), differences in the Xbal digests are however apparent 
(lane 6, line 2A and lane 10, line 7A); the presence of more than one band in the Xbal 
digests is most likely to be a result of incomplete digestion, that digests differ shows that 
the lines are not related, j *
In line 3A several bands are apparent in both the EcoRl and the Xbal digests (lane 7, 
EcoRl digest and lane 8, Xbal digest). In the EcoRl digest a band of 5.6Kb is present, 
this band which represents linear plasmid DNA indicates that the plasmid has integrated as 
concatamers. In addition to the 5.6Kb species, bands of a higher Mwt are apparent, these 
can in part be explained by partial digestion, see Figure 3D.5. The slowest migrating band 
in the EcoRl digest has a Mwt greater than 9.4Kb and could be an 11.2Kb band produced 
by a partial. The middle band which cannot be explained by a partial digestion could be 
produced by the cleavage in a terminal plasmid at the site of integration and in a flanking 
genomic DNA. Several bands apparent in the Xbal digest can be explained by the partial 
digestion of the concatameric DNA, a band migrating between 9.4Kb and 6.15Kb is 
probably an 8.4Kb partial fragment. As proposed for the EcoRl pattern the middle band in 
the Xbal digest probably represents cleavage in the genomic DNA and in the terminal 
plasmid of the concatamer.
* The highest copy number of the four lines analysed is seen in line 3A; when compared to 
the genome equivalent in lane 4 it is apparent that in this cell line the plasmid has integrated 
at least 100 times; other lines analysed, 2A, 7A and 8A are.positive but the copy number is 
not as high as 3A, estimates of copy number for each line are for 2A, 10; for 7A 50 
copies/cell and for line 8A less than 1 copy/cell.
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Figure 3D.5 Possible partial digest bands in line 3A. The pattern of partial restriction bands 
occurring in line 3A which appears to be the only line analysed which has integrated the plasmid as 
concatamers is shown.
The Southern blot data confirms the Western blot data in that the high expression line 3A 
has the highest DNA copy number with the plasmid integrated as concatamers.
A weak signal is observed in line 8A (Figure 3D.4, lanes 11 and 12), in this particular line 
the plasmid copy number is less than one per cell. The DNA is present but the expression 
of the Rl truncation was not apparent by Western analysis (see Figure 3D.3).
3D.4 Sub-cellular localisation of the amino terminal region in cell lines
3D.4.1 Crude subcellular fractionation
Cells were seeded on 10cm plates, plates were set up in duplicate for whole cell fraction
comparisons and the effect of dexamethasone by increasing the amount of protein, on
localisation was also determined. Monolayers to be fractionated were incubated in
10.9mlhypotonic buffer, homogenised and spun for 1 hr at 100K. Pellets were resuspended in^or 
lx boiling mixture; soluble fractions were made up to a volume of 0.6ml and 0.3ml 3x 
boiling mixture was added. Whole cell extracts were incubated and harvested in 0.6ml of 
isotonic buffer. Equal volumes of each sample; whole, particulate and soluble were loaded 
onto a 10% SDS-PAGE. Proteins were transferred onto nitrocellulose and probed with 
polyclonal antibody 77.
Figure 3D.6 shows the autoradiograph of the Western blot (using Amersham ECL 
detection). In the high expression line, 3A, the majority of the amino terminal region
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localises to the soluble fraction (lane 7); when expression is enhanced by dexamethasone a 
substantial amount of the amino terminal region is detected in the particulate fraction (lane 
9).
Rat-1 3 A 3A+dx
^  p <rir"w p s"^"~w p s
1 2  3 4 5 6 7 8 9  10
Figure 3D.6 Western blot of cell line 3A separated into particulate and soluble 
fractions. Equal total numbers of cells were harvested, for whole fractions (W, see lanes 2, 5 and 8), 
monolayers were harvested in IX boiling mix, fractions of cells were prepared by harvesting cells, lysing and 
removing insoluble material by centrifugation, pellets were resuspended in a volume of buffer equivalent to 
that of the supernatant.
3D.4.2 Localisation of HSV-1 Rl
The intracellular localisation of Rl in both infected cells and in cell lines was investigated 
by immunoflouresence. The localisation of R l in cells infected with the wt and the mutant 
tsK was determined. In a tsK infection at the non-permissive temperature, immediate early 
genes are over-expressed, R l although not a typical immediate early is also over­
expressed. Using this virus the effect of the small subunit, R2 on the localisation of R l 
can be determined. During infection R l undergoes proteolytic cleavage (Ingermarson and 
Lankinen, 1987), it is possible that once it has undergone cleavage the localisation of the 
cleavage products may differ from that of full length R l, by comparing the localisation of 
the amino terminal region in cell lines to its localisation in the infected cell any role of the 
C-terminal sequences on its localisation can be determined.
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3D.4.2.1 Localisation of R l in infected cells
Infections using either wt or tsK were carried out in BHK cells seeded onto coverslips. 
Coverslips were then incubated with the R l specific monoclonal antibody 1026. 
Infections using the tsK mutant were carried out at either the non-permissive temperature 
(39°C) or the permissive temperature (31°C) and allowed to proceed for 4 hr. Infections 
with wt virus were carried out at 37°C, and to allow expression of R2, infections were 
carried out for 8 hr the pattern of Rl localisation in wt infected cells is shown in Figure 
3D.7 (a and b)
Figure 3D.7 (a) Mock infected BHK cells 
(photographed at 40x magnification)
■
E m
Figure 3D.7 (b) wt infected cells. Localisation of R l in cells infected 
with wt virus at 10t>fu/cell, fixed at 8 hr post-infection. Stained with mAb 1026. 
(photographed at 40x magnification)
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Figure 3D.7 (c) wt infected cells.(31°) Localisation of Rl in cells infected 
with wt virus at lOpfu/cell, fixed at 8 hr post-infection. Stained with mAb 1026.
(photographed at 40x magnification)
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In cells infected with the wt virus R l localises throughout the cell. The pattern of staining 
is punctuate with discrete spots of fluorescence observed. Differences in the level of 
staining between cells can be explained by differences in the uptake of virus between cells, 
cells showing weak fluorescence being infected with fewer virus particles.
3D.4.2.2 Localisation of R l in BHK cells infected with tsK
The localisation of R l in cells infected with tsK at both the permissive and non-permissive 
temperature was determined, see Figure 3D.8 (a and b, permissive temperature) and Figure 
3D.9 (a and b, nonpermissive temperature)
Figure 3D.8 (a) Mock infected BHK cells (31°C)
(photogr aphed at 60x magnification)
Figure 3D.8 (b) BHK cells infected with tsK (31 °C). Cells were 
Infected with tsK at infection was allowed to proceed for 4 hr before fixing, 
cells were stained with mAb 1026. (photographed at 60x magnification)
146
Chapter 3. Results and Discussion
Mock infected cells show a grainy background. In cells infected with tsK at the permissive 
temperature, as found for infection with wt, R l is localised to discrete sites located 
throughout the cell, with in some cells a concentration of antigen is observed around the 
nucleus.
Figure 3D.9 Mock infected BHK cells (39°C).
(photographed at 60x magnification)
Figure 3D.9 (b) BHK cells infected with tsK (39°C). Cells
were infected with tsK, infection was allowed to proceed for 4 hr before 
fixing. Cells were stained with mAB 1026.
(photographed at 60x magnification)
The localisation of R 1 in cells infected with tsK at 39°C is similar to that observed in cells 
infected with tsK at the permissive temperature and cells infected with wt virus. The
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localisation of R 1 does not appear to be affected by the presence of the small subunit 
which is absent in the tsK non-permissive infection. In all infections the localisation is 
throughout the cell, and is in some cells a concentration around the nucleus.
3D.4.2.3 Localisation of N-terminal region in stably transformed cell lines
With the cleavage of R l between the unique N-terminal region and the conserved 
reductase regions it is possible that the N-terminal region may show a different 
intracellular localisation to full length R l. Using the stably transformed cell lines the 
localisation of the N-terminal region was investigated. Cells were seeded onto coverslips 
and allowed to become 60-70% confluent before being paraformaldehyde fixed, cells were 
then stained with the R l specific monoclonal antibody used in infected cells. The 
localisation of the N-terminal region was investigated in three independently isolated cell 
lines, which were shown to express this truncation (section 3D.4), the localisation of this 
region is shown in Figure 3D. 10 (a to d).
Figure 3D. 10 (a) Rat-1 cells stained with mAb 1026
(photographed at lOOx magnification)
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Figure 3D. 10 (b) Localisation of N-terminal region in line 2A.
(photographed at lOOx magnification)
/
Figure 3D. 10 (c) Localisation N-terminal region in cell line 3A.
(photographed at lOOx magnification)
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Figure 3D. 10 (d) Localisation of N-terminal region in cell line 8A.
Cell lines (a to d) were stained with mAb 1026 
(photographed at lOOx magnification)
In all cell lines investigated the N-terminal region shows an almost exclusive cytoplasmic 
localisation. As found for R l in infected cells the N-terminal region localises to discrete 
areas of the cytoplasm, the pattern in the cell lines is however more punctate; the punctate 
spots are more discrete than observed in the BHK infected cells, it is unlikely, although 
possible, that the cell lines (Rat-1 compared to BHK) may in some way influence the 
localisation. There is, as observed in some infected cells, a concentration of the punctate 
spots in the vicinity of the nucleus, and in certain cells weakly fluorescent spots are 
observed within the nucleus.
3D.5 Growth of HSV-1 on cell lines.
The effect of the constitutive expression of the N-terminal region of R l on the growth of 
HSV-1 was determined. Cell lines were infected with 5pfu/cell of HSV-1 (17+) and the 
amount of cell-released virus produced after certain time points was determined. 
Infections were allowed to proceed for 72 hr. A representative growth curve for such an 
experiment is shown below, Figure 3D. 11, viral replication on the cell lines was compared 
to its replication on the parental cell line Rat-1.
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Figure 3D. 11 Growth of HSV-1 on cell lines expressing the N-terminal region of 
HSV-1 Rl. Three independently isolated cell lines were analysed for the effect of constitutive expression 
of the Rl N-terminal region, the lines tested 2A, 3A and 8A are compared to the parental line Rat-1, the key 
indicates the relevant curves for each line.
Compared to the parental line Rat-1 all three cell lines analysed show a reduced ability to
replicate HSV-1, or possible to release HSV-1. The amount of virus produced at between
12-36 hr is considerably lower than observed for Rat-1 cells. Throughout infection the cell
lines were monitored for effects of infection, in particular it was noted that even after 36 hr
there was no obvious cytopathic effect, and at 72 hr the amount of visible plaques apparent
were low, the plaque number for the 72 hr timepoint was counted for each line, the line 2A
contained the largest number of plaques (>200/60mm plate) and line 3A having the lowest
number of plaques (<100/60mm plate). The plaques appeared morphologically normal.
The amount of plaques produced at the 72hr time point does not correlate with amount of
virus released, as analysed by the single step growth curve, the virus titre does not show a
significant increase between the 36 hr time point when no plaques were observed and the
72 hr time Doint when plaques become apparent. It is possible that the few plaques 
j virus
observed are^replicating in cells which are neomycin resistant.but lack the N-terminal 
region. The virus may effectively adsorb to the cells in the 1 hr period normally used for 
infections and later be released into the medium without penetrating the cell. Further 
experiments are needed to determine the exact mechanism by which the cell lines reduce 
cell-released virus yields, it may be that the block is only in the release of the virus from 
these lines and that had the cell-associated virus been determined the yield may not differ.
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3D.6 Discussion
The association of the HSV-2 Rl N-terminal region with plasma membranes has been 
demonstrated (Chung et al., 1990), to determine if the HSV-1 Rl N-terminal region shows 
a similar localisation the intracellular localisation of both full length Rl in the infected cell 
and the N-terminaljregionin stably transformed cell lines was determined. The pattern of 
localisation in both was similar, localising to discrete areas of the cytoplasm with a 
concentration of foci around the nucleus. The identity of these sites has yet to be 
determined. In the infected cell Rl shows a very strong staining around the nucleus this 
could possibly be the Golgi. However in the cell lines this very strong peri-nuclear 
staining is not observed although the foci are more concentrated around the nucleus. It is 
possible that these discrete areas are small cytoplasmic organelles, similar to endosomes, 
small membrane structures are found in the cytoplasm. Like the mammalian reductase 
large subunit of HSV-1 Rl localises to the cytoplasm (Engstrom et al., 1984) although the 
mammalian enzyme is distributed throughout the cytoplasm rather in foci. The crude 
fractionation experiment, in which cells were separated into soluble and particulate 
fractions showed, that in cell |lines investigated, the N-terminal region although mainly 
soluble was present in the particulate fraction. This may indicate that the association of the 
N-terminal region with membranes is transient or weak, dissociation from membranes 
occurring relatively easily. Membrane association may be mediated by a lipid, through 
anchoring mediated by the lipid. HSV-2 Rl myristolyation (Chung et al., 1990) and 
potential lipid modification have been identified in HSV-1 Rl.
Perhaps one of the most interesting findings in the analysis of the stably transformed cell 
lines is their ability to impair the replication of HSV-1. The amount of virus released from 
cell lines infected with HSV-1 is reduced by 100-fold when compared to the parental cell 
line, Rat-1. Virus release is also delayed even after 72 hr the amount of virus released can 
not be compared to the amount of virus released after 12 hr in the Rat-1 cells. To 
determine the exact role of the N-terminal region in blocking viral replication several 
experiments are needed to determine the efficiency of uptake into these cells as well as the 
expression of the different virus genes.
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* A region rich in aspartic acid residues located between 190 and 234 may mediate 
the interaction of the N-terminus with the basic polypeptides. This region also rich in 
serine residues probably contains the site of the N-terminal region 
autophosphorylation. !'
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4 .  General Discussion
The large subunit of HSV ribonucleotide reductase is unusual in: a) its pattern of 
expression, being expressed in the presence of cycloheximide, unlike the small subunit 
which is a typical early gene (Clements et al., 1977), expression of Rl does not require de 
novo synthesis of viral proteins, b) the simplex members of the alphaherpesviruses 
subfamily contain a 325 amino acid extension at their amino terminus, which shows no 
homology to any other reductase large subunits which have been sequenced (Nikas et al., 
1988; Chung et al., 1989), this region is not required for in vitro reductase activity 
(Conners al., 1992).
R l autophosphorylation: self-regulation o f protein kinase activity or another activity? 
Comparison of the autophosphorylating activities of HSV-1 and HSV-2 Rl both 
overexpressed in E.coli and purified to apparent homogeneity using the same purification 
scheme, showed that there are little, if any, differences in the autophosphorylation 
activities. Basic polypeptides which stimulate protein kinase autophosphorylation were 
assayed for their ability to stimulate HSV-2 Rl autophosphorylation. In contrast to 
previous reports (Chung et al, 1990), where polylysine was shown to stimulate HSV-2 Rl 
autophosphorylation only protamine, the basic polypeptide reported to stimulate HSV-1 Rl 
autophosphorylation (Conner et al, 1992b), had any affect on the autophosphorylation of 
full length HSV-2 R l. HSV-2 Rl autophosphorylation was^further stimulated by the 
addition of histones to the assay, this further increase in actvit) was observed only in the 
presence of protamine. Histone stimulation of protein kinase autophosphorylation has 
been reported previously; autophosphorylation of [ casein kinase II is stimulated by 
protamine, addition of histones to the assay leads to a further increase in activity (Palen 
and Traugh, 1991). Autophosphorylation of protein kinase C is also stimulated by both 
histones and protamine (Chauhan and Chauhan, 1992). This stimulation of protein kinase 
C autophosphorylation by basic polypeptides is thought to be physiologically important. 
Interactions between protein kinase C and basic polypeptides in vivo may modulate 
protein kinase C activity in the absence of its phospholipid activators. Protamine, a 
polypeptide rich in arginine residues, can stimulate both HSV-1 and HSV-2 Rl 
autophosphorylation in vitro. In vivo Rl autophosphorylation could be controlled by its 
mteraction with cellular proteins rich in basic residues.
Autophosphorylation is a way in which a protein can self-regulate its activity, it is an 
activity commonly associated with protein kinases. Autophosphorylation reactions have
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also been described for proteins which are not protein kinases. Protein kinase 
autophosphorylation can be specifically stimulated by the binding of a regulatory ligand.
iWith the dsRNA-dependent protein kinase the autophosphorylation is completely dependent on 
its interaction with dsRNA, only once dsRNA binds to this kinase and the kinase 
autophosphorylates can exogenous substrates be phosphorylated (Thomas and Samuel, 
1993). Growth factor receptor autophosphorylation occurs only after it binds a specific 
ligand. Intramolecular autophosphorylation is a mechanism by which many protein 
kinases control their transphosphorylating activity. A serine/threonine protein kinase
which specifically phosphorylates a protein phosphatase becomes 10-fold 
more active towards exogenous substrates after its autophosphorylation (Guo et al, 1993).
Autophosphorylation has also been observed in proteins which do not function as protein 
kinases. The eukaryotic heat shock response protein, hsp90, autophosphorylates 
(Csermely and Kahn, 1991). Phosphorylation of hsp90 was shown to be substrate-specific, 
no exogenous substrates tried were phosphorylated by hsp90. The autophosphorylation of 
hsp90 was shown to be stimulated by basic polypeptides, in particular histones, the 
interaction with histones has been proposed to be physiologically important. A 
conformational change induced by the phosphorylation of hsp90 may mediate its 
interaction with steroid receptors and other proteins (Csermely et al, 1993). Notably the 
hsp90 ATP binding site shows no homology to ATP binding sites in protein kinases, but is 
however typical for a heat shock protein. The autophosphorylation of R1 may be 
important in modulating a non-kinase activity associated with the N-terminus, that R1 may 
not be a protein kinase can not therefore be ruled out.
An alternative catalytic core in the HSVR1 kinase?
The intrinsic autophosphorylating activity of HSV-1 R1 (Conner et al, 1992b) is a feature 
of the unique amino terminal region, as previously shown for HSV-2 R1 the unique amino 
ierminus (Luo et al, 1991; Luo and Aurelian 1992; Ali et al, 1992). Regions important in 
ihe autophosphorylating activity of HSV-1 R1 were mapped by both insertion and deletion 
mutagenesis. C-terminal deletion of the unique amino terminal region to amino acid 257
showed that the basic catalytic core must be completely contained within this region.
C-teminal
^ucietion to amino acid 257 removes amino acids which have been postulated to be of 
catalytic importance (Chung et al, 1989). That the 257 deletion is active indicates that 
original predictions are inaccurate. A protein kinase catalytic core normally spans some 
200 amino acids, that the HSV-1 catalytic core is contained within the region between the 
proposed nucleotide binding motif at amino acid 114 and residue 257, a distance of around 
140 amino acids is unlikely ^
biidfng site016 ^  N‘terminaI region of HSV-1 R1 must contain an alternative nucleotide
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Residues critical for protein kinase function, subdomains, were identified, firstly by sequence 
comparisons (Hanks et al., 1988) and latterly by site-directed mutagenesis (Gibbs and 
Zoller, 1991). A protein kinase can be separated into two functional regions. An ATP 
binding region and a region which directly facillitates phosphate transfer. The ATP 
binding site typically contains a glycine triad, which directly interacts with ATP, and 
downstream a lysine and a glutamic acid residue which stabilise the binding of ATP. The 
lysine and glutamic acid residues are essential for protein kinase activivty. Residues that 
are practically invariant in all protein kinases are shown in Figure 4.1(a). There are) rare 
examples of protein kinases which do not have a typical nucleotide binding glycine triad, 
with some lacking one or two of the glycines (Taylor, 1992). Mutation of this region in 
several protein kinases can produce a range of affects on kinase activity, activity can be 
completely destroyed (Odawara et al, 1989), or significantly up-regulated (Pelley et al., 
1989). Protein kinase has been described which lack one, two or all three glycines 
(Herman et al., 1991). It is possible that in both HSV-1 and HSV-2 R1 the nucleotide 
binding motif predicted is incorrect, and that another region upstream of the predicted site 
binds ATP. Residues which are crucial in protein kinase function are; a lysine typically 
located within the 23 amino acids downstream of the nucleotide binding site and a 
glutamic acid residue. Together they form an ion pair which promotes the formation of a 
stable complex between the kinase and the phosphate, mutation of the lysine destroys 
activity (Gibbs and Zoller, 1991).
Insertion into the proposed nucleotide binding site of the R1 unique amino terminal region 
leads to decreased activity, however as mentioned previously the expression of this 
particular mutant was poor, so differences can in part be explained by the reduced amount 
of this particular mutant. Deletion of a region spanning the nucleotide binding site, from 
amino acids 43 to 136 completely destroys activity, indicating that this region is essential 
for R1 autophosphorylation, and it is likely that this region contains residues important in 
catalysis. Mutation of both the proposed nucleotide binding site and downstream lysine 
residue in HSV-2 R l, only slightly reduces the activity (Luo and Aurelian, 1992); 
indicating that phosphate transfer is mediated by either another residue or that the lysine 
prediction is incorrect
The autophosphorylating activities of HSV-1 and HSV-2 Rl are similar, it is therefore 
reasonable to assume that their catalytic residues will be conserved. Within the N-terminus 
of HSV-1 Rl there is only one lysine and in HSV-2 there are two, one of which is 
positionally conserved with HSV-1. There is no glutamic acid residue within the normal 
spacing observed downstream of these lysines in HSV-1 and HSV-2, instead an aspartic 
acid residue, another acidic amino acid, is located. It is possible that in the tertiary 
structure the loss of a ethyl group (see figure 4.1 (c)) may be compensated for by the lysine
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being in closer proximity to the aspartic acid residue. Potential residues located within the 
first 257 amino acids of HSV-1 Rl are shown in Figure 4.1 (b), the residues chosen as 
potential catalytic sites are conserved in HSV-2 Rl although the spacings between the 
residues differs slightly.
Notably, insertion into amino acid 22, some 100 amino acids upstream of the nucleotide 
binding site leads to a large reduction in activity. This region of the N-terminus may either 
be catalytically or structurally important in the autophosphorylation reaction, and it is 
possible that this region may fall into or close to another potential nucleotide binding site.
In vivo latency experiments with N-terminal HSV-1 mutants will determine the 
importance of this region in the establishment, maintenance and reactivation of the 
virus in the latent life cycle. If the current model for latency used for this type of 
analysis, the mouse foot-pad model, fails to show any differences with the N-terminal 
mutants compared to the wild-type, other models (dexamethasone and hypothermia 
induced reactivation models for example) which stimulate reactivation of HSV-1 in 
ganglia before ganglia explantation may produce different results. In situ 
hybridisation experiments could be used to determine the effect of mutation in the N- 
terminal region has on the expression of viral genes during reactivation.
If, as possible, mutation of the N-terminal region fails to have an affect on virus 
latency then biochemical analysis will be needed to determine the role of this region. 
Initially the interactions of this region with cellular/viral proteins will need to be 
characterised by co-precipitation experiments to determine if there are any strong 
interactions (pull down experiments with the N-terminus coupled to a matrix is an 
alternative way to carry out this type of analysis). The identity of the protein(s) 
interacting with the N-terminus can then be identified using the yeast two hybrid 
system allowing the interacting protein cDNA to be isolated and sequenced.
Once the N-terminal region has been purified to apparent homogeneity kinetic 
analysis can be carried out. With its purification the identification of the 
autophosphorylation site and residues involved in catalysis can be determined by site- 
directed mutagenesis. Sites which could be mutated include residues located around 
amino acids 257 which appear to function normally to down regulate activity and 
also, the lysine located at amino acid 59 which may be the'actual site of phosphate 
transfer.
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H SV-1 1 4 0  ADVPTEALGGPPPPPRFTLGGGCCSCRDTRRRSAVFGGEGDPVGPAEFVS 
I I I I I I I II I I II I I I I I
H SV-2 14 2  PEPQGPQAVPPPPPPPFPWGHECCARRDAR GGAEKDVGAAESWS
HSV-1 1 9 0  DDRSSDSDSDDSEDTD SETLSHASSDVSGGATYDDALDSDSSSD
I I I I I II I I I I I I II I I I I I I I I I I I
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NH2
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I
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I
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I
H
Figure 4.1 An alternative catalytic core in HSV-1 Rl amino terminal region. Residues 
which are conserved i n protein kinases are shown in (a), residues similar to those identified in (a), with the 
exception of a glutamic acid residue located within the N-terminal domains of both HSV-1 and HSV-2 Rl 
which may be catalytically important are shown in (b)in bold. The structure of glutamic acid and aspartic 
acid is shown in (c)
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Regulation o f HSV-1 kinase activity
A region which may be important in the control of Rl autophosphorylation has been 
identified; insertions into amino acid 257 and 262 increased Rl autophosphorylation, most 
apparent in the 257 insertion mutant, and C-terminal deletion to amino acid 257 also 
produced a significant increase in autophosphorylating activity. The region identified 
which down-regulates Rl autophosphorylation maps to between amino acids 257 and 292. 
Comparison of the autophosphorylating activities of the 257 deletion mutant with that of 
the 292 deletion shows that the increased activity of 257 is due to the removal of the 
additional C-terminal amino acids. The identification of a region which acts normally to 
down-regulate autophosphorylation is not surprising, in many protein kinases a region may 
impair autophosphorylation by masking either the active site or site of phosphate transfer.. 
In the human insulin receptor (a tyrosine kinase) a region of deletion of 115 amino acids 
lead to a increased ability of this receptor to autophosphorylate (Sung et al, 1994), it has 
be postulated that this region acts tp down-regulate receptor activity in the absence of 
insulin, insulin binding promotes a conformational change in this region. In the HSV Rl 
N- terminal domain a ligand interaction may be required to stimulate autophosphorylation 
by inducing of a conformational change which then releases active sites from inhibition by 
amino acids located around 257.
The importance o f proteolytic cleavage in the Rl kinase activity
HSV-1 Rl undergoes proteolytic cleavage in infected cells, cleavage of R l occurs in the 
region between the unique N-terminus and the conserved reductase portion of the protein 
(Lankinen et al, 1989). The N-terminal region of Rl can be removed without affecting the 
in vitro reductase activity (Conner et al, 1992a). This raises the question of the 
importance of the N-terminus in the in vivo reductase activity. The reductase regions of Rl 
may act to !modulate the N-terminus kinase activity by either promoting or preventing its 
interaction with other proteins before the release of this region by proteolysis. Within the 
reductase portion of Rl there is a leucine repeat region (Chung et al, 1991), which has 
been shown to be important in Rl dimerisation (Conner et al, 1993), recently a cellular 
serine/threonine protein kinase with a leucine repeat region toward its C-terminus has been 
identified (Ing e ta l, 1994; Ezoeetal, 1994), the importance of this leucine repeat region 
in the activity or function of this cellular kinase is currently unknown. Rl dimerisation 
may modulte N-terminus autophosphorylation by preventing its interaction with other 
proteins or stimulatory ligands. Cleavage of Rl may alter N-terminal autophosphorylation, 
releasing the N-terminus and thereby promoting its interaction with its substrate(s). The 
expression of Rl at immediate early times in infection suggests that R l may be an 
important virus regulatory protein, Rl may in fact be essential in the modulation of another 
immediate early protein function, by directly or indirectly influencing the phosphorylation 
state of an immediate early gene product. Of the four immediate early proteins which are
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phosphorylated both Vmw63 and VmwllO phosphorylation has been shown to occur later 
in infection than Vmwl75 phosphorylation, which appears to be phosphorylated 
immediately after translation (Wilcox et al, 1980). Vmw63 an arginine rich protein is a 
potential candidate for phosphorylation by the N-terminal kinase in vivo: arginine rich 
polypeptides stimulate the activity of both HSV-1 (Conner et al., 1992b) and HSV-2 
Rl (section 3C.5.2). Alternatively, the substrate could be a cellular protein whose 
phosphorylation is required to modulate the functions of the immediate early proteins.
The N-terminus: its role in neurotropism
Both HSV-1 and HSV-2 Rl are expressed as immediate early virus proteins, the 
expression of Rl mRNA is not blocked by cycloheximide whereas R2 is a typical early 
virus gene, no mRNA is observed in the presence of cycloheximide (Clements et al., 
1977). The presence of Rl at immediate early times suggests that it plays a regulatory role 
as other HSV-1 immediate early gene products are known to be involved in regulation of 
virus gene expression in some way. Interestingly, consensus DNA sequences required for 
AP-1 binding have been identified within the promoter of both HSV-1 and HSV-2 Rl. 
Transient expression assays with a plasmid containing the HSV-2 Rl promoter fused to the 
CAT reporter gene showed that expression of CAT was increased by co-transfection with a 
construct expressing c-jun (the DNA binding part of the typically bipartite complex), 
further increases were observed when the c-fos (strong transactivator part of complex) was 
also co-transfected (Wymer et al., 1992). In other neurotropic viruses AP-1 elements have 
been identified in regulatory regions. In JC virus, a neurotropic virus which causes the 
demyelinating disease progressive multifocal leukoencephalopathy , AP-1 sites were 
shown to bind proteins from cell nuclear extracts; it was proposed that binding to this site 
may play a role in the control of basal expression from the promoter/enhancer (Amemiya 
et al., 1992). In addition AP-1 may be involved in enabling HCMV (a lymphotropic 
herpesvirus) to replicate in the central nervous system (seen in patients with AIDS); a 
number of AP-1 elements have been identified in the HCMV immediate early gene 1 
enhancer region (Sambucetti et al., 1989).
C-fos expression has been extensively studied in the mouse nervous system reviewed in 
(Morgan and Curran, 1991), and recently a transgeneic mouse was made in which the c-fos 
promoter was placed upstream of the lacZ open reading frame (Smeyne et al, 1992). 
Levels of c-fos were dramatically increased in the nervous system following treatment of 
these mice with various stimuli including the convulsants. Natural stimuli such as light 
promoted c-fos expression in localised regions of the brain, ganglia and retina (Smeyne et 
al., 1992). C -fos is increased within trigeminal ganglia after explantation (Sharp et al, 
1989). It is possible that upon neuronal damage or stimulation that HSV Rl is expressed. 
The immediate early polypeptide VmwllO contains within its intron several AP-1 sites
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(Hayward, 1993), it is also possible that this intron functions as an enhancer region and 
VmwllO expression may be stimulated by c-fos and c-jun induction in the neuron. 
Together VmwllO and Rl may be important in the modulation of cellular proteins which 
in promote the expression of other virus genes. HSV-1 mutants in Vmwl 10 show only an 
impaired ability to reactivate from latency (Clements and Stow, 1989), VmwllO is still 
believed to be important in efficient reactivation. C-fos and c-jun stimulation occurs when 
a cell is about to enter apoptosis, it seems plausible that if a neuron is undergoing apoptosis 
that the Rl and VmwllO expression may allow a more efficient reactivation in this 
particular situation.
A mechanism by which HSV-1 Rl may act to modulate gene expression has recently 
become apparent; Smith et al, 1994 have demonstrated that HSV-2 Rl interacts with 
protein which controls the turnover of GTP by the cellular protein p21ras. The GTPase 
activating protein, GAP120 is co-precipitated with Rl from cell lines expressing HSV-2 
R l. In the presence of Rl GAP 120 phosphorylation is stimulated, the phosphorylation of 
GAP 120 prevents it interacting with and inactivating p21ras. The interaction between 
HSV-2 Rl and GAP 120 is a function of the N-terminal domain, deletion part of the N- 
terminal region prevents this Rl interaction. Increased p21ras activity has recently been 
shown to be important in the expression of all genes, its Effect on gene expression is 
thought to be mediated by preventing repression of transcription by p53 a tumor 
suppressor protein which represses transcription by its interaction with a basal transcription 
factor, the TATA binding protein (Abdellatif et al, 1994). Alternatively this interaction 
may be a way in which the HSV-1 and HSV-2 Rl N-terminal regions differ.
There are many aspects of both the maintenance and reactivation stages of the latent state 
which may ultimately be controlled by the phosphorylation state of certain proteins. With 
very little current knowledge of the exact steps or phases which switch the virus into the 
lytic cycle it is difficult to speculate how the N-terminal region may be important.
Future work
The exact role of the N-terminal region will be determined by the construction of a deletion 
mutant in which only the N-terminus of reductase has been deleted, the construction of this 
mutant is currently underway. The exact effect of this mutation on virus replication will 
hopefully help to provide an explanation for the simplex specificty of this region. Further
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mutants can then be constructed using the mutations isolated which up-regulate and down 
regulate activity in vitro.
The stable deletion isolated which has increased activity is a particularly good candidate 
for future structural studies, which in turn will provide valuable insights into potential 
catalytic residues.
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